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1.1 The Hygiene hypothesis in allergy and asthma development 
Based on epidemiological data, in latest ‘80s Strachan proposed the Hygiene
Hypothesis. He suggested that infections and unhygienic contact with older 
siblings of trough other exposures show protection from the development of 
allergic illnesses. This has evolved in various ways exploring the role of viral and 
bacterial infections, the impact of environmental exposure to bio-allergens such 
as microbes and their compounds, their effects on underlying responses of our 
innate and adaptive immunity. The relationship between a host's immune 
response, characteristics of the invading microorganism, the interactions 
between a genetic background and a range of exposures become more evident. 
All these could bring together to the clinical presentation of a complex disease 
so-called asthma and allergic illnesses (von Mutius, 2007). Allergic diseases are 
inflammatory disorders that develop on the basis of complex gene-environment 
interactions. The prevalence of allergies is progressively increasing and seems to 
be associated with modern lifestyle. Moreover, it was hypothesized that high 
living standards and hygienic conditions are correlated with an increased risk for 
the development of an allergic disease. The Hygiene hypothesis states that due 
to reduced exposure to microbial components, the proposed allergy-preventing 
potential of these factors is no more present in sufficient qualities and/or 
quantities, which leads to an imbalance of the immune system with a tendency to 
the development of allergic diseases. Meanwhile, numerous epidemiological 
studies are sustaining this theory, generating cellular and molecular designs for 
the underlying mechanisms that were then followed up by use of well-defined 
animal models for studying human allergies, which include changes in the 
balancing of T helper cell 1 (TH1), T helper cell 2 (TH2) and regulatory T cell (Treg)
responses triggered by altered or missing innate immune cell activation. 
Consequently, a proper activation of cells of the innate immune system via their 
pattern recognition receptors (PRRs) has been demonstrated to play a crucial 
role in early determining of immune system and suppression of the development 
of TH2-driven allergic immune responses. These processes start already in utero
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and prenatal as well as early postnatal developmental stages seem to represent 
a window of opportunity for allergy-preventing environmental influences (Garn, 
2007). Nevertheless, asthma, atopic dermatitis and atopic rhinoconjunctivities are 
three distinct conditions, which are characterized by inflammatory processes, 
with CD4+T helper (TH)-cell responses of the TH2-cell phenotype. Cytokines that 
are secreted by TH2 cells such as interleukins: IL-4, IL-5, IL-9 and IL-13, are 
important mediators of asthmatic and allergic inflammation, characterized by 
increased specific immunoglobulin E (IgE), mast-cell degranulation and 
eosinophil-mediated inflammation - against common, ubiquitous bio-allergens 
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Tab.1.1a IgE-mediated reactions to extrinsic antigens. The symptoms experienced by the 
patient can be very different depending on whether the allergen is injected, inhaled or eaten, and 
depending also on the dose of the allergen (according to: Janeway jr. 2006. Immunobiology - the 
immune system in health and disease, Handbook 6th Edition). 
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Once sensitized, re-exposure to allergen induces an inflammatory reaction of the 
affected organ - the bronchial system, the nasal and ocular mucosa, or the skin. 
In the airways of individuals with acute asthma diagnosis, this inflammatory 
response results in airway-narrowing because of mucosal edema, smooth-
muscle constriction, mucus hypersecretion and epithelial-cell detaching process, 
whilst chronic inflammation - chronic asthma diagnosis - might lead to permanent 
structural changes, such as smooth-muscle hypertrophy and subepithelial 
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Fig.1.1 Immunological pathways present in asthmatic airway-epithelium. Asthma is 
characterized by inflammatory processes with CD4+T responses of the T 2-cell phenotype. TH H2 – 
type cytokines, important mediators of asthmatic and allergic inflammation such as IL-4, IL-5, IL-
9, IL-13 induce increasing of immunoglobulin E (IgE) level, eosinophilic cell number, respective 
mast-cell degranulation (according to: Devereux, 2006. The increase in prevalence of asthma and 
allergy: food for thought. Nature Reviews Immunology, 6: 869-874) 
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At present, atopic disease are the most common chronic illnesses in children 
living in the industrialized world. In general, asthma and atopy rates are higher in 
western countries with a high degree of industrialization than in developing 
countries with a large rural population (Kabesch, 2004). Living conditions on 
farms differ in many ways from those of other families: more pets, larger family 































































Tab.1.1b Mammalian toll-like receptor ligands with known signaling pathways utilized by 
each receptor and their functional significance in asthma (according to: Eisenbarth, 2004. 
Understanding asthma pathogenesis: linking innate and adaptive immunity. Cur.Opinion in 
Pediatrics, 16: 659-666) 
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Therefore, the exposure to certain immune-modulators specific for farm life may 
prevent the occurrence of these conditions. Frequent contact with live stock is 
further associated with the protective effect of farm life. A dose-response 
relationship between exposure to farm animals and the prevalence of atopic 
disease was reported among farmer's children in Bavaria (Von Ehrenstein, 
2000). More insights with regard to assumed microbial components responsible 
for the allergo-protective effects came again from the farming studies suggesting 
that lipopolysaccharide (LPS), a Gram- bacterial membrane component might be 
one of these factors. The Allergy and Endotoxin Study (ALEX Study) shown that 
endotoxin concentration was highest in stables from farmer families and farmer 
house holds contain much more endotoxin that non-farmer environments. 
Indeed, it has become evident that immune responses against all those allergens 
are initiated by Toll-like receptors (TLR) signals that recognize a variety of 
structures derived from all kind of microorganisms (Tab.1.1b)(Bauer, 2007). 
1.2 Prenatal physiological determinants and allergy development
Pregnancy – a complex interaction between genetic, anatomic, endocrine, 
immune and neurological systems is a delicate balance of hormonal and 
immunological functions, almost certainly affected by environmental factors. The 
influence of the environment and other exogenous agents on mechanism of 
pregnancy plays an important role in the development of fetal and newborn 
immunity, and allergic diseases later in life. Increasing evidence suggests that 
prenatal and early postnatal environmental determinants play an important role in 
the development of allergy and asthma. Tolerance programming starts in early 
life, even before birth. Indeed, the presence of allergen specific T cells has been 
demonstrated in humans at the time of birth suggesting that specific immune 
responses are develop in utero (Prescott, 1999; Szepfalusi, 1997). 
Prenatal events - have the capacity to contribute to airway inflammation on two 
broad levels: (i) through effects on the development airway structure and 
function, and (ii) by immune effects that may alter the risk of subsequent allergic 
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sensitization. The growth and development of the airway in utero appears to be 
an important determining factor in infant’s lung function. Children with 
undeveloped airways are more likely to have milder respiratory tract symptoms 
with viral infections such as Respiratory Syncytial Virus (RSV) (Prescott, 2006; 
Martinez, 1995; Openshaw, 2003). Although, fetal immune responses are 
typically skewed towards TH2 in pregnancy (Prescott, 1998), a number of subtle 
differences have been found in neonates who go on to develop allergic disease 
(Prescott, 2003) and even if this was thought to be genetically programmed, 
there is now evidence that in utero exposures can influence fetal immune 
function. Maturation of the fetal immune system occurs primarily during the first 
two trimesters of pregnancy. The development of clinical tolerance continues 
after birth and the first two years of life seems to be particularly important 
(Prescott, 1998). Moreover, transplacental allergen transfer has been 
demonstrated in animals and humans (Holloway, 2000). The intrauterine allergen 
exposure may happen both, via transfer of allergens in the amniotic fluid - across 
fetal membranes and via different crossways of placental tissues. However, so 
far is not clear: (i) whether transplacental allergen transfer happens in general, 
(ii) at what stage of pregnancy it occurs predominantly and (iii) which transfer 
mechanism illustrates better the transplacental allergen passage (Loibichler, 
2002). Nevertheless, the placental barrier plays an active role in the decision of 
whether an antigen crosses the placenta or not. In that way, the transplacental 
transfer of allergens may be part of a mechanism protecting the fetus. Before 
birth, professional antigen-presenting cells (APCs) in the peripheral blood, 
dendritic cells (DCs) are not equipped with a mature set of costimulatory 
molecules enabling them to present professionally antigen to circulating antigen-
specific T cells. Such stimulation of T cells would lead to tolerance induction to 
those antigens encountered before birth (Szepfalusi, 2000; Szepfalusi, Loibichler, 
2000). Physiological data indicate that, there are two pathways for allergen 
transfer across human placenta: transcellular and paracellular pathways (Sibley, 
1988; Schneider, 1991). The two cell layers forming the exchange barrier are the 
fetal endothelium and the syncytiotrophoblast. Contrary to the endothelium, the
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syncytium has no lateral cell membranes forming an intercellular space (Leach, 
1992). However, the continuous structure of the syncytiotrophoblast is interrupted 
by degeneration. The gap is immediately filled by fibrinoid account for 
approximately 7% of the villous surface of the normal human term placenta 
(Nelson, 1990). Recently, the permeability for macromolecules trough the 
syncytiotrophoblast discontinuities on placental villi has been reported for 
horseradish peroxidase (HRP) and alfafetoprotein ( -FP) both with molecular 
weight of 40kDa (Edwards, 1993; Brownbill, 1995). Alternatively, the syncytium 
can be passed transcellularly. It is well known that, immunoglobuline G (IgG) 
crosses the placenta via the neonatal Fc receptor FcRn expressed on 
syncytiotrophoblast and endothelial cells (Saji, 1999; Leach, 1996; Simister, 
1996) from early gestation, becoming maximal in the last week of pregnancy 
(Malek, 1996).  The newborn has initial antibody levels comparable to those of 
the mother, because of the transplacental transport of maternal IgG. As the 
transferred IgG is catabolized, antibody levels gradually decrease until the baby 
himself begins to produce necessary amounts of IgG at about 6 months of age. 
Thus, IgG levels are quite low between the ages of 3 months and 1 year when 
active IgG antibody responses are poor. In some infants this can lead to a period 
of increased susceptibility to infection (Fig.1.2). Besides, lack of immunoglobulin 
A (IgA) can be associated with the predisposition to lung infections with various 
pathogens and is consistent with the role of IgA in defense at the body's surface. 
Based on those findings, we believe that controlled maternal allergen exposure 
could actively induce allergen-specific tolerance in the fetus. Potentially allergens 
encountered by the mother induce the transamniotic transfer of maternal IgE, 
such as gut-associated IgE receptor-mediated antigen, and consequently the 
allergic sensitization (Jones, 1999). Despite high molecular weights (MW> 500 
kDa) of the other studied allergens it could be speculated that 
transplacentalallergen transfer mainly occurs by a paracellular route (Tab. 1.2). 
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Fig.1.2 Immunoglobulin levels in newborn infants fall to low levels at about 6 months of 
age. Human babies are born with high levels of IgG, which is actively transported across the 
placenta from the mother during gestation. After birth, the production of IgA and IgM starts almost 
immediately, but the IgG levels delay between the ages of 3 - 9 months to 1 year of age can 
leadto susceptibility to allergic disease (according to: Janeway, CA. jr., 2006. Immunobiology - 
the immune system in health and disease, Handbook the 6th Edition). 
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Tab.1.2 The immunoglobulin isotypes. There is evidence that exposure to allergen complexes 
with the active transport of IgG across the placenta mostly in the third trimester of pregnancy 
(according to: Janeway jr., 2006. Immunobiology - the immune system in health and disease, 
Handbook the 6th Edition). 
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In early postnatal period, environmental exposure plays a crucial role in driving 
immune maturation, which appears to depend on exogenous factors (microbial 
exposure) to develop normally. The pattern of environmental antigen exposure 
determines the specificity of responses required for host defense and local 
conditions during antigen-processing in local tissue appear to influence the 
patterns of immune maturation and resulting immune responses. Local 
encounters with noxious environmental factors, including irritants and respiratory 
pathogens, are likely to influence the development of immune networks in the 
airways and the propensity for chronic inflammation. In other words, it is now well 
recognized that natural exposure to microbes through mucosal surfaces in the 
gastrointestinal tract, respiratory tract and skin are critical for the development of 
clinical tolerance. As is mentioned, all these observations are directly linked to 
the Hygiene hypothesis which states that exposure to microbial agents play an 
important role in immunoprotection. Indeed, microbes are now viewed as 
important immunoregulators in addition to their role as pathogens (Renz, 2002).
In conclusion, maternal and fetal allergen exposure is a common phenomenon, 
which challenges the conventional opinion that the unborn should be protected 
from pathogenic allergens but, the presence of allergens per se in fetal 
circulation may in fact be part of the normal development of immunity (Loibichler, 
2002). As pregnancy is a TH2 - biased phenomenon, but allergy is characterized 
by a TH2 dominance too, the required postnatal TH1 immunity development could 
be influenced by the pregnancy TH1/TH2 immune balance through antigen 
specific exposure, dose- and time-depending (Raghupathy, 1997; Wegmann., 
1993).
1.2.1 Immunological factors 
The immunological interaction between mother and the fetus remains a scientific 
mystery. In normal pregnancies, the maternal immune system does not react to 
spermatozoa or the embryo, even though they express antigens that are 
exogenous to the maternal system. Maternal-fetal tolerance has been compared 
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to that of the semi-allogenic fetal graft and may be the result of a complex array 
of mechanisms, including: HLA-G expression of trophoblast, the leukemia 
inhibitory factor (LIF) and its receptor (LIFR), the indoleamine 2, 3-dioxigenase 
(IDO), the TH1/TH2 balance, suppressive macrophages, hormones such 
progesterone (P), placental growth hormone (PGH), CD95 and its ligant, and 
annexin II), definitively are pregnancy-specific and interconnected (Thellin, 2003; 
Thellin, 2000). Immune responses can be triggered by a variety of endogenous 
and exogenous factors, as well as the production of anti-paternal antibodies, 
autoimmune disorders leading to the production of autoimmune antibodies (anti-
phospholipid antibodies, anti-nuclear antibodies, and polyclonal B cell activation), 
infections, stress, and toxic agents (Thellin, 2003; Giacomucci, 1994).
1.2.2 Endocrine factors 
Progesterone is one of the two main hormones (the other one being estrogen) 
produced each month by the ovaries of menstruating women (being produced in 
smaller amounts by the adrenals). It is the major female reproductive hormone 
during the later two weeks of the menstrual cycle, made by the corpus luteum of 
the ovary. It is normal for the levels of progesterone to rise and fall during the 
monthly cycle. Progesterone production starts just before ovulation each month 
and increases rapidly after ovulation. It prepares the lining of the uterus for the 
fertilized egg and maintains pregnancy. The name itself tells the story: 
progesterone = promotes gestation hormone. It acts on the reproductive tract in 
preparation for the initiation and maintenance of pregnancy by inhibiting 
contraction of the uterus and the development of new follicles (Niswender, 2000). 
Follow oocyte fertilization the developing embryo secrets human chorionic 
gonadotropin hormone (hCGH) which sustains progesterone levels. During 
pregnancy, fetoplacental estrogen, progesterone and adrenocorticoid hormones 
are secreted into both fetal and maternal circulation (Gabbe, 2002). It is 
produced by the placenta as well during pregnancy and in small amounts by the 
adrenal cortex. Moreover, progesterone maintains a normal menstrual cycle and 
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plays an important role during pregnancy by preparing the tissues lining the 
uterus for implantation by the fertilized egg. It helps prepare the breasts for milk 
production. For mothers, progesterone plays a protective role in preventing some 
chronically diseases such as breast- and uterine cancer. It also stimulates normal 
bone growth and thyroid function. It has many opposite, balancing activities to 
those of estrogen. In addition to normalizing blood sugar levels and water 
metabolism, progesterone has in general a calming effect on the central nervous 
system too. Estrogen production is mainly under the control of the fetus and is 
primary signal by which the fetus directs essential physiologic processes that 
affect fetal well-being. By 20th week of pregnancy, approximately 90% of 
maternal estriol excretion can be accounted for by dehydroepiandrosterone 
sulphate (DHEA-S) production by the fetal adrenal gland. Estrogen affect 
progesterone production, uterine blood flow, mammary gland development and 
fetal adrenal gland function (Speroff, 1999).  
1.2.3 Physical and chemical agents 
Immunotoxicity may occur when the immune system acts as a passive target to 
chemicals or it responds to the antigenic properties of a chemical as part of a 
specific immune response (Damstra, 2002). Toxic substances that alter 
metabolism or vascularization can disturb placental development and thus 
impeding or blocking mechanisms of tolerance and protection, and increase the 
chance of fetal rejection (Thellin, 2003).
1.3 Fetal development of innate and adaptive immunity
1.3.1 The implantation window
Implantation is different from the established pregnancy in that it involves 
intensive tissue remodeling to create a new foeto-maternal organ, placenta.
Thus, de novo created new organ evolving from trophoectoderm derived from the 
invasive ectoplacental cone to create the differentiated placenta (Chaouat, 2006).
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The uterus and the blastocyst must be synchronized to allow suitable 
implantation and development. Synchronization results from the adjustment of 
the blastocyst development and the status of the endometrial receptivity. In the 
majority of species, the implantation takes about 1-2 days and if asynchrony 
exceeds, this interval of time implantation is severely impaired. However, the 
uterus must be ahead of the embryo in terms of cycle status. The embryo is able 
to adapt to a poorly synchronized uterine environment by arresting its 
development. An extreme example of that blastocyst capacity is given by species 
presenting delayed implantation. The uterine differentiation is less flexible and 





Pre-receptive phase Receptive phase Refractory phase
Beginning of the 
Implantation Window
End of the 
Implantation Window
Fig.1.3.1 Schematic illustration of the implantation window – pre-receptive, receptive and 
refractory phases occur in pregnant uterus during implantation (according to: Chavatte-Palmer P. 
and Guillomot M., 2006. Comparative implantation and placentation, Embryo implantation: from 
basic to clinics. Handbook of 1st EMBIC Summer School)
During the pre-receptive and receptive phases the embryonic development is 
sustained by a favorable uterine environment, whereas at the refractory phase, 
the uterine environment becomes hostile for the embryo. Perhaps, the uterine 
refractory status depends on the synthesis and secretion of embryotoxic factors 
in the uterine environment. The timing range of the implantation window is 
species specific. It needs that the uterus undergoes specific tissue remodeling, a 
process which is characterized by four important events: (i) decidualisation, 
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which involves an important change of the uterine stroma and uterine adhesion 
molecules; (ii) transformation of the uterine arteries into functional spiral arteries; 
(iii) several cellular fluxes; (iv) transient secretion of inflammatory cytokines. 
Thus, the implantation process initiates when embryos at the blastocyst stage 
breach the uterine epithelial cell layer, endometrium, creating the beginning of 
the intimate interactions between the zygote and maternal systems. At this time, 
the pregnant uterus undergoes a radical structural transformation. 
Decidualization, the proliferation and differentiation of uterine stromal cells, 
increases the thickness of the uterine wall by approximately five fold. Endometrial 
stromal cells, at the site of implantation begin to differentiate into primary 
decidual cells. Cells that are more distal to the implantation site differentiate into 
secondary decidual cells (Theiler, 1972; Theiler, 1983). This differentiation and 
reorganization of cells allows the placenta to be positioned in the mesometrial 
decidua (Hunt, 1997). Uterine NK (uNKs) cells traffic to the site of implantation, 
proliferate immediately and become mesometrial localized. Here uNK cells form 
a lymphocyte-rich structure known as the metrial gland or mesometrial lymphoid 
aggregate of pregnancy (Adamson, 2002; Ashkar, 2000). They are a major 
source of interferone gamma (IFN ) (Platt, 1998; Saito, 1993), which plays a key 
role in early pregnancy, inducing decidual artery remodeling (Ashkar, 2000). IFN
has been shown to regulate 2-macroglobulin, a regulator of proteases and 
cytokines produced from the mesometrial decidua that are important for 
successful pregnancies. But, a vast subpopulation of NKT cells has been 
observed in the peri-implantation uterus. These cells express the NK marker 
NK1.1 and are V 14+ - - and CD4 /CD8 . In mice, these cells are generally restricted 
by the non-classical MHC molecule CD1d, express TCR  chains with invariant 
usage of V 14 and J 281 genes, and recognize a variety of non-mammalian 
glycolipids, like -galactosylceramide ( -GalCer), (Matsuda, 2001). V 14 NKT 
cells are suspected to react with an unidentified fetal antigen that appears to 
regulate their expansion (Dang, 2001). Neutrophils are almost exclusively limited 
to the leading edge of enzymatic digestion. At this site they are likely involved in 
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phagocytosis of cellular waste from decidual cells killed by invading trophoblasts 
(Parr, 1990). 
1.3.2 Adhesion - Embryo division and maturation 
To implant, the embryo itself has to undergo several stages: the initial divisions 
first depends on the expression of Organic Cation Transporter 3 transcription 
factor (OcT3), expressed in germ cells, blastomers until morula stages, and later 
divisions are controlled by the mitosis promotion factor, an heterodimer of the 
phosphor protein cell division cycle 2 (CdC2) and cyclin B. After a variable period 
of time in the uterine horn, the free floating embryo positions itself near the 
uterine epithelium (apposition stage) and then adheres by both mechanical and  
chemical junctions or bonds. The first steps of this process are very similar to the 
ones seen in the rolling and adhesion events seen when a lymphocyte homes or 
adheres to a vessel. In this process, an important role is played by a series of 
complementary adhesion molecules, such as E cadherins and integrines. Early 
human blastocysts express 1 and 5 integrin subunits, E cadherin and zonula
occludens 1 protein (ZO-1). In both cases of adhesion of a lymphocyte to the 
endothelial wall and of adhesion of the embryo, a key role is played by L-selectin, 
and antibodies to L-selectin do block implantation, (Genbacev, 2003). The 
expression of adhesion molecules is similar to an inflammation process, with high 
local expression of such inflammatory molecules as interleukin 1 (IL-1), colony- 
stimulating factor 1 (CSF-1), interferone gamma (IFN ) and tumor necrosis factor 
alfa (TNF ). In variance with what is seen in established pregnancy, several of 
these inflammatory cytokines are necessary for successful implantation. The IL-1 
system has been implied by C.Simon et al. as mandatory, since IL-1 RA injection 
was claimed to prevent implantation (Simon, 1997). Two cytokines seem very 
important: IL-11, which plays a role in the formation of the decidual tissue at 
implantation site. IL-11R KO mice are sterile (Bilinski, 1998) and in human a 
subset of sterile women have too low uterine IL-11 production. LIF was the first 
cytokine shown by KO to be obligatory for implantation: LIF KO mice do not 
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implant, even in case of transfer of LIF+ producing embryos and this defect is 
corrected by maternal infusion with recombinant LIF (Stewart, 1992). In human, 
too low level of LIF induce sterility (Delage, 1995; Laird, 1997), but too high level 
seems to reflect a chronic TH1 - like syndrome, and thus also correlates with 
sterility. Another important cytokine at that stage is indeed CSF-1, which acts as 
a uterine growth factor for trophoectoderm and later on differentiated 
trophoblasts (Bartocci, 1986).
1.3.3 Embryo – the wonder graft?
After adhesion, embryo becomes a graft. Before adhesion he required the 
hatching from the zona pellucida, and prepared by embryonic signals. Until 
hatching, the zona pellucida has protected the embryo from immune attack and 
immune recognition. Adhesion and invasion will confront the outer layers of the 
embryo with the maternal immune system. At this stage, a broad and increasing 
number of uNK cells occur, but relatively few local T cells and most of the 
macrophages which were present in the early steps have been missing from the 
future decidua basalis, a phenomenon termed by Robert Fauve immuno – 
repulsion. The few T cells which remain are mostly but not exclusively, T cells. 
That the T cells do recognize the foetus is exemplified by the fact that maternal 
antipaternal alloantibodies are detectable in pregnant women (Bell, 1983). To 
minimize any risk of pregnancy, the placenta has a selective and programmed 
expression of major histocompatibility complex (MHC) antigens. In mammals, 
there never is expression of MHC class II antigens on placenta (in mice cause 
abortion and implantation failure). There is expression in rodents of polymorphic 
MHC antigents (H-2 K, D and L in mice) on the outer layers of the placenta, the 
spongiotrophoblast (Zuckermann, 1986). The human placenta seems to evolve 
towards a polymorphic MHC negative barrier, the villous syncytiotrophoblast 
being MHC - class I negative at least as far as membrane expression is 
concerned, whereas the so-called extravillous trophoblast has lost expression of 
HLA-A and HLA-B, but maintains expression of HLA-C (King, 2000; Le Boutellier, 
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2000). From immunological point of view there are many threats to well 
development of pregnancy, such as alloantibodies, complement system, CD8+T
cells or NKs. In fact, there is a specific protection to counter it is exemplified by 
data from Xu et al., where KO mice for complement receptor 1-related 
gene/protein y (CRRY) results in early peri-implantation fetal destruction in both 
syngeneic and allogeneic breeding (Xu, 2000). The equivalent protection in 
human and mice is offered by membrane cofactor protein (MCP) and decay 
accelerating factor (DAF), and it is probable the cause, that a part of early 
embryonic losses in human are related to lack of expression of such factors. The 
role of complement, once its cytotoxic effects regulated the placental growth. 
Another risk results from activated CD4+T cells, which induce the neutralization 
activity of indoleamine 2, 3-dioxigenase (IDO), that causes abortion in allogeneic 
but not syngeneic pregnancy (Mellor, 2004). IDO might be also involved in the 
generation of paternal antigen specific T suppressor cells and Tregs which have 
been implied in the success of pregnancy (Chaouat, 1980; Aluvihare, 2005). The 
most important risk to the fetus is caused by NKs. Also, there is obviously that 
up-regulation of NK cytotoxic activity induces implantation failure or early 
pregnancy loss by CD8+ differentiated cytotoxic T cells in mice, too (Baines, 
1993). It is important to mention that NK cells are continuously inhibited in 
physiological conditions by inhibitory killer Ig-like receptors (iKIRs) binding to self 
MHC. The absence of the proper self MHC at membrane surface of a cell 
prevents such a binding, diminishing the inhibition process, and lysing the target 
cell. But the cells also display an array of activator KIRs receptors and ligation of 
these by MHC class I molecules induces the secretion of cytokines (Lanier, 2005; 
Parham, 2004; Dietl, 2006). A significant role is also played by decidual dendritic 
cells (DCs). Some of their cytokines are required for successful pregnancy 
(Genbacev, 2003). 
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1.3.4 The invasion process accompanied by uterine modifications 
The invasion process represents the first step towards the establishment of what 
Peter Medawar in 1953 defined as the Nature's allograft, where a minimal 
immunosuppression is needed. The invasion process involves penetration of the 
stroma after degradation of extracellular stromal matrix. Invasion requires a 
balance of adhesion molecules and under hormonal condition of embryonic 
matrix metalloproteases (MMPs) and tissue inhibitors of MMP (TIMPs), with a net 
balance in favor of proteases, such as: MMP above TIMPs and urokinase
plasminogen activator (uPA) above plasminogen activator inhibitor-2 
(placental PAI-2). In fact, LIF is very important in the initiation of implantation by 
activation both proteases and protease inhibitors, but the final net balance is in 
favor of proteases. In general, these molecules are themselves under the up- 
and down-regulation inflammatory and anti-inflammatory cytokines, which exert 
opposite effects. IL-1  activates MMPs, inhibits TIMPs, whereas TGF-  down 
regulates it. TGF-  is found in great amount in the decidua basalis. 
Consequently, the embryo promotes its invasion, whereas the uterus resist to it. 
However, the blastocyst implantation implies profound changes of the 
endometrium, which will favor adhesion of the trophoblast and limit it to the 
proper location in the uterus. Major cellular changes of the endometrium involve 
both the luminal epithelium and the stroma. In rodents and human the epithelial 
cells transform as bulbous structures named pinopodes during the luteal phase 
of the cycle which corresponds to the implantation window (Given, 1989; Nikas, 
1999). In rodents, the transformation may be associated with reabsorption 
(endocytosis) of the luminal fluid by the epithelial cells. The stromal response to 
implantation is diversely pronounced according to species but in most species, 
inflammatory manifestations are observed such as an edema associated with 
increased of capillary permeability and vasculogenesis. The most pronounced 
stromal transformation is the decidual reaction observed in species with invasive 
implantation. The decidualisation is complete in rodents and primates. In rodents, 
the decidual reaction is localized to the implantation site, whereas in higher 
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primates or human, the whole endometrium is affected. In these species, a 
similar reaction is observed at the end of the cycle and is followed by the 
menses. From the cytological aspect, it is an epithelial differentiation of the 
stromal fibroblasts associated with a proliferation and polyploidy. The decidual 
reaction is triggered by the blastocyst at time of implantation. Uterine 
decidualisation can be induced by various inflammatory stimuli: physical 
(trauma), chemical (CO ), and physiological (prostaglandins PGF -2 and PGE2 2,
histamine, platelet-activating factor PAF). But all the other factors are effective on 
ovarian steroids, estradiol (E ) and progesterone (P ), where the ratio E /P2 4 2 4 in 
pregnant endometrium became optimal only with an intact luminal epithelium. 
The decidual cells produce glycogen, alkaline phosphatase (AP), -Actin,
prolactin and growth factors such as transforming growth factor -alfa and –beta 
(TGF-  and TGF- ), insuline like-growth factor (IGF) and insuline like-growth 
factor binding protein-1 (IGF-BP-1), tumor necrosis factor-alfa (TNF- ),
granulocyte-macrophage colony-stimulating factor (GMC-SF), which play a role 
in trophoblast growth and differentiation. 
1.3.5 Hormonal influence upon pregnancy cytokine pattern 
Possible candidates include the measurement of various molecules involved in 
implantation, sampled by uterine flushing or endometrial biopsy. Mediators like 
as metalloproteases, integrins and cytokines have been successfully quantified. 
Cytokines are among the most of those mediators. In all aspects, a common 
sequence of hormonal impregnation is needed for preparation of the 
endometrium in implantation. Ovarian steroids, estradiol (E2) and progesterone 
(P4) produced during the oestrous cycle are the main factors which control the 
endometrial receptivity. The pre-ovulatory surge of E2 acts on proliferation and 
differentiation of the uterine cells. Progesterone stimulates the synthesis of 
uterine secretions which sustain the embryonic development until it implants, but 
progesterone receptors disappear from uterine epithelium just prior to 
implantation in most species (Spencer, 2004). According to the species at time of 
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implantation, E2 stimulation is necessary in rodents but not in human. Various 
paracrine factors like histamine, platelet activating factor (PAF), prostaglandins 
and pro-inflammatory cytokines such as colony stimulating factor-1 (CSF-1), 
interleukins (IL-1, IL-2, IL-3, IL-11), transforming growth factor beta (TGF- ) and 
leukemia inhibitory factor (LIF) are produced by the receptive endometrium 
under the control of P  and/or E4 2 (Carson, 2000). Receptors of these cytokines 
have been found on the blastocyst. Thus it is likely that implantation is under the 
control of complex exchanges between the uterus and the embryo, but most of 
these mechanisms remain to be determined. Also, the steroid hormones may 
initiate a downstream cascade of molecular events through local paracrine/ 
autocrine molecules. The attention is focused on cytokines that have been 
documented in KO mice model as essential for the implantation process.
In 1992, Stewart et al. demonstrated the absolute necessity of leukemia inhibitory 
factor (LIF) in murine implantation by monitoring the reproductive performance of 
LIF KO mice (Stewart, 1992). The implantation blockade observed in LIF-mice 
could be partly corrected by an intra-peritoneal administration of recombinant 
murine LIF (Chen, 1995). LIF protein and mRNA are present in the human 
endometrium throughout the cycle but increase significantly during the luteal 
phase (Vogiagis, 1996; Arici, 1995; Charnock-Jones, 1994). The human 
endometrium epithelial cells express mRNA for LIF receptor components as well 
as the blastocyst itself (Cullinan, 1996; Chen, 2000). Those findings suggest that 
LIF plays an important role in the embryo-endometrium communication (Haines, 
2000). The presence of other cytokines was detected in human endometrium 
such as CSF-1, TNF or IFN families, IL-11, IL-8 and the remarkable CD56+ cells
so-called uterine natural killer cells (uNKs). 
Many observations suggest that pregnancy is associated with an altered TH1/TH2
balance and thus, normal pregnancy is characterized by a TH2-biased cytokines 
balance at the periphery. Also, immunoglobulin synthesis in pregnant women is 
increased (Myers, 1985), whereas cell-mediated responses are decreased 
(Santoli, 1976). The incidence of viral infections (Pickard, 1968) and tumors 
(Gleicher, 1979) is higher in pregnant women than in non-pregnant individuals. 
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Cytokines relevant to pregnancy may be generally divided into two categories, 
some of them being harmful for pregnancy by increasing cell-mediated immunity 
(TH1 type cytokines) and others exerting a beneficial effect by inhibiting strong 
cellular responses (TH2 type cytokines). The ratio of TH1/TH2 type cytokines is 
significantly higher in supernatants of decidual cells, than in those peripheral 
lymphocytes (Wegmann, 1993). Low doses of GM-CSF, IL-3 or anti-TNF
reduce resorbtion rates in a murine abortion model (Chaouat, 1989), whereas
administration of TNF- , IFN-  or IL-2 to normal pregnant mice causes abortions 
(Parant, 1990). But, the picture is more complex at the feto-maternal interface, 
where cytokines are not constantly secreted by immune cells (Chaouat, 2004).
Inflammatory cytokines like LIF are needed for implantation, whereas IFN-  is 
needed at low quantity for vascular development and transformation of uterine 
spiral arteries. The production of these cytokines is influenced exclusively by 
hormonal environment. LIF production (essential for embryo implantation) is up-
regulated by IL-4 and progesterone, and is down-regulated by IL-2, IFN-  and 
IFN- (Piccinni, 1998). Antigen-specific T cell clones derived in the presence of 
progesterone, exhibit significantly increased ability to produce IL-4 and IL-5 in 
comparison with T cell lines derived in absence of progesterone, and antigen-
specific T cell lines generated in the presence of P developed into T cell clones 
showing a TH0 instead of TH1-like cytokine profile (Piccinni, 1995). In vitro PIBF 
treatment of activated lymphocytes favors the production of TH2 type of cytokines 
(Par‚ 2000). Joachim et al., detected reduced PIBF concentrations, together with 
increased resorbtion rates where corrected by treating the animals with 
progesterone, and this was accompanied by a significantly increased decidual IL-
4 production. Signal-transducing activators of transcription (STAT) such proteins 
like STAT6 and STAT4 specifically mediate signals from IL-4 and IL-12 
receptors, respectively (Nelms, 1999). PIBF induces phosphorylation as well as 
nuclear translocation of STAT6, and exerts a negative effect on STAT4 
phosphorylation. Thus, during normal pregnancy the PIBF demonstrated 
immunomodulatory efects of PIBF, mediated via altered cytokine production of 
the lymphocytes. Furthermore, the altered TH1/TH2 balance observed in pregnant 
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individuals might be attributable to the described effect of PIBF. The fetal-
placental unit is a semi-allograft because of the paternal genetic contribution. 
Subsequently, there is a maternal immune response to the allogeneic pregnancy. 
The constituents of the maternal immune reaction to the allogeneic stimulus are 
not different from any other immune reaction and allogeneic conceptus 
(trophoblast) is in principle like all other allogeneic tissue grafts. The immunologic 
recognition of pregnancy and the subsequent activation of the maternal immune 
system is necessary for a successful pregnancy. It results in an upregulation of 
progesterone receptors on activated lymphocytes among placenta cells and 
decidual immune cells. Accordingly, the immunological pregnancy protective 
effects of progesterone might be manifested through the subsequent mechanism: 
after recognition of fetally derived antigents, activated lymphocytes develop 
progesterone receptors. 
1.4  Comparative Placentation: Human versus Mouse 
1.4.1  Human placenta development and trophoblast differentiation 
The phenomenon of placentation passes through several phases before reaching 
its mature form found in term pregnancies, but the interfaces relevant to 
reproductive immunology and the basic structure of the placenta at term which is 
responsible for the physiological function of the placenta are completed quite 
rapidly. At the end of first trimester of pregnancy, the most important phase of 
maturation has been completed. This explains in part, the reason why invasive 
behaviour of trophoblast cells is detected mainly in the first trimester and is 
practically cancelled out at term. The primitive trophoblast (epithelial-like cell) of 
the chorion frondosum erodes the decidua, destroying glands and stroma but 
leaving the maternal arterioles and venules. These dilate to form sinusoids. The 
chorionic villi, lying in a pool of maternal blood, divide repeatedly to form complex 
tree-like structures in which branches of the umbilical vessels form vascular 
cascades closely related to the surface trophoblast epithelium. The branches of 
the original villi, themselves termed villi, are of two types (Fig.1.4.1a, b).
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The majority float freely in the maternal blood and are known as terminal villi. A 











Fig.1.4.1a Schematic illustration of the villi branches. Fetal artery and vein invade the chorionic 
epithelium of terminal and anchoring villi. They are separated from maternal blood through different 
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Fig.1.4.1b The anchoring villus intimate architecture. The inner cell layer formes 
Cytotrophoblast cell layer, while the outer cell layer the Syncytiotrohoblast cell layer (according to: 
Miller A., Cllander R., 1989. Obstetrics illustrated, Handbook, 4th Edition) 
Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany
1.  Introduction 
________________________________________________________________
     31
The trophoblastic epithelium lines the whole cavity containing the maternal blood 
in which the terminal villi are suspended. The syncytiotrophoblast possesses, 
among other properties, some of characteristics of vascular endothelium thus 
preventing the possibility of trombosis. Villi are present over the whole surface of 
the blastocyst. As the blastocyst enlarges it compresses the superficial decidua 







Fig.1.4.1c Implantation process in normal human pregnancy. Three types of decidua are 
present during pregnancy evolution: decidua capsularis, decidua vera and decidua basalis 
(according to: Miller A., Cllander R., 1989. Obstetrics illustrated, Handbook, 4th Edition) 
The compression of the decidua capsularis gradually cuts of the circulation 
through it. The result in atrophy and disappearance of the villi is in association 
with it. The surface of the blastocyst becomes smooth and this portion of the 
chorion is known as the chorion leave. At the opposite pole of the blastocyst the 
villi proliferate and enlarge and this is known as the chorion frondosum. The 
connecting stalk of the embryo is attached to the wall of the blastocyst at this 
point. Ultimately with the expansion of the blastocyst the decidua capsularis 
comes in contact with the decidua vera and the uterine cavity is obliterated 
(Fig.1.4.1d).
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Fig.1.4.1d Human fetal development. The functional placenta develops in the same time with the 
foetus, providing him an authentic comfort into uterus (according to: Miller A., Cllander R., 1989. 
Obstetrics illustrated, Handbook, 4th Edition) 
The umbilical cord has two arteries - one vein (human), and one artery - one vein 
(mouse), embedded in Wharton's jelly which is a loose myxomatous tissue of 
mesodermal origin. This jelly acts as a physical buffer and prevents twisting of the 
cord and interference with circulation (Fig.1.4.1e).
Fig.1.4.1e Development of the human umbilical cord The umbilical cord has two arteries-one 
vein in human, embedded in Wharton's jelly (according to: Miller A., Cllander R., 1989. Obstetrics 
illustrated, Handbook, 4th Edition) 
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The umbilical vessels are generally attached to the placenta near its centre. They 
immediately divide repeatedly to form branches all over the surface (disperse
placenta) or sometimes, the main vessels may extend almost to the margins of 
the placenta before dividing (magistral placenta) (Fig.1.4.1f).
Fig.1.4.1f Umbilical cord vessels dispersing human healthy term placenta - there is a short 
communicating branch between the two umbilical arteries just as they reach the placenta surface. 
This serves to equalize the pressure and flow to each half of the placenta. (according to: Miller A., 
Cllander R., 1989. Obstetrics illustrated, Handbook, 4th Edition, 1989) 
The fully formed human placenta is a disc, approximately 2.5 – 3.0 cm in 
thickness, tapering towards the edges. It weights roughly 500 g and is dark red, 
the color being due mainly to the maternal blood in the intervillous spaces. The 
functions of the placenta depend on the structure and health of the placental villi. 
These villi are bathed in maternal blood but there is not direct connection 
between fetal and maternal blood. The structures between the two circulations 
make up the so-called placental barrier (Fig.1.4.1g).
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Fig.1.4.1g Placental barrier. Human and rodents present identical placental barrier architecture 
(according to: Miller A., Cllander R., 1989. Obstetrics illustrate, Handbook, 4th Edition) 
The barrier effect is reduced in two ways. Small polyploidy extensions of the 
syncytial cytoplasm – microvilli - increase the surface for absorption, secretion 
and interchange between the two circulations. In human, as the pregnancy 
increases in size especially after the 16th week, the syncytiotrophoblast is 
reduced in thickness without alteration of its microvillous structure. The fetal 
mesoderm is reduced in amount and the vessels of the villi dilate. Thickness of 
placental barrier at 12th week is 0.025 mm, in comparison with term placenta 
0.002 mm.
1.4.2 Mouse placenta development and trophoblast differentiation
The mouse placenta is derived from multiple cell lineages being a combination of 
both fetal and maternal tissues. Trophoblasts, epithelial-like cells, derived from 
the trophoblasts lineage, invade the uterus to establish an intimate contact 
between fetus and mother (Cross, 2003). To control the maternal response to 
invasion, additional roles have been evolved in the mammalian placenta, 
including: (i) the production of hormones to adapt systemic maternal functions, 
and (ii) to provide a broad of growth factors to adjust the local uterine 
environment. But many of these functions are observed across different species 
evolution, too (Painter, 2002; Callard, 1993; Hughes, 1993; Renfree, 1993). In 
mice, twelve hours after fertilization on E0.5 (embryonic age ½ day, respectively 
12 hours after conception), a sequence of cellular divisions create a cellular 
structure like-ball of undifferentiated cells termed morula (it is assumed that 
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fertilization occurs at the mid-point of the dark cycle, usually midnight, for mice 
kept on a 12 hours light  12 hours dark cycle). By E3.5 the blastocyst forms 
between 32 - 64 cells. Two different cell types can be distinguished at this time 
point: the inner cell mass (ICM) and trophoectoderm.  The ICM consists of the 
innermost cells of the blastocyst. They are undifferentiated stem cells which give 
rise to the entire embryo proper as well as the mesenchymal (mesodermal) 
components of the placenta such as stromal cells and blood vessels. The ICM 
(inner cell mass) differentiates into the three germ layers of the embryo during 
gastrulation: (i) endoderm or hypoblast, (ii) mesoderm, and (iii) ectoderm or 
epiblast. Primitive endoderm begins to differentiate at approximately E4.0 from 
the free surface of the ICM of the blastocyst. This lineage has been 
demonstrated to only differentiate into the extraembryonic parietal and visceral 
endoderm of the yolk sac. Primitive endoderm does not contribute to the 
endodermal tissues of the fetus (Gardner, 1982). At approximately E4.5 the core 
ICM cells of the blastoyst derive the primitive ectoderm that divides rapidly and 
generates all tissues of the fetus itself (Theiler, 1972; Theiler, 1983). The cells 
outside of the blastocyst differentiate into an epithelium so-called trophoectoderm 
which contains the first cells of the trophoblasts lineage that will contribute 
exclusively to the epithelial composition of early placenta until term. The 
trophoectoderm cells that are adjacent to the ICM will become polar trophoblasts 
and those, not adjacent to the ICM will become mural trophoblasts. At the 
implantation time point, mural cells stop dividing, become large and form the 
primary trophoblasts – giant cells. Polar trophectoderm cells remain diploid, 
maintaining proliferation and later will become polyploidy giant cells, respectively 
chorion cells generating an extensively placental tissue (Theiler, 1972; Theiler, 
1983; Hogan, 1994). The labyrinth’s morphogenesis begins with interposition of 
allantoic cells and fetal blood vessels into the chorionic plate. The labyrinth 
contains both trophoblasts and mesodermally derived cells from embryonic 
origin. Labyrinth growth can be separated into four distinct steps: (I) 
chorioallantoic fusion (attachment of the allantois to the chorionic plate) at E8.5, 
(II) early morphogenesis and syncytiotrophoblast differentiation, (III) expansion of 
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the labyrinth, and (IV) vascularization of the labyrinth (Cross, 2001). The labyrinth 
begins to function as a nutrient transport unit around E10.5, permiting the 
exchange of gases, nutrients and wastes between mouse mother and fetus. The 
closest region to fetus of the placenta is called - the chorionic plate. Here the yolk 
sac inserts and the umbilical cord originates. Fetal capillaries derived from the 
umbilical blood vessels branch from the chorionic plate and ending with a 
network of sinuses containing maternal blood in the labyrinth (Zuckermann,
1986). Finally, although the placental vascular system is not a distinct layer, it is 
considered one of the most critical features of the placenta, because a 
systematic description of placental functions would be incomplete without it. 
Blood vessel formation in the placenta occurs by angiogenesis and is regulated 
by multiple genes. Also, at E10.5 maternal blood vessels pass through the giant 
cell and spongiotrophoblast layers and reach the labyrinth zone forming close 
contact with fetal capillaries. The mature mouse placenta is established already 
by day E10.5. The zygote-derived components of the mature placenta consists of 
trophoblasts (extra embryonic ectoderm), endothelial and stromal cells 
(extraembryonic mesoderm), (Rodriguez, 2004). Within the placenta, the 
trophoblasts lineage has differentiated and reorganized to generate cell subtypes 
with distinct endocrine, vascular, immune and transport function capabilities 
(Cross, 2001). Moreover, by E13.5 of placental development, the 
spongiotrophoblast layer becomes adjacent to the maternal component of the 
placenta as the giant cells by this point are no longer maintained (Jaffe, 1990). 
Thus, an abnormal development or function of labyrinth can result in impaired 
fetal development (Rodriguez, 2004), (Fig.1.4.2a). 
Similar to human placenta, the mouse placenta is named “haemochorial” 
(maternal blood vessels are in direct contact with placenta trophoblasts), 
(Wooding, 1994). Further development of the placenta relies on the 
interdependence of allantoic mesodermal cells and chorion trophoblasts (Hanato, 
2003).
Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany
1.  Introduction 
________________________________________________________________






















Fig. 1.4.2a An overview of placental development in mice – morphological aspects of early 
placental development (according to: Cross JC., 2005. How to make a placenta: Mechanisms of 
Trophoblast Cell Differentiation in Mice – A Review. IPFA 2004 Award in Placentology Lecture. 
Placenta, vol 26, suppl A, Trophoblast Research, vol 19) 
The fully developed placenta contains four main layers: (i) the giant cell layer, (ii) 
the spongiotrophoblast layer so-called junctional zone and few glycogen 
trophoblasts cells (forming together the feto-maternal interface), (iii) the labyrinth 
layer (placental barrier), and (iv) the chorionic plate (contains trophoblast stem cell
layer until pregnancy term).
The trophoblasts giant cells form the outmost layer of the placenta, are directly 
adjacent to maternal tissues, and perform several functions. They are a very 
invasive cell beeing the first to mediate implantation and the process of migration 
into the uterine wall (Cross, 2001). Later they produce several hormones and 
cytokines that promote both local and systemic physiological adaptations in the 
mother, including the regulation of maternal blood flow to the implantation site, 
production of progesterone from the ovary, lactogenesis and pancreatic islet 
hyperplasia (Linzer, 1999; Cross, 2002). The majority of primary and secondary 
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giant cells are morphologically similar and express genes in common. Giant cells 
are easy recognizable in placental sections, due to their extremely large nuclei. 
They secret immunosuppressive agents during implantation and also, produce 
angiogenic factors such as, vascular endothelial growth factor (VEGF) and 
proliferin that are thought to target maternal vasculature and promote 
development and growth of vessels to the implantation site (Adamson, 2002).
The spongiotrophoblast layer was once thought to simply be a structural zone to 
support the underlying villi (vascular processes), but they produce a significant 
amount of polypeptide hormones (Linzer, 1999; Soares, 1996). The layer is a 
compact cellular zone that is perfused only by maternal blood and together with 
the giant cells, resist to maternal decidua aggressively (Zuckermann, 1986).
Glycogen trophoblast cells appear within the spongiotrophoblast layer starting 
after about E12.5. Later, they invade into the uterus in a diffuse interstitial pattern 
and continue to express markers typical of spongiotrophoblast but not of 
trophoblasts giant cells. The developmental origin of these cells is not clear, 







Fig.1.4.2b Mouse placental layers illustration – a cross-section of mouse healthy term 
placenta. Developed placenta contains four main layers: (i) the giant cell layer, (ii) the 
spongiotrophoblast layer so-called junctional zone and few glycogen trophoblasts cells (forming 
together the feto-maternal interface), (iii) the labyrinth layer (placental barrier), and (iv) the 
chorionic plate, the closest placenta area to the fetus (contains trophoblast stem cell layer until 
pregnancy term). Magnification of 10x (Patrascan, C.C. - current doctoral study)
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Fig.1.4.2c Mouse chorionic plate illustration – under chorioamnion, trophoblast stem cell layer 
is relived together with fetal blood vessel derived from umbilical cord (Patrascan, C.C. - current 




Fig.1.4.2d Central uterine artery lined by trophoblasts cells invading decidua, placental bed 
in opposed direction to fetal blood vessel – illustration with two different magnifications of 10x 
and 20x by light microscopy (Patrascan, C.C. - current doctoral study) 
CT
ST
Fig.1.4.2e Mouse placenta trophoblasts layers. They are attached one to another forming 
together with fetal endothelium the placenta barrier. Illustration with high magnification of 60x by 
light microscopy; CT - CytotrophoblastST – Syncytiotrophoblast (Patrascan C.C. - current doctoral 
study)
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Syncytiotrophoblast cells form the nutrient transport surface within the labyrinth 
layer of the rodent placenta. They arise from the fusion of trophoblast cells that 
have left the cell cycle (Cross, 2000), therefore the syncytiotrophoblast cells 
contain multiple diploid nuclei. Differentiation of these cells does not begin until 
after attachment of the allantois to the chorion at E8.5 implying that signals from 
the allantois may provide a signal to initiate the process. The differentiation is 
initiated and controlled by the activity of the glial cells missing homolog 1 - Gcm1 
transcription factor (a chorion-specific transcription factor). Gcm1 mRNA 
expression occurs in small clusters of cells within the chorion layer as early as 
E7.5, a layer that is comprised of trophoblast stem cells. The sides of expression 
later coincide with sites in the chorion where differentiation and villous 
morphogenesis begin (Anson-Cartwright, 2000; Basyuk, 1999). At cellular level, 
Gcm1 is sufficient to promote differentiation of trophoblast stem cells towards the 
syncytiotrophoblast and to block their ability to differentiate into trophoblasts giant 
cells (Hughes, 2004).
Trophoblast stem cells emerge from the polar trophectoderm that overlies the 
inner cell mass in the blastocyst. They proliferate in response to close contact 
with the inner cell mass, now known to be mediated by fibroblast growth factor-4 
(FGF4) (Rossant, 2001). FGF4 continue to be expressed by the embryonic 
ectoderm after implantation and indeed FGF4 - dependent trophoblast stem cells 
lines can be isolated from the adjacent trophoblast layer, so-called chorion 
trophoblast or extraembryonic ectoderm. Trophoblast stem cells can proliferate in 
culture for many generations and differentiate into differentiated trophoblasts cell 
subtypes, both in vivo and in vitro indicating that they are multipotent. 
Trophoblast stem cells lines resembling those derived from blastocysts or early 
post-implantation chorion have not been successfully isolated from tissues older 
than E7.5-8.0 (Takana, 1998; Uy, 2002; Hemberger, 2004). This suggests that 
growth of the placenta after E7.5 must be due to proliferation and differentiation 
of a distinct trophoblasts progenitor cell type. Thus, trophoblast stem cells are 
induced to proliferate and maintain their stem cell phenotype through the 
Fibroblast growth factor receptor 2 (Fgfr2), (Takana, 1998). The identification of 
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FGF4 as a critical factor was based on the findings that mutation in both the Fgf4 
gene, which is expressed by embryonic ectoderm (Feldman, 1995; Goldin, 2003)
or in the FGF receptor gene 2 such as Fgfr2, which is expressed in 
trophectoderm (Arman, 1998), results in failure of trophoblast proliferation. The 
TGF-  related growth factor Nodal is required to maintain trophoblasts stem cell 
(TSCs) fate by cooperating with FGF signaling (Guzman-Ayala, 2004).
1.4.3 Placental functions 
Is remarkable how the placenta a single organ, acts functionally as several 
organs: kidney, lungs, liver and gut, with the main functions resembling transport, 
respiratory, metabolic, endocrine and immunological. The placenta supplies 
nutrients to fetus and delivers waste from him, being also responsible for water 
and oxygen exchange. Placenta cells produce several steroids and peptide 
hormones, growth factors, cytokines, and other bioactive factors, and are able to 
metabolize at least some of these products (Forouzan, 2003). The total of all of 
these placental functions could be viewed as various brands of protection, 
against malnutrition, dehydration, suffocation, toxic metabolites and/or infections 
(Lacroix, 2002).
Respiratory function – in the fetus, the lungs are collapsed therefore, oxygen is 
provided through the placenta. It allows the passage of oxygen and nutrients 
from the mother's blood through placental barrier to the baby's blood. From here, 
it flows through the umbilical cord into the baby. The right side/left side circulation 
of the newborn is not the case in the fetus. With the lungs collapsed, there is no 
need for the right side of the heart to send blood to the lungs, because the blood 
is already oxygen rich, thanks to the placenta. Instead, there are two short cuts 
that allow the blood to bypass the fetal lungs. One is called the ductus arteriosus 
and the other is the foramen ovale. The ductus arteriosus steals blood normally 
routed to the lungs and lets it flow straight into the aorta and to the rest of the 
body. The foramen ovale is actually a hole in the middle wall of the heart itself, 
allowing blood in the right side to flow through the wall into the left side and out, 
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likewise, to the rest of the body. In both cases, the lungs are bypassed (Gerard, 
1999). The fall in pressure as the maternal blood enters the placenta and the 
resulting slow flow supports the feto-maternal interchange. Maternal blood has a 
relatively high O  and a low CO  content. The passage of O2 2 2 to the fetus and of 
CO2 to the mother occurs by a process of simple diffusion. In addition, fetal 
haemoglobin has a greater ability to take up O  than adult haemoglobin does.2
Transport and metabolic functions – placenta synthesizes glycogen, cholesterol 
and fatty acids, which serve as sources of nutrients and energy for the embryo 
and fetus. Carbohydrates, simple lipids and proteins are all transferred across 
the placenta. This occurs either by a diffusion process for glucose, but less 
permeable to fructose and other common disaccharides, or by special transport 
mechanisms – pinocytosis for amino acids (transporter proteins and peptides). 
The transfer of maternal antibodies (mainly IgG) is important in providing passive 
immunity to the newborn. Another maternal protein – transferrin – carries the iron 
ions (Fe3+) to the placental surface from there it is actively transported into the 
fetal tissues.
Excretory function – Urea is present in the same concentration in both fetal and 
maternal blood - the fetus eliminates carbon dioxide (CO2) and waste materials 
(e.g. urea and bilirubin) into the maternal circulation.
Endocrine function - The placenta produces: (i) human Placental Growth 
Hormone (hPGH), (ii) Insulin-like Growth Factor (IGF), (iii) Relaxin, (iv) human 
Chorionic Gonadotrophin Hormone (hCGH), (v) human Placental Lactogen 
Hormone (hPLH), (vi) Endothelial Growth Factor (EGF), (vii) Estrogens and 
Progesterone (Fig.1.4.3).
Steroids hormones easily cross the placental barrier, but protein hormones are 
much more poorly transported (but maternal thyroid hormone gains slow access 
to the fetus and fetal insulin can reduce symptoms of maternal diabetes). 
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Fig.1.4.3 Placenta endocrine 
functions (according to: Miller 
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Placental activity
1.4.4 Amniotic fluid: source and composition 
Amniotic fluid composition is not a simple transudate. The substances 
concentration of amniotic fluid are the same as those found in maternal plasma, 
although some may rise or fall in concert with the maternal blood. As pregnancy 
progresses the fetal urine is relatively greater component of the amniotic fluid. 
Therefore, the content of it may reflect fetal renal function. The amniotic fluid 
volume increases up to the 37th th week (human) and 16  day (mice) falls slightly 
up to term and then more rapidly thereafter. The fluid is replaced every 3 hours 
but it may derive from several sources, mainly from amnion. Amniotic fluid 
source, results from both sides maternal - fetal circulation and amnion via three 
paths: (i) directly from maternal circulation; (ii) by diffusion through umbilical cord; 
(iii) mainly secreted by amnion membrane. Also, the creatinine level which rise 
sharply at about 38th week in human pregnancy, have been used as a test of 
fetal maturity. Furthermore, in the composition of amniotic fluid the chorionic 
gonadotrophin, placental lactogen, estrogens, progesterone and 
hydroxycorticosteroids are found in considerable quantities. Prostaglandins of 
two types are found: type E, in early pregnancy and type F, at term. Also, other 
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cell types are found in early pregnancy, such as: eosinophils and basophils. They 
are derived from fetal skin, mouth, vagina and bladder. 
1.4.5 Interactions between trophoblasts and other cell types in both 
mammalian species: human & mouse 
In human placental villi, proliferating trophoblasts are in close contact with the 
villous stroma essentially composed of fetal fibroblasts. Fetal fibroblasts promote 
the migration of trophoblasts through the secretion of insulin-like growth factor-1 
(IGF-1), which promotes the migration of IGF-1 receptor positive CTB in 
trophoblast columns (Aplin, 2000; Lacey, 2002). In the decidua, the extravillous 
invasive trophoblasts (EVT) are in close contact with decidual cells as well as 
with maternal leukocytes such as uterine natural killer cells (uNKs), APCs, 
macrophages and T cells. These maternal cells secrete a large range of factors 
(including ECM, growth factors, cytokines, proteases and inhibitors) that 
modulate trophoblast invasion. But, the precise mechanism by which the 
maternal immune system deals with fetal derived antigens during pregnancy is 
still not completely determined. The mostly requirement for maternal APC to 
present antigens to fetal lymphocytes makes these cells an integral part for the 
induction of immunological responses. Therefore, it could be assumed that APC 
at the foeto-maternal interface would be ideally located for presenting fetal 
antigens in an inducing tolerance pathway. Endometrial tissue and decidualized 
endometrium in humans and rodents contain numerous leukocytes with the 
morphology and the phenotype of APC. It is clear that at least three populations 
of APC, the macrophages, dendritic cells and mature monocytes-derived APC 
could be found in the decidua of pregnant uterus (Fig. 1.4.5a, b, c, d).
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SP -spongiotrophoblast, GC – giant cell




Fig. 1.4.5a, b Maternal cells of pregnant decidua. Mouse placenta 1st trimester of 
pregnancy, respective E 7.5-9.5 (embryonic day) (according to: Kruse A. et al., 2005. 
Regulation of leukocytes recruitment to the murine maternal/fetal interface. Immunology of 














SP -spongiotrophoblast, GC – giant cell




Fig. 1.4.5c Maternal cells of pregnant decidua. Mouse placenta E 10-13.5 (embryonic day). 
(according to: Kruse A. et al., 2005. Regulation of leukocytes recruitment to the murine 
maternal/fetal interface. Immunology of pregnancy. Chem. Immunol Allergy, Basel, Karger, vol 
89, pp 105-117) 
Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany
1.  Introduction 
________________________________________________________________












SP -spongiotrophoblast, GC – giant cells




Fig. 1.4.5d Maternal cells of pregnant decidua. Mouse placenta E 17.5-20 (embryonic day) 
(according to: Kruse A. et al., 2005. Regulation of leukocytes recruitment to the murine 
maternal/fetal interface. Immunology of pregnancy. Chem. Immunol Allergy, Basel, Karger, vol 
89, pp 105-117) 
The specialized APC present fetal antigens derived from the invasive 
trophoblasts to the maternal immune system. It seems possible that intradecidual 
microenvironment and cellular interactions decide whether APC will acquire 
characteristics and functions of classical antigen-presenting mature dendritic 
cells (DC) with T activating features, or arrest the APC in an immature state 
which is though to mediate tolerance induction (Lutz, 2002). It is remarkable that 
many of the factors described so far to promote tolerogenic DC, are present in 
abundance in the decidua. Hopefully, further research on decidual APC will shed 
light on how these cells help to create the delicate balance between tolerance to 
fetal antigens and immunity to hostile agents (Kämmerer and Markert, 2005). 
1.4.6 Maternal immune response throughout pregnancy and 
immunosuppressive agents of the placenta 
The close association of fetal and maternal tissues involves the maternal immune 
system in direct contact with foreign fetal antigens. Because the placenta is not 
considered a classical privileged site, mother becomes sensitized to paternal 
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antigens during pregnancy (van Kempen, 2001) as evidence by alloantigen-
specific alterations in maternal T and B cell phenotypes (Jiang, 1998; Tafuri, 
1995). Numerous studies have demonstrated that upon recognition of fetal 
antigen, immunoreactive T and B cells are deleted or down-modulated 
throughout pregnancy (Ait-Azzouzene, 1998; Zhou, 1998). Regulation of the 
maternal innate immune system in response to pregnancy is also critical for fetal 
survival (Hunt, 2000; Sacks, 1999). Indeed, it appears that, instead the maternal 
immune system is involved in intimate interaction with the fetal-placental entity. 
Often it has been hypothesized that the nature and constituents of the maternal 
immune reponse during pregnancy is modulated by the fetus (Dang, 2001). In 
human - fetal extravillous cytotrophoblasts (in mice – trophoblast giant cells) at 
the maternal-fetal interface lack classical MHC class molecules (Faulk, 1976; 
Rodriguez, 1997). Instead these trophoblasts in human express a MHC class Ib 
molecule, so-called human leukocyte antigen G (HLA-G), which is thought to 
provide fetal protection from maternal uNKs – mediated lysis (Kovats, 1990; 
Lanier, 1999). In mice, the cloning of a new nonclassical MHC class Ib gene, 
termed blastocyst MHC, has been described that is expressed in both blastocyst 
and placenta (Sipes, 1996). This gene resembles human HLA-G in structure 
which, unlike classical MHC I molecules may play an important role in immune 
surveillance to allow the maternal immune system to recognize virally infected 
trophoblasts cells (Wei, 1990).
Other studies have shown the role of these molecules in protecting trophoblasts 
from uNK cell-mediated lysis by allowing trophoblasts to be recognized as self. 
Nevertheless, the close association of maternal and fetal-maternal tissues 
exposes the maternal immunity to paternal derived antigens and many studies 
are focusing on how this mechanism occurs (Erlebacher, 2001; Loke, 2000).
Placenta apparently evades the maternal immune system by expression of 
immunosuppressive agents. Specific trophoblasts cell types have been shown to 
produce progesterone, metalloproteases, and inhibitors of complement (Cross,
1994; Munn, 1998; van Vlasserlaer, 1984), (Fig.1.4.6).
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Fig.1.4.6 Maternal immune system influences the development of the child’s adaptive 
immune response. The intrauterine environment correspond to a physical and biochemical 
support and it is not likely that the maternal immune system accepts a pregnancy just due to 
either a lack of fetal antigen presentation or from maternal immunological ignorance of the 
pregnancy. Placental tissue acts as an immunologically like-tissue and monitors the development 
of pregnancy, leading it into a TH2 immunity direction (the prenatal conceptual immunity 
dominance)
The complement inhibitor - Crry, is a member of a family of ubiquitously 
expressed molecules that negatively regulates complement components C3 and 
C4 (Molina, 2002). Disruption of Crry lead to deposition of complement 
associated with placental inflammation, leading to embryonic lethality. In human 
placenta, trophoblasts expressed complement regulatory proteins, presumably to 
circumvent complement-mediated lysis as well (Holmes, 1992). Expression of 
indoleamine 2, 3-dioxygenase (IDO), a tryptophan-catabolizing enzyme is shown 
to be present in trophoblasts. IDO is though to reduce local concentration of 
tryptophan below the threshold required for normal T cell function at the fetal-
maternal interface (Munn, 1998; Munn, 1993; Kamimura, 1991). In the absence 
of tryptophan, cell cycle progression is stopped at a mid-G1 arrest point in T cells 
(Munn, 1999). Other immunosuppressive agents secreted at the maternal-fetal 
interface such as prostaglandin E2, TGF-  and IL-10 have a fetal protective role 
against maternal lymphocytes attack (Wegmann., 1993; Clark, 1990; Clark, 
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1998). Also, human placental trophoblasts express L-selectin, a carbohydrate 
binding protein, which mediates interactions with the uterus that may be critical in 
establishing a successful pregnancy (Genbacev, 2003). Immune evasion by the 
fetus is demonstrated by expression of FasL at the fetal-maternal interface which 
is thought to act by preventing passage of activated FasR+ immune cells. In gld
mice, a mutant line that lacks functional FasL, extensive leukocytic infiltrates and 
necrosis at the fetal-maternal interface are observed from E10.5 resulting in 
increased resorbtion and smaller litter sizes (Hunt, 1997; Suda, 1995). 
1.5 Introduction to the biology of Toll-Like Receptors (TLRs) and 
 pathogen-associated molecular patterns (PAMPs) 
Toll-like receptors are type I transmembrane proteins that are evolutionary 
conserved between insects and vertebrates (Rock, 1998). In Drosophila fly, Toll
was first identified as an essential molecule for dorsal-ventral patterning of the 
embryo and subsequently as a key molecule for the antifugal immune response 
in the adult animal (Anderson, 1985; Lemaitre, 1996). A homologous family of 
Toll receptors, termed Toll-like receptors (TLRs) exists in vertebrates (Rock, 
1998). Up to now, 13 members (TLR1-13) have been reported being fundamental 
in recognition of pathogen associated molecular patterns (PAMPs). The family of 
TLR recognizes broad and diverse PAMPs from different pathogenic origins such 
as bacteria, viruses, fungi or protozoan parasites (Tabeta, 2004; Takeda, 2005).
One subfamily of TLRs that consists of TLR1, TLR2, TLR4, TLR5, TLR6 and 
TLR11 is expressed on the surface of cells and recognizes diverse structures. In 
contrast, the other subfamily is formed by TLR3, TLR7, TLR8 and TLR9 that are 
localized inside the cell in the endoplasmic reticulum and endosomes or 
lysosomes, where these receptors recognize bacterial and viral nucleic acids. 
Therefore, different TLRs present diversity within PAMPs recognizition. 
Lipotheicoic acid (LTA) - an amphiphilic negatively charged glycolipid and 
lipoproteins – is a strong immune stimulator and activates TLR2 (Schwandner, 
1999; Takeuchi, 1999). TLR2 dimerises with TLR1 and TLR6 allowing a 
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discrimination of differences within the lipid part of lipoproteins. The TLR2/TLR1 
heterodimer recognizes triacylated lipopeptides, whereas the TLR2/TLR6 
complex is activated by diacylated lipopeptides (Alexopoulou, 2002; Ozinsky, 
2000; Takeuchi, 2001; Takeuchi, 2002). TLR3 recognizes double-stranded RNA 
(dsRNA) and the synthetic analog polyinosine-polycytidilic acid (poly I:C) and 
induces type I IFN (Alexopoulou, 2001). dsRNA is generated as an intermediate 
during the replication cycle of single-stranded RNA (ssRNA) or DNA viruses 
(Matsumoto, 2004). Since dsRNA is a common viral PAMP, TLR3 could be the 
key receptor in an antiviral immune response. Furthermore, the endotoxin 
lipopolysaccharide (LPS), a compound of the outer cell membrane of Gram-
bacteria is a very potent PAMP among the cell wall components. The active 
component of the LPS a lipid fraction - Lipid A - is an immune activator molecule 
(Alexander, 2001). TLR4 is the key molecule of LPS induced signaling (Poltorak, 
1998) and utilizes several cofactors and adaptor molecules for efficient 
recognition. LPS associates first with LPS binding protein (LBP) and then with 
soluble sCD14, a glycosyl-phosphatidyl-inositol (GPI) anchored protein 
(Heumann, 2003). This complex binds to the lymphocyte antigen 96 (MD2) and 
associates with TLR4 which leads to its aggregation and subsequent signaling 
(Poltorak, 1998; Shimazu, 1999). Many pathogens are motile and use a flagellum 
as the motility apparatus. The major component of the flagellum is flagellin, an 
activator of TLR5 (Hayashi, 2001). TLR5 recognizes a domain D1 of flagellin that 
is relatively conserved among various species (Smith, 2003). Single-stranded 
(ss) guanosine and/or uridine rich RNA and ssRNA viruses such as Influenza 
virus, Vesicular Stomatitis Virus (VSV), Newcastle disease virus (NDV) are 
recognized by the complex TLR7/TLR 8 (Diebold, 2004; Heil, 2004; Lund, 2004; 
Kato, 2005). Both genes are homologous to each other and are located on the X 
chromosome (Chuang, 2000; Du, 2000). TLR9 recognized bacterial genomic 
DNA. The stimulatory effects of bacterial DNA is due to the presence of 
unmethylated CpG dinucleotides in a particular base context named CpG-motif. 
The immunostimulatory effects of bacterial DNA can be mimicked by synthetic 
oligodeoxynucleotides containing a CpG-motif (CpG-ODN), (Krieg, 1995).
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1.5.1 TLR signaling pathways: the repercussion on TH1/TH2 immunity 
TLR - mediated signaling is initiated after ligand binding which presumably leads 
to receptor dimerization. The receptors undergo conformational change and 
recruit adapter molecules to their intracellular domain termed Toll/IL1-receptor 
like domain (TIR domain) which is shared by the TLR and IL1-receptor signaling 
pathway (Medzhitov, 1997; O'Neill, 1998). Four different adapter molecules have 
been identified: Myeloid differentiation protein 88 (MyD88), (Wesche, 1997; 
Adachi, 1998; Medzhitov, 1998), TIR-associated protein (TIRAP)/MyD88-adaptor 
like (MAL), (Fitzgerald, 2001; Horng, 2001), TIR-domain containing adaptor 
protein inducing IFN-  (TRIF)/TIR-domain containing molecule 1 (TICAM 1) and 
TRIF-related adaptor molecule (TRAM),  (Yamamoto, 2002; Oshiumi, 2003; 
Yamamoto, 2003a). Moreover, MyD88 and TRIF are important for the activation 
of distinct signaling pathway and lead to the production of proinflammatory 
cytokines and type I IFN. The adapter protein TIRAP/MAL is required for 
recruiting MyD88 to TLR2 and TLR4 along with TRAM, a TLR4 specific adaptor, 
which bridges TLR4 and TRIF (Kagan, 2006; O'Neill, 2006). MyD88 is the  
“master” adapter molecule, a protein utilized by TLRs, except TLR3. MyD88 is 
recruited to the cytoplasmic TIR domain through interaction with its TIR domain. 
Recruitment of MyD88 is followed by engagement of IL1 receptor associated 
kinase 4 (IRAK-4) and IL1 receptor associated kinase-1 (IRAK-1) which is 
phosphorylated by IRAK-4. Moreover, phosphorylated IRAK-1 associates with 
TNF receptor associated factor-6 (TRAF-6), whilst oligomerization leads to 
activate of the transcription factor NF-kB (Cao, 1996; Muzio, 1998; Li Q, 2002). 
TLR3 and TLR4 utilize TRIF to produce IFN-  and IFN inducible genes (Hoebe, 
2003; Yamamoto, 2003b). TRIF interacts with receptor-interacting protein-1 (RIP-
1) and TANK binding kinase 1 (TBK-1) to initiate NF-kB activation and IRF-3, 
IRF-7 phosphorylation (Fitzgerald, 2003; Sharma, 2003; Meylan, 2004). 
Phosphorylated IRF-3 and IRF-7 form homodimers, translocate into the nucleus 
and regulate the expression of IFN-inducible genes by binding to interferon 
stimulated response element (ISRE), (Sakaguchi, 2003; Honda, 2005). In pDC, 
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IFN  production via TLR7 and TLR9 is strictly dependent on MyD88 and 
contrasts the TRIF dependency of IFN production via TLR3 and TLR4. In 
general, TLR-mediated activation if immune cells leads to the production of IFN ,
proinflammatory cytokines such as TNF , IL-1 and IL-6 as well as the regulatory 


































































Fig.1.5.1 TLR signaling pathways. Activation of TLR induces secretion of proinflammatory 
cytokines, type I IFN and anti-inflammatory IL-10 depending on a specific TLR, cell type and the 
adaptors used for signal transduction MyD88, TIRAP, TRAM, and TRIF, The relationship of TLRs 
by their ligands leads to the activation of a signaling cascade with subsequent induction of genes 
that are involved in the immune response against pathogens. In general, three major pathways 
are activated: (i) the activation of the transcription factor NF-kB, which acts as a master switch for 
inflammation, (ii) activation of the MAP kinases p38 and Jun amino-terminal kinase (JNK), which 
participate in increased transcription and (iii) the type I IFN production via IFN regulatory factors 
(IRFs) (according to: Bauer, S. et al., 2007. Immunobiology of toll-like receptors in allergic 
disease. Immunobiology 212, pp 521-533) 
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-/-Accordingly, MyD88 mice lack of TLR mediated signaling resulted in increasing 
TH2 response with strong IgE production (Schnare, 2001). The importance of 
TLR signaling in TH1 immune responses implies that variations in TLR 
expression and activity may influence the development and severity of allergic 
diseases. Also, for some TLR, such as TLR2 and TLR5 conflicting results have 
been observed regarding the induction of a TH1 or TH2 polarization depends on 
the purity of the ligand (Agrawal, 2003; Didierlaurent, 2004; Velasco, 2005). 
Thus, the concentration of LPS may settle on what type of immune response is 
initiated. Low concentrations may induce MyD88 independent TH2 activation, 
whereas higher LPS concentrations induce a MyD88 dependent TH1 response 
(Eisenbarth, 2002; Kaisho, 2002). For the MyD88-independent immune activation 
pathway via TRIF and TLR3, a strong induction of a TH1 response has been 
reported (Wang, 2002).
1.5.2  TLR signaling in trophoblasts cells throughout normal and  
pathological pregnancies 
Toll-like receptors (TLR or TLRs) are widely expressed throughout the immune 
system, specifically in the innate immune system. These proteins can also be 
expressed by non-immune cells, particularly if such cells are able to contribute to 
an inflammatory response, and most tissues express at least one TLR 
(Zarember, 2002). Toll-like receptor expression by mucosal systems is important 
for host defense against pathogens (Gewirtz, 2003; Yuan, 2004). While most 
studies have focused on the intestinal and respiratory tracts, there is growing 
evidence that the mucosal epithelium of the female reproductive tract (FRT) is 
also an important immunological site (Wira, 2004; Quayle, 2002). Hence, Toll-like 
receptors are expressed by endometrial epithelium and the epithelial cells (e.g. 
placenta) of the lower reproductive tract and furthermore, these cells are able to 
respond to microorganism trough these receptors (Fichorova, 2002; Schaefer, 
2004; Young, 2004). During pregnancy there is a strong immunological presence 
at the fetal-maternal interface on placenta tissue, particularly by the innate 
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immune system (Mor, 2002). The role of the immune system at the fetal-maternal 
interface is thought to facilitate implantation and placental development, whilst 
promoting fetal tolerance and protection (Audus, 2002; Moffett-King, 2002). 
However, a certain level of host defense at this site is also required. While 
immune cells such as macrophages and NK cells are present at the maternal-
fetal interface (Mor, 2002), they may not be the only cells able to respond to 
bacteria. In addition to the classical immune cells, placental cells – trophoblasts – 
may also have the potential to function as a component of the innate immune 
system (Guleria, 2000). Currently, little is known about the role of Toll-like 
receptors during pregnancy. Normal term placental tissue has been shown to 
express TLR1 to TLR10 in human and TLR1 to TLR13 (except TLR10) in mouse 
at the mRNA level. Syncytiotrophoblast and intermediate trophoblast of term 
placenta express at the protein level, TLR2 and TLR4 (Holmlund, 2002). In 
contrast (Kumazaki, 2004) shown in human, that the TLR4 positive placental 
cells might be term extravillous and intermediate trophoblasts. Such contradictory 
findings might be a result of the type of antibody that detects TLR4 complexes 
with the adaptor protein MD-2 whilst others used an antibody that detects TLR4 
alone (Holmlund, 2002). Nonetheless, these findings do suggest that 
trophoblasts cells may interact with microorganisms present already at the 
implantation site being able to initiate an immune response. Therefore, the 
trophoblasts function as an active member of the innate immune system (Guleria, 
2000). Abrahams et al. demonstrated the expression of TLR2 and TLR4 mRNA 
in first trimester placental tissue. They could show that the villous cytotrophoblast 
and extravillous trophoblasts cells from first trimester trophoblast cell populations 
are expressing these receptors. Instead, first trimester syncytiotrophoblasts do 
not express these TLRs suggesting that the placenta serves as a highly 
specialized barrier, protecting the developing fetus against infections (Abrahams, 
2004). These studies of the lack of TLR expression by the outer trophoblasts 
layer – syncytiotrophoblast - is analogous to studies of mucosal epithelial cells of 
the intestinal tract which have been shown to express TLR4 and TLR5 only on 
their basolateral side (Gewirtz, 2001). These cells will only respond to a 
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bacterium that has invaded the basolateral compartment from the apical side. 
Since a pathogen is characterized as a microorganism that breaches certain 
physical barriers, these observations have helped to explain how an immune 
response can be mounted against pathogenic, but not commensal bacteria. 
Similarly, a microorganism will only be a threat to the fetus if the TLR-negative 
syncytiotrophoblast cell layer is breached and the pathogen has entered either 
the decidual or the placental villous compartments. Therefore, the placenta can 
distinguish between pathogenic and commensal microorganisms during 
pregnancy. Thus, once a microorganism has gained access to the TLR-positive 
trophoblasts cells, a response may be rising but the type of pathogen and the 
specific receptor activated may have a significant impact on the type of response 
generated by the cells of the placenta. The function of Toll-like receptors at the 
feto-maternal interface is an area of research still at the beginning. It is known 
that trophoblasts cells from term placental explants can produce IL-6 and IL-8 
following ligation of TLR2 or TLR4 by Zymosan or LPS (Holmlund, 2002). 
Treatment of term trophoblasts cells with LPS has also been shown to induce the 
production of nitric oxide - which has potent anti-microbial properties and MMP-2 
(Nakatsuka, 2000). Studies on first trimester trophoblasts have shown that 
treatment with LPS induces the production of G-CSF and RANTES (Svinarich, 
1996). Recently, in some studies was found that activation of TLR4 by LPS 
generated a classical TLR response, characterized by the enhanced production 
of both pro- and anti-inflammatory cytokines (Abrahams, 2004). Together, all 
these studies suggest that trophoblasts cells can indeed function similarly to cells 
of the innate immune system, by recognizing and responding to components of 
microorganisms.
Since clinical studies have shown an association between intrauterine infections 
and preterm labor, Preeclampsia and Intrauterine Growth Restriction (IUGR)
(Concalves, 2002; Romero, 2003; von Dadelszen, 2003; Hsu, 1995; 
Arechavaleta-Velasco, 2002) some studies shown that TLR expressed at the 
fetal-maternal interface may play an important role in the mechanism of 
pathogenesis. Certain intrauterine infections during pregnancy may have either a 
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direct or an indirect effect upon trophoblasts cell survival, depending upon which 
TLR could be activated. The Gram+ bacteria expressing peptidoglycan (PG) or 
lipoteichoic acid (LTA) may directly promote trophoblasts cell death through 
TLR2 signaling pathway. Recently, soluble TLR2 (sTLR2) has been identified 
(LeBouder, 2003). This protein may function by modulating specific TLR-
mediated responses. Alternatively, soluble forms of TLR may bind to 
microorganisms and flag them for destruction by the complement system or by 
phagocytosis (Mezdhitov, 2002). Consequently, the soluble TLR (sTLR) may 
provide new markers of pregnancy complications as well as a potential target for 
therapeutic interventions. Therefore, animal models used for pregnancy 
complications have been generated by the administrations of high amounts LPS 
(Kaga, 1996; Vizi, 2001; Benett, 2000; Baines, 1996; Orgando, 2003). LPS, 
through TLR4, triggers first trimester trophoblasts cells to produce high levels of 
TH1 cytokines, suggesting that both TNF  and IFN , may induce trophoblasts 
apoptosis and fetal loss at this pregnancy stage (Yui, 1994; Garcia-Lloret, 1996; 
Ho, 1999; Crocker, 2001; Aschkenazi, 2002). Hence, while LPS does not directly 
induce trophoblasts cell death, the intense inflammatory response generated by 
either trophoblasts or decidual immune cells following its activation may provide 
an alternative mechanism for the induction of trophoblasts cell death other then 
pregnancy at term.
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Allergic disorders including allergic rhinitis, atopic dermatitis, food allergies and 
allergic bronchial asthma are inflammatory diseases which employ a vary risk of 
factors. Their identification such as: smoking, indoor allergen exposure, RSV 
infection, the appearance of allergic disease lead to the identification of 
protective factors. Thus, based on epidemiological data the Hygiene hypothesis 
(proposed for the first time by Strachan, in 1989) shows that certain life 
circumstances are strongly related with protection against allergies becoming 
asthma associated. Remarkable evidence is that the cross-sectional study on the 
prevalence of allergy to schoolchildren in farmer versus non-farmer environment. 
Children from farmer locations have a 50% less risk of an allergy and asthma 
disease as children from non-farming life circumstances. An immune protection is 
indispensable to the higher exposure to bacterial antigens such as farming 
environment, unpasteurized cow's milk. These observations suggest that 
exposure to farming environment may influence the developing immune system 
leading to a reduced risk for the development of allergies. Therefore the 
applicable window of opportunity is defined by exposure to the protective 
environmental factors early in life, starting already in utero.
The theme of the presented doctorate’s thesis is defined as: The role of Toll-like 
receptors in the development of immunological tolerance in neonates, part of the 
research project SFB - TR22/A18 so-called: Mechanisms of pre- and postnatal 
instruction of allergic respiratory diseases in the mouse model of experimental 
asthma. It has in focus the epidemiological data regarding the differences into 
development of immune systems from children growing-up into farming and non-
farming environments.
But how could we manage nowadays the allergies in our children?  
What is the starting point of avoidance of these aggressive phenomena? 
Regarding these questions we hypothesized that: The activation of Toll-like 
receptors in the placenta plays an important role in prenatal transmission of anti-
allergic protective immunological effects from mother to fetus. 
2. Hypothesis and aims of the study 
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This hypothesis is strong supported by other two observations that assumed: 
(i) in mother, the prenatal induction and instruction of well defined immune 
and placental positive cells is mediated by innate regulatory pathways 
(Toll-like receptors)
(ii) the perinatal exposure to bacterial constituents induce in newborn and 
infant a switch of TH2-phenotype into an anti-allergic TH1 immune 
response
Accordingly, the aims of the study are: - to monitor the complexity of pregnancy 
by mimicking the farming environment in our laboratory with an established 
animal model, in order to compare the human and mouse morpho-pathology and 
placental immunology (from trophoblast stem cells – TSCs - to entire placental 
tissue). Regarding, pregnant mice are supplemented with Gram+ bacteria 
(Lactobacillus rhamnosus GG or LGG), Gram- bacteria (Acinetobacter lwoffii F78 
or Ac. lwoffii F78) and Gram- bacterial active component (Lipid A or LA, derived 
from LPS/E.coli). The ending point of the doctoral experimental work was to 
design a potential maternal anti-allergic protective molecular mechanism to the 
fetus. This is supported by the beneficial effects transmitted from mother to her 
concepti, and converted-like the development of TH1 immunity in the offspring.
Starting from the new insights that TLR signaling pathways expressed in 
placenta are responsible from the defensive/protective mechanisms against 
allergy disorders, we carried out perinatal (pre- and postnatal) experiments on 
the establish mouse model regarding to human disorders with a great technical 
performance of a broad of biochemical, immunological and molecular biology 
methods. Finally, the perinatal results add evidences that the farming 
environment circumstances are crucial in a well developing pregnancy phenotype 
and consequentially, educating the children’s immunity fighting against allergies 
via TLR signaling pathways. 
3. Principles, materials and methods 
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3.1 Design of experimental protocols for perinatal study 
3.1.1 Intrauterine experimental animal model – prenatal exposure to farm 
environment containing non-pathogenic bacteria 
Female Balb/c strain mice, 6-8 weeks old, received either intragastric (i.g.) 
Lactobacillus rhamnosus GG - a Gram+ 8 bacteria (concentration of 10  CFU/200 
l per application, reconstituted in PBS) and intranasal (i.n.) Acinetobacter lwoffii 
- a Gram- 8bacteria (concentration of 10  CFU/50 l per application, reconstituted 
in PBS) and Lipid A - the active component of LPS derived from E.coli, a Gram-
bacteria (10 μg/50 l per application, reconstituted in PBS). Maternal 
supplementation started 10 days before conception every second day and 
continued until term of pregnancy. Age-matched control animals received PBS. 
All females were sacrificed at term of pregnancy to perform the blood, amniotic 
fluid, small intestine spleen, and placenta analyses for TLR, cytokine and 
chemokine, and steroid hormones expression using immunological, molecular 
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Fig.3.1.1 Experimental protocol of prenatal supplementation with non-pathogenic bacteria 
- Lactobacillus rhamnosus GG – Gram+ - bacteria strain, Acinetobacter lwoffii F78 – Gram  bacteria 
strain, Lipid A - the active component of LPS (a Gram- bacterial membrane component - 
Escherichia coli), whilst the age-matched control animals received PBS 
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3.1.2 Acute asthma animal model – OVA sensitisation and challenge of the 
offspring
-/-Wild type female used as control and M D88 , TLR2-/-/3-/-/4-/-/7-/-/9-/- and 
TNFp55-/- deficient mice female mice C57BL/6J strain, 6-8 weeks old received 
intranasal (i.n.) lyophilized Acinetobacter lwoffii F78 (concentration of 108 CFU/50 
l per application, reconstituted in PBS). Maternal supplementation started 10 
days before conception every second day being maintained until term of 
pregnancy. Age-matched control animals received PBS.  Later after birth, asthma 
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Fig.3.1.2 Experimental protocol of acute asthma animal model – OVA sensitisation and 
challenge of the offspring - Acinetobacter lwoffii F78 prenatal supplementation is followed by 
induction of acute in offspring by OVA sensitization and challenge, whilst the age-matched control 
animals received only PBS. 
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Offspring mice were sensitized twice with intraperitoneal (i.p.) injections of 200 μl 
Ovalbumin (OVA)/Al(OH)3 per application (10 μg OVA emulsified in 1.5 mg 
Al(OH)  as adjuvant reconstituted in PBS)3 at the age of 28 and 42 days. At days 
48, 49, 50 the subgroups of offspring were placed one after other into a Plexiglas 
chamber and exposed (challenged) to the aerosolized OVA (1% wt/vol 
reconstituted in PBS) for 20 minutes time exposure. Lung function analysis was 
carried out with respect to monitor the airway-hyper-reactivity (AHR) to -Acetyl-
Methacholine (MCh) using the non-invasive method so-called Head-out Body-
Plethysmography. The middle-expiratory airflow (EF50) of bronchial 
responsiveness to -Acetyl-Methacholine (MCh) was measured 24h (day 51) 
after the last OVA aerosol challenge. Subsequently, after 48h (day 52) the
animals are euthanized by neck dislocation, the trachea is canulated and washed 
5 x 1 ml of cold PBS to obtain the bronchoalveolar lavage (BAL). The total 
number of leukocytes was determined by using a CasyTT Cell Counter (Schaerfe 
System, Reutlingen, Germany). Furthermore, to obtain the alveolar cells and cell-
free lavage fluid, BALF is centrifugated at 300g for 10 minutes under temperature 
of 4°C. Investigating the airway inflammation was important to quantify the 
protein production (cytokine and chemokine measurement by ELISA and CBA 
methods) from cell-free lavage fluids which were preserved at -80°C and then, 
the cellular composition of BAL fluids (total number of leucocytes, number of 
eosinophilic cells - granulocytes, lymphocytes, macrophages and neutrophils). 
Therefore, alveolar cells were suspended in 1 ml of PBS, total cell numbers were 
determined before the cytospins were prepared. The cytospins were dried and 
stained with May-Grünwald Giemsa staining method. Macrophages, neutrophils, 
lymphocytes and eosinophils were simple differentiated by light microsopy.
3.2 Mouse strains 
For the prenatal study – intrauterine animal model - female and male Balb/c 
strain mice, aged 6-8 weeks were obtained from Harlan-Winkelmann GmbH, 
Hannover, Germany, while the postnatal study required different mouse strain 
Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany
3. Principles, materials and methods 
________________________________________________________________
62
such as wild type and deficient mice, in order to demonstrate the hypothesis of 
the study. Regarding, MyD88-/-, TLR 2-/-/3-/-/4-/-/7-/-/9-/- -/- and TNF deficient mice 
and wild types litermates, C57BL/6 background were kindly obtained from 
different collaborators: Prof. Dr. Stefan Bauer and PD Dr. Philipp Yu (Philipps-
University of Marburg/Lahn, Institute of Immunology, Biomedical Research 
Center – Biomedizinische Forschung Zentrum), Prof. Dr. rer. nat. Carsten 
Kirschning (Technical University of München and Institute for Medical 
Microbiology, University of Duisburg-Essen), Prof. Dr. med. Klaus Pfeffer 
(Heinrich-Heine-University of Düsseldorf, Institute of Medical Microbiology). 
Animals were maintained on germ-free conditions and OVA-free diet receiving 
food and water ad libidum being bred and experimented at the Medical Research 
Center and Biomedical Research Center Laboratories, Marburg/Lahn, Germany. 
All experimental procedures were performed in accordance with German and 
international guidelines, and were approved by local authorities 
(Regierungspraesidium Giessen).
3.3      Bacterial strains 
+ probioticLactobacillus rhamnosus GG (LGG) - a Gram  bacteria strain so-called 
bacterium that was originally considered to be a subspecies of Lactobacillus 
casei (L. casei), but later genetic research found it to be a species of its own. 
LGG inhibits the growth of most harmful bacteria in the intestine. The 
lyophilisated LGG was purchased from Valio GmbH, Helsinki, Finland. 
-Gram  bacteria belonging to the PhylumAcinetobacter lwoffii F78 (Ac. lwoffii) - a 
Proteobacteria. As a non-motile bacterium, Acinetobacter species are oxidase-
negative illustrating pairs under microscopically magnification. Acinetobacter 
species are generally considered nonpathogenic to healthy people but most 
infections occur in immunocompromised individuals. Many of the immune 
activating abilities of LPS could atributes to the Lipid A unit. It is a very potent 
stimulant of the immune system, activating cells (e.g. monocytes or 
macrophages) at picogram per milliliter quantities. When present in the body at 
high concentrations during a Gram- bacterial infection, it may cause shock and 
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death by an immune overreaction. Acinetobacter lwoffii F78 bacterial strain was 
identified and kindly provided by Prof. Dr. Otto Holst - Division of Structural 
Biochemistry, Research Center Borstel, Leibnitz-Center for Medicine and 
Biosciences, Germany. 
-Lipid A (LA) - the active part of LPS (E.coli membrane component, a Gram
bacteria) consists of two glucosamine (carbohydrates/sugars) units with attached 
acyl chains or fatty acids, and one phosphate group on each carbohydrate. The 
optimal immune activating Lipid A structure is believed to contain 6 acyl chains. 
Four acyl chains attached directly to the glucosamine sugars are -hydroxyacyl
chains usually between 10 and 16 carbons in length. Two additional acyl chains 
often attached to the -hydroxy group. Lipid A has four - C14 hydroxyacyl chains 
attached to the sugars, and one C14 and one C12 attached to the -hydroxy 
groups. The biosynthetic pathway for Lipid A in E. coli has been determined by 
the work of Christian R. H. Rätz in the past 20 years (Rätz, 2002). Lipid A with a 
reduced number of acyl chains can serve as an inhibitor of immune activation 
induced by Gram- bacteria, and synthetic versions of these inhibitors are in 
clinical trials for the prevention of harmful effects caused by -Gram  bacterial 
infections. On the other hand, modified versions of Lipid A can be used as 
components of vaccines (adjuvants) to improve their effect. Furthermore, Lipid A 
and/or LPS is believed to activate cells via Toll-like receptor 4 (TLR4), MD-2 and 
CD14 on the cell surface. Lipid A was provided from Sigma GmbH, Deisenhof, 
Germany.
3.4      Methods - RNA and DNA Analysis 
3.4.1 Polymerase Chain Reaction (PCR) of RNA isolated and cDNA 
synthesis from maternal small intestine, spleen, placenta and 
trophoblast stem cells (SM10 cell line) 
RNA was isolated from maternal organs such as spleen and placenta with the 
TriFast lysis buffer (Peqlab GmbH, Erlangen, Germany) according to 
manufacturer’s instructions. Previously, 50-100 mg of organ was perfused with 
Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany
3. Principles, materials and methods 
________________________________________________________________
64
cold and sterile PBS, then frozen-up in liquid nitrogen and homogenized in 
TriFast lysis buffer. Afterwards the mechanically disruption tissues was done 
using a mortar and pestile. The suspension obtained is trasfered into a liquid-
nitrogen-cooled, appropriately sized tube and allow the liquid nitrogen to 
evaporate without allowing the sample to thaw. The tissue suspension was 
maintained 5 minutes at room temperature for enzymatic digestion. The phase 
separation process is the next step. Volume of 200 μl of Chloroform pro 1ml 
TriFast lysis buffer was added and the whole mixture was centrifuged for 5 
minuntes at 12,000g under 4ºC. The supernatant as a transparent phase 
contains the total RNA from the entire tissue was transferred into new 1.5 ml 
Eppendorf tube. The extracted RNA was precipitated using Isopropanol (absolute 
solution), followed by a new centrifugation for 10 minutes at 12,000g under 4ºC. 
Then, the RNA pellet is washed out with 1 ml Ethanol 75% (v/v) pursued by a 
new centrifugation of 5 minutes at 12,000g under 4ºC. The RNA pellet could be 
preserved with Ethanol 75% (v/v), in freezer at -20ºC for one month or could be 
solubilised by solving the pellet into 60 μl Rnase-free water and incubate for 10 - 
15 minutes at 55ºC. Thus, the total RNA extracted from tissue was used 
immediately proceeding cDNA synthesis reverse transcription or preserved as 
biomaterial storage in freezer at -80ºC for several months. Furthermore, from 
maternal gut and placental trophoblast stem cells (SM10 cell line) RNA was 
isolated by using the Rneasy Lipid Tissue Mini Kit (50) (Qiagen GmbH, Hilden, 
Germany), respective the Rneasy Mini Kit (50) (Qiagen GmbH, Hilden, Germany) 
according to manufacturer’s instructions. Previously, the placental trophoblast 
stem cells were treated with Beta-mercaptoethanol ( -ME) reconstituted in RLT 
lysing buffer (guanidine thiocyanate salting solution) with dilution of 1:100, in 
order to disrupt the cell membrane (for a number of pelleted cells <5 x 106 was
used 350 μl of RLT lysing buffer). The contaminating genomic DNA was removed 
by DNase treatment (DNA-free Set; Ambion Company, Austin, TX, USA) or 
DNase digestion column from RNase-free DNase Set (Qiagen GmbH, Hilden, 
Germany). Alternatively, residual DNA could be removed by a DNase digestion 
after RNA extraction by using the Rneasy Cleanup Mini Kit (50) (Qiagen GmbH, 
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Hilden, Germany). The reason of using different kits is given by the organ 
constitution itself in order to obtain a high quality of RNA extracts.
The cDNA synthesis was performed by Omniscript Reverse Transcriptase Set 
(Qiagen GmbH, Hilden, Germany). This is a standard protocol for first-strand 
cDNA synthesis using 50 ng to 2 μg RNA. The efficiency of the synthesis is 
highly dependent on the quality and quantity of the starting RNA template. In this 
regard, the concentration of tissues isolated of total RNA was measured by 
Spectrophotometer at specific parameters: OD240-260nm, DF=50, integration time 5 
sec, F= 40, conc.units μg/ml. For RNA sequences quality, a normal PCR was 
performed (TAE running buffer, RNA - Agarose powder, Sample Loading Buffer 
and RNA Ladder 100bp as marker from Sigma, Germany). Template cDNA 
generated by this Omiscript Reverse Transcriptase method is suitable for the 
standard PCR, real-time RT-PCR, but also, synthesis of double-stranded cDNA 
for cloning, labeling for microarrays, analysis of transcription start by primer 
extension, serial analysis of gene expression (SAGETM), exponential RNA 
amplification (NASBA©, TMA), linear RNA amplification, rapid amplification of 
cDNA Ends (RACE).
3.4.2 Real-time RT-PCR or Quantitative Reverse Transcriptase – PCR
 (qRT- PCR) of mRNA TLR and mRNA TH1/TH2 cytokine  
The Omniscript Reverse Transcriptase is a recombinant heterodimeric enzyme 
expressed in E.coli. The quantity of isolated RNA corresponds to the entire 
amount of RNA including (ribosomal) rRNA, (messenger) mRNA, viral RNA and 
carrier RNA present in tissue and regardless of the primers used or cDNA 
analysed. It was not used a separated denaturation and annealing steps 
necessary for some RNAs with a high degree of secondary structure. In this 
case, the isolated RNA was denaturated in RNase-free water reagent by 
incubation at 55ºC for 5 minutes and placed immediately on ice. Concentration 
and length of the primers (Oligo-dT and gene-specific) used were optimized 
individually (e.g.Oligo-dT has 18 nuclotides, therefore the final concentration 
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used must be in the range of 0.1-1.0 μM) that specifically hybridize to the poly-A-
tail of mRNAs. For the quantification of RNAs transcripts, real-time RT-PCR was 
used because is a high sensitive and reliable method.
Real-time – PCR (RT-PCR) begins with reverse transcription of RNA into cDNA, 
followed by PCR amplification of the cDNA. The quantity of cDNA is determined 
during the exponential phase of PCR by the detection of fluorescence 
fluorophores incorporated into the PCR product such as SYBR® Green. The level 
of the transcrips was calculates from the number of the PCR cycles at which the 
threshold is exceeded, thus called the threshold cycle  or the crossing point. 
Real-time RT-PCR or Quantitative RT-PCR (qRT-PCR) was performed using the 
QuantiTect SYBR® Green PCR Kit (Qiagen GmbH, Hilden, Germany) and listed 
mouse Toll-like receptors specific primers such as TLR 1 to 9 or cytokines, 
chemokines or other immunomodulatory molecules:
- mouse TLR1 primer (sense 5 –TGT CCA AGC TGA GGG TCC TG-3, antisense 
5-GCT TGA GGC TGA CTG TTC GG-3)
- mouse TLR2 primer (sense 5- GCC AAG AGG AAG CCC AAG A-3, antisese 5- 
AAG GGC GGG TCA GAG TTC TC-3) 
- mouse TLR3 primer (sense 5- AAC AAC GCC CAA CTG AAC CC-3, antisense 
5- TGC CGA CAT CAT GA GGT TG-3)
- mouse TLR4 (sense 5- GCA GGT GGA ATT GTA TCG CC-3, antisense 5- TTC 
GAG GCT TTT CCA TCC AA-3) 
- mouse TLR5 primer (sense 5- ACC AAC GTC ACC CTG TTC GG-3, antisense 
5- GAC CGC ATG GCT TCC TCT TC-3) 
- mouse TLR6 primer (sense 5- CGA GCC TGA GGC ATC TAG ACC-3, 
antisense 5-GAG CAA CTG GGA GCA GAT CC-3) 
- mouse TLR7 (sense 5- TCC CAG AGG CCC ATG TGA TC-3, antisense 5- 
CCA GAT GGT TCA GCC TAC GG-3) 
- mouse TLR9 primer (sense 5- GGG CCC ATT GTG ATG AAC C-3, antisense 
5- GCT GCC ACA CTT CAC ACC AT-3) 
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Other primers used, such as: 
- mouse IL-4 primer (sense:5’-TCA ACC CCC AGC TAG TTG TC-3, antisense 
5’-TGT TCT TCG TTG CTG TGA GG-3) 
- mouse IL-10 primer (sense 5- GCA TGG CCC AGA AAT CAA GG-3, antisense 
5- TCT TCA CCT GCT CCA CTG CC-3) 
- mouse TNF  primer (sense 5- AGC CCA CGT CGT AGC AAA CC-3, antisense 
5- TAC AAC CCA TCG GCT GGC AC-3) 
- mouse IFN  primer (sense 5- GCG TCA TTG AAT CAC ACC TG-3, antisense 
5- TGA GCT CAT TGA ATG CTT GG-3) 
- mouse IL-1ß primer (sense 5- GGG CTG CTT CCA AAC CTT TG-3, antisense 
5- CTG GAA GGT CCA CGG GAA AG-3)
- mouse GAPDH primer (sense:5’-CGT CTT CAC CAC CAT GGA GA-3’, 
antisense:5’-CGG CCA TCA CGC CAC AGT TT-3’) 
- mouse L32 primer (sense 5- AAG CGA AAC TGG CGG AAA CC-3, antisense 
5- CTG GCG TTG GGA TTG GTG AC-3) 
- mouse Foxp3 primer (sense 5- TCC AAT CCC TGC CCT TGA CC-3, antisense 
5- CAC ATC ATC GCC CGG TTT CC-3) 
- mouse GATA-3 primer (sense 5- GTC ATC CCT GAG CCA CAT CT-3, 
antisense 5- AGG GCT CTG CCT CTC TAA CC-3) 
- mouse T-bet primer (sense 5- CCT GGA CCC AAC TGT CAA CT, antisense 5- 
AAC TGT GTT CCC GAG GTG TC) 
An initial denaturation step for 15 minutes at 95°C, 55 PCR cycles of 94°C for 15 
seconds, 60°C for 30 seconds and 72°C for 15 seconds were applied. Finally, 
product homogeneity was verified by melting curve analysis. PCRs were 
performed using LightCycler Equipment (Roche Company, Indianapolis, USA), 
and the crossing points were calculated using the second derivative maximum 
method (included in LightCycler Software) for unknown samples and for DNA 
standards of known concentrations generated from purified PCR-products of the 
respective gene. Unknown sample concentrations were calculated according to 
the standard curve and expressed as percent of average control. Sample 
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equality or normalization was confirmed by comparable expression of the 
housekeeping genes GAPDH or L32. After the protocols were established the 
experiments were replicated two times. 
3.4.3 TLR and TH1/TH2 cytokine quantification by LightCycle after in vitro 
antigens stimulation of trophoblast stem cells (TSCs, SM-10 cell line)
Placental - Trophoblast Stem Cells (TSCs), SM-10 cell line passaged several 
weeks until the cell number was sufficient for stimulation. After trypsination 
followed by washing steps, the cells were counted by CASY TT Cell Counter 
System, and 1 x 106 cells/ml/well cultured in 24-well flat-bottom plates at 37ºC in 
a cell incubator, under 5% CO2 and 95% humidified atmosphere. Two different 
protocols was performed, first for 3.5 x 105 6cells/ml/well and secondly, 1 x 10
cells/ml/well. Cells were stimulated with four different allergens, such as 
Lactobacillus rhamnosus GG (LGG), Lipid A (LA active component of 
LPS/E.coli), Lipopolysaccharide (LPS/E.coli) and Acinetobacter lwoffii F78 (Ac. 
lwoffii) at three different concentrations of 10, 50, 100 ng per 1 ml cell 
suspension, incubation time of 24 and 48h, respectively. The cell-free 
supernatants were harvested and levels of IL-4, IL-10, IL-1ß, TNF , IFN  were 
measured using Enzyme-Linked ImmunoSorbent Assay (ELISA). Remaining 
cells were used in cDNA synthesis. Furthermore, mRNA TLR1 to TLR9, 
cytokines and chemokines expression (IL-4, IL-10, IL-1ß, TNF  and IFN ) were 
quantified by LightCycler System as described above.
3.5 Protein Analysis 
3.5.1 Measurement of cytokine and chemokine in bronchoalveolar lavage 
fluid, amniotic fluid and plasma of un-/pregnant mice by Cytometric 
Bead Array (CBA) 
Cytometric Bead Array (CBA) is a FACS-based method for analyzing the 
expression of multiple analytes such as cytokines, chemokines, inflammatory 
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mediators, immunglobulines and cell signaling molecules from different biological 
fluids. Measurement of cytokines and chemokines in bronchoalveolar lavage 
fluid, amniotic fluid and plasma of un-/pregnant mice, such as IL-4, IL-5, IL-10, IL-
12p70, IL-1ß, MCP-1,IL-13, TNF , IFN  were determined by Cytometric Bead 
Array (CBA; BD Biosciences, San Diego, CA, USA) followed the manufacturer s
instruction. There are two commercially available kits: the BDTM TH1/TH2
cytokines Kit (IL-4, IL-5, IL-13, TNF , IFN ) and the BDTM Inflammation Kit (IL-10, 
IL-12p70, IL-1ß, MCP-1). Different dilutions in range 1:2, 1:4 until 1:4096, in a 
total volume of 1000 l per tube of cytokine standards were used. Prior the BAL 
fluid, plasma and amniotic fluid samples were diluted 1:2 and added of 1 l BD 
Capture Beads Solution (PE-conjugated antibody), in a total volume of 50 
l/probe. Both standards and samples were incubated for 1 hour at room 
temperature (RT) avoid of light. After incubation step, 1 ml of washing buffer
solution was added in each tube and centrifuged at 200g for 5 minutes. The 
supernatant was taken off and the remaining sediment of protein was diluted in 
300 l washing buffer solution. The samples were analyzed by FACScan /CBA 
Software - Becton Dickinson Company, USA.
3.5.2  Measurement of OVA-specific antibodies in offspring blood serum by  
Enzyme-Linked Immunosorbent Assay (ELISA) 
Enzyme-Linked ImmunoSorbent Assay (ELISA) is a biochemical technique used 
mainly in immunology to detect the presence of an antibody or an antigen in a 
sample. Performing an ELISA involves at least one antibody with specificity for a 
particular antigen. The sample with an unknown amount of antigen is 
immobilized on a solid support (polystyrene microtiter plate) either non-
specifically (via adsorption to the surface) or specifically (via capture by another 
antibody specific to the same antigen, in a sandwich ELISA method), (Fig.3.5.2). 
Thus, levels of OVA-specific IgG1, IgG2a and IgE antibody titers were measured 
by the ELISA technique. The 96 well microtitre plates (Nunc GmbH, Wiesbaden, 
Germany) were coated with ovalbumin – OVA - (grade VI; Sigma GmbH, 
Germany) at 4°C. 
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Fig.3.5.2 Enzyme-Linked Immunosorbent Assay (ELISA). The first antibody binding specific 
antigen, followed by a covalently binding between antibody and a ligand exposed to specific 
developing chromogen (according to: Male, D., 2004. Immunology – an illustrated outline. 
Handbook, the 4th Edition, Elsevier Science)
After incubation, plates were rinsed with a washing solution of 0.1% (v/v)  Tween 
20/PBS and blocked with diluted bovine serum albumin 1% (w/v) BSA/PBS for 2 
hours at room temperature. Diluted serum samples and monoclonal OVA-specific 
IgE (Serotec GmbH, Düsseldorf, Germany), IgG2a (Dianova GmbH, Hamburg, 
Germany) and IgG1 (Sigma GmbH, Germany) standards are added and the 
plates are incubated overnight at 4°C. After a new washing step, the plates are 
coated with biotin-conjugated anti-mouse IgE, IgG  or IgG1 2a (BD Biosciences 
Company, San Diego, USA) and incubated for 2 hours at RT. In the second-step 
horse-radish peroxidase-conjugated streptavidin (Sigma GmbH, Germany) is 
added for 30 minutes, at RT, devoid of light. Plates are developed with specific 
peroxidase substrate (Roche GmbH, Mannheim, Germany). Microtitre plates are 
read by ELISA Reader Program - Magellan3 (Tecan GmbH, Crailsheim, 
Germany).
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3.5.3 Measurement of TH1/TH2 cytokines in offspring bronchoalveolar 
lavage fluid (BALF) by Enzyme-Linked Immunosorbent Assay 
(ELISA)
Differential cell counts in bronchoalveolar lavage fluid (BALF) are done after 48h 
from the last allergen challenge, as describe above. Total leukocytes counts are 
determined with an automated Casy TT Cell Counter (Schärfe Systems, 
Reutlingen, Germany). BALF cells were placed in a cytospin and centrifuged at 
300g, then stained with May-Grünwald Giemsa staining solution after a prior 
fixation in Methanol. BALF cell differentiation and counts is performed by light 
microscopy using standard morphologic criteria. Differential cell counts of 100 
leukocytes are performed in duplicates. Remaining BALF volume is centrifuged 
at 300g and cell-free supernatants were stored in freezer at -20°C for a later 
measurement of cytokine and/or chemokines levels, such as: IL-4, IL-5, IL-10, IL-
13, TNF , IFN  by using specific antibodies (ELISA). Prior, either the samples 
are diluted in a range of 1:20 and 1:50 and all first antibodies in a range of 1:250, 
1:500, 1:1000 in coating buffer containing 0.1 M NaHCO3 with pH 8.3. The 96 
well microtitre plates (Nunc GmbH, Wiesbaden, Germany) are coated with 50 
l/well primary antibody and incubated over night in fridge at 4°C. After 
incubation the plates are washed with 150 l/well washing solution 0.1% (v/v) 
Tween 20/PBS using Tecan Columbus Washer System. The plates are blocked 
with 100 l/well blocking solution 1% (w/v) bovine serum albumin - BSA/PBS for 
2 hours at RT. Thus, after a new washing step with the starting concentration of 
1000 pg/ml (TNF  and IFN ) and 500 pg/ml (IL-4, IL-5, IL-10, IL-13) the diluted 
samples and seven standards, respectively diluted 1:2 are added 50 l/ml. The 
microplates are incubated 2 hours at RT. After incubation step the plates are 
washed again, the diluted 1:1000 secondary antibody, a biotin-conjugated anti-
mouse is added in a volume of 50 l/well and incubated for 2 hours at RT, on a 
specific microplates shaker system. In the second-step horse-radish peroxidase-
conjugated streptavidin (Sigma GmbH, Germany) is added for 30 minutes, at 
room temperature devoid of light. Microplates are washed and developed using 
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100 l/well BM Blue POD Substrate (Roche GmbH, Mannheim, Germany), for 30 
minutes at RT into a dark space. The colour reaction is stopped with the 50 
l/well of stop solution (2 M H2SO4) and read by ELISA Reader Program - 
Magellan3 (Tecan GmbH, Crailsheim, Germany), at a wavelength of 450 nm with 
a reference wavelength of 620nm. 
3.5.4 Measurement of TH1/TH2 cytokines in offspring after in vitro OVA re-
stimulation of splenic mononuclear cells (MNCs) by Enzyme-Linked 
Immunosorbent Assay (ELISA) 
The entire offspring mouse spleen is meshed through a nylon sieve and 
resuspended into 5 ml of sterile RPMI cell culture medium (RPMI 1640, 
Cedarlane Company, Hornby, CAN) containing  heat-inactivated Fetal Calf 
Serum 10% (v/v) (FCS), 100 U/ml Peniciline-Streptomycine, 1% (v/v) L-
Glutamine. The splenic mononuclear cells were isolated by density gradient 
centrifugation (Lympholyte® M, Cedarlane, Burlington Company, MA, USA). After 
two washing steps the cells were counted by CASY TT cell counter system and 
cultured in the 24-well flat-bottom plates in cell incubator under specific 
parameters (37ºC, 5% CO 6 and 95% humidified atmosphere). Thus, 2 x 102
cells/ml/well were stimulated with 50 μg/ml OVA in a total volume of 1ml cell 
suspension. After 72 hours incubation time, cell-free supernatants are harvested 
and levels of IL-4, IL-5, IL-10, IL-13, TNF , IFN  are measured using Enzyme-
Linked ImmunoSorbent Assay (ELISA) method.
3.5.5 Measurement of pregnancy steroid hormones in blood serum (BS) 
and amniotic fluid (AF) of un-/pregnant mice by Enzyme-Linked 
Immunosorbent Assay (ELISA) 
From all supplemented and control groups the steroids hormonal level of 
estrogen and progesterone (Progesterone human serum-calibrator 50, Beckman 
CoulterTM, USA) in blood serum and amniotic fluid is quantified by ELISA 
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technique. Following the intrauterine experimental protocol un-/pregnant female 
mice of Balb/c and C57BL/6 strains are supplemented with LGG, Ac. lwoffii F78, 
LA and control animals with PBS and incubated for 10 minutes at 55ºC. The 
blood was collected from tail in sterile condition, before mice were euthanized at 
pregnancy term (day 18) and preserve for 60 minutes in fridge at 4°C followed by 
a centrifuged step with 4000 rpm, for 20 minutes at RT. Collecting amniotic fluid, 
the pregnant mice are euthanized, the uterus was opened and a volume of 50-
1000 l had been pulling out with a sterile syringe. Either, serum or amniotic fluid 
can be preserved for later analysis in freezer, at -20ºC for one month.
3.5.6     Western Blot Analysis (WB): TLR detection in maternal organs 
      
Western blot (WB) is a method to detect a specific protein in a given sample of 
tissue homogenate or extract. It uses gel electrophoresis to separate native or 
denatured proteins by the length of the polypeptide (under denaturing condition) 
or by the 3-D structure of the protein (native/non-denaturing conditions). After cell 
or tissue extraction the proteins are then transferred to a special membrane 
(Nitrocellulose or Poly-1,1-difluoroethene or polyvinylidene difluoride - PVDF),
where they are detected using specific antibodies (monoclonal and/or polyclonal
antibodies) to the target protein. This has dramatically reduced the time to carry 
out a blot. Maternal organs such as small intestine, spleen and placenta are 
collected into liquid nitrogen, preserved and stored in freezer at -80°C. For 
protein extraction the thawing process is initiated using a new protocol. TriZol 
lysing buffer 1 mL is used for 50 mg organ (as well as  5 x 106 cells/ml culture 
medium) to lyses the cells, respective to destroy both connective tissue and 
membrane cells, in order to release the entire amount of proteins. The separation 
phase step containing RNA (transparent supernatant, SN) and proteins tissue 
mixture (the sediment) is performed using 200 μl of Chloroforme followed by cold 
centrifuged under 4°C temperature, for 15 minutes at 12,000g. Thus, the 
supernatant containing isolated total RNA could be preserved in absolute EtOH, 
in freezer under -80°C, whilst sediment containing total amount of proteins is 
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treated with Isopropanol for protein extraction. A new centrifugation is performed 
for 10-15 minutes under 4°C at 12,000g. The protein pellet is treated with 2 ml 
Guanidinehydrochlorid 0.3 M in Ethanol 95% (v/v) followed by ultrasonification for 
10 minutes. This extraction process is performed twice and followed by a protein 
washing step with absolut EtOH. By incubation step the protein pellet is 
denaturated by 40 μl Lämmli buffer, for 5 min at 95°C, followed by a new 
centrifuged 10-15 minutes under 4°C at 12,000g. The samples are preserved in 
freezer under -80°C. After the protein extraction the concentration is measured 
using the BCA Kit a protein concentration measurement method by the 
manufacturer’s intructions. Absorbtion curve is completed by Tecan Reader 
Program – Magellan 3 at the wave leght of 562 nm. Previously, the SDS
dispersive gel and collector gel are prepared and the spacers are loaded with 25 
l of mixture solution containing protein and sample buffer (diluted 30:1) and 
protein marker (MagicMarkTM XP Western Protein Standard). The proteins 
negatively charged by SDS, leave themselves from an uncolored 
Polyacrylamidgel on a Nitrocellulose membrane after the Semydry buffer is 
applied. Methanol a potent activator of the membrane is applied before the 
protein transfer. Thus, the TLR2 and TLR4 target proteins are transferred for 1h 
at 65V to a membrane of Nitrocellulose or PVDF the blot equipment which 






Fig.3.5.6 Western Blot Analysis (WB) – the target  proteins transfer process from SDS gel to a 
Nitrocellulose or PVDF membrane was utilized to express TLR in placental, gut or spleen 
maternal tissues. 
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The protein transfer is verified by Ponceau staining before the antibodies are 
added. The membrane is washed with distillated water and blocked by a blocking 
solution of Milk 3% (wt/v) reconstituted in PBS, for 30 min. The target proteins 
are detected in two steps for 1 hour at RT, roller-shacked. As first antibody rabbit 
anti-mouse TLR2 and TLR4 monoclonal or polyclonal antibodies diluted into milk 
solution (diluted 1:400) are used and as secondary antibody an anti-rabbit-goat 
HPR-conjugated (diluted 1:2000), respectively. After the antibodies are applied, 
the membrane is washed twice in TTBS. The development step is done by Picco 
Developer Kit/Femto solution (Pierce Company, USA), and dry with non-porously 
Whatmann papers. A Röntgen Polymer Film was laid over the membrane being 
closed into a black box and avoiding light at different time-points, in order to 
become high quality images. Because the detection of targeted proteins by WB is 
very sensitive method, specific antibodies, fresh made gels and buffers is 
mandatory to be done before to start. 
3.5.7 Magnetic-Absorbed Cell Sorting (MACS): positive selection of total 
+CD45  cells from murine placenta 
Magnetic-activated cell sorting (MACS) is a method used for separation of 
various cell populations depending on their surface antigens (CD molecules).
The term MACS is a registered trademark of Miltenyi Biotec. Since fluorophore-
conjugated antibodies are much more prevalent, it is possible to use magnetic 
beads coated with anti-fluorochrome antibodies. They are incubated with the 
fluorescent-labelled antibodies against the antigen of interest and may serve for 
cell separation with respect to the antigen. Thus, the separated mixture of cells is 
incubated with magnetic beads solution. Afterwards, the cell solution is 
transferred on a column placed in a strong magnetic field. In this step, the cells 
attached to the beads (expressing the antigen) stay on the column, while other 
cells (not expressing the antigen) flow through.
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Fig.3.5.7 Placental immune cells isolation by positive selection - MACS System and 
characterisation by Flow Cytometry System. The experimental protocol includes four other 
protocols of work, such as: (1) mouse placenta perfusion; (2) mechanical tissue destruction; (3)
placental immune cells isolation; (4) positive selection; (5) placental cell characterisation. 
By this method, the cells can be separated positively or negatively with respect to 
the particular antigen(s). Removing the MACS column from the magnetic field a 
positive selection the cells expressing the antigen of interest, which attached to 
the magnetic column are washed out into a separate glass vessel.
The general experimental protocol of placental immune cells isolation includes 
five other protocols of work applied exclusively for placental tissue in animal 
model, such as: (1) mouse placenta perfusion – after a prior mouse’s 
anaesthesia, a total perfusion of the mouse is needed (through the left ventricle 
of the heart, using a sterile 10 cc syringe and 4-8 ml saline solution  NaCl 0.9% 
(v/v), with a constant pressure solution); then, a local placenta perfusion is 
performed; (2) mechanical tissue destruction by a Cell-Shredder (79400S 
Medicons, 50 m, DAKO Cytomation, Hamburg, DK) and DAKO Medimachine 
(DAKO Cytomation, Hamburger, DK); the placenta pieces are placed into a steel 
mesh with 50 m pore diameter grated, followed by five times rinse with cold 
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PBS; thus the placenta cell suspension obtained is stored immediately in ice; (3) 
placental immune cells isolation with Lympholyte M, Percoll®/PAN-COLL mouse 
or Ficoll Isopaque gradient solutions (ussualy to isolate cells of different densities 
and in particular, to purified the lymphocytes). The diluted sample of cell 
suspension added to the gradient solution and centrifuged. Because red blood 
cells and polymorphs remained into cell suspension after perfusion they 
sediment to the bottom of tube, while the lymphocytes and some macrophages 
remain at the interface. Lymphocyte population may be further depleted of 
macrophages by adherence or by letting the phagocytes take up iron filings and 
then removing them with a magnetic field system), and (4) positive selection by 
MACS method using the CD45 Isolation Kit (Miltenyi Biotec, Germany). Prior to 
cell suspension load onto a MACS® Column (placed into a strong magnetic field 
of a MACS Separator), the CD45+ cells are magnetically labelled with CD45 
Microbeads and incubated at 4°C for 20 min, avoid light. The magnetically 
labelled CD45+ cells are retained on the column. The unlabeled cells run through 
and this cell fraction is depleted of CD45+ cells. After column removal from the 
magnetic field, the magnetically retained CD45+ cells can be eluted as the 
positively selected cell fraction. The 5th experimental protocol includes placental 
cell characterisation using an extra-cellular staining protocol and capturing the 
cell population images by a sorting instruments, like FACS (fluorescent-activated 
cell sorting system). This method is useful for isolation of a particular cell type. 
Magnetic beads conjugated to an antibody against an antigen of interest are not 
always available, but there is a way to circumvent it.
3.5.8 Characterisation of placental immune cells by Flow Cytometry 
(FACS)
+Subsequent to MACS positive selection of total CD45  lymphocytes of placental 
tissue the cell suspension is centrifuged at 350g, for 10 minutes then washed 
with sterile PBS, and the pellet resuspended in 1 ml FACS buffer. The cell 
number is counted and the suspension volume is split in four tubes. FACS tube 
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6contains 1 x 10 cells/333 μl FACS buffer, then centrifuged at 350g for 10 
minutes (using centrifuge brakes). After centrifugation the cell pellet is 
resuspend in 1 l mice serum and 9 l FACS buffer. Additionally, the placental 
immune cells are harvested and stained with fluorochrome-conjugated 1 l
mouse-Abs and rat-Abs as isotype control (Fig./Tab.3.5.8).
Tubes 1 2 3 4 Isotype control 
FITC CD 3 CD 25 NK 1.1 CD 11c Rat IgM,k 
PE CD 8 CD 69 B 220 CD 11b Rat IgG2a,k 
PerCP C D 4 CD 4 CD 3 CD 3 Rat IgG2a,k 
APC CD 45 CD 45 CD 45 CD45 Rat IgG2b,k 
Tab.3.5.8 Experimental protocol of placental immune cells. An extracellular staining method 
developed exclusively for FACS analysis 
Erytrocytes Granulocyte Mph DC
Mouse Pluripotent Stem Cells
B cell Th cell Tc cell Treg cell NK cell
Antigen-presenting cells T cells
CD11b
CD11c
CD11b CD11c CD45R(B220) CD4 CD8a CD4CD25 CD49b(DX
Placenta immune cells
Fig.3.5.8 Schematically illustration of placental immune cells and specific markers 
(according to: MACS® Animal Cell Isolation Scheme – The optimal solution for cell isolation in 
immunological research, Miltenyi Biotec GmbH, 2007)
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Incubation step is performed at room temperature, 20 minutes avoid of light. 
Then, the cell pellet is washed out in 1 mL FACS buffer and centrifuged at 350g, 
for 10 minutes and resuspend in 300 l Cell-fix solution of 1% (v/v) (dilution of 
1:10 of 4% formaldehyde reconstituted in distillated water). Using appropriate 
laser detectors, they send to the cells characteristic light signals in followed 
range of the wavelength of light emissions: 515-545 nm/564-606 nm/650 nm. 
The system is setting for the four colors analysis of cell surface antigens, such 
as: FITC, PE, Per CP and APC marks. The FACS sorting system consists of the 
Flow Cytometer as a sensor unit, a computer workstation and various software 
programs. Placental immune cells were analyzed by means of flow cytometry on 
a FACScan by using the CellQuest 3.22i Software (Becton Dickinson Company 
and Apple McIntosh PC, Franklin Lake, USA).
3.5.9 Offspring lung and maternal small intestine, spleen and placenta 
histopathology: Haematoxylin & Eosin (HE) and Periodic acid-Schiff 
(PAS) staining methods 
Previously, the organs were perfusing with PBS buffer, pH 7.2 and in situ fixed 
with formaldehyde 4% (wt/vl) solution. Entire tissues were paraffin-embedded 
and 3 μm sections cut by Microtome. Tissue histopathology including the tissue 
structural alter, inflammatory cells accumulation and mucus production were 
observed with Haematoxylin/Eosin (H&E) and Periodic acid-Schiff (PAS) stained 
sections using high-power light microscopy. Paraffin-embedded sections like 
maternal small intestine, spleen and placenta respective offspring lung are 
deparaffinized and rehydrated in xylene 2 x 15 minutes, respectively 2 x 5 
minutes in a descending concentration of ethanol (100%, 90%, 80%, 70% and 
50%) (v/v). Thus, the samples are prepared for the staining steps in 
Haematoxylin solution/Gill III - 10 minutes and Eosin solution – 5 minutes. 
Following staining steps, tissue slides are fixed with an ascending series of 
ethanol (70%, 80%, 90% and 100%), 1 x 1 minute and into Neo-clear solution or 
Xylol, 1 x 15minutes. The slides are counterstained with Neo-Mount or Entellan-
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New. Haematoxylin/Eosin (H&E) is a qualitative analysis of histological 
preparations. The staining procedure allows the differentiation of various cells 
using morphological criteria. The system uses two different colors specific for the 
basophile/azurophile - Haematoxylin (blue staining) and the acidophil/eosin - 
Eosin G. (red staining). The Haematoxylin binds mainly to positively charged 
proteins, such as histones in the cell nuclei (hence turn the cell nucleus blue), 
while Eosin binds to negatively charged proteins from the target cell or rest of the 
tissue.
The reaction of Periodic acid selectively oxidizes the glucose residues, resulting 
aldehydes that react with the Schiff reagent and creates a purple color. PAS 
staining is mainly used for staining structures containing a high proportion of 
carbohydrate macromolecules such as: glycogen, glycoprotein, proteoglycans
typically found in connective tissues, mucus, and basal lamina. Deparaffinization 
and rehydration steps are identical as in H&E staining. Thus, the sections are 
bathed 1 x 5 minutes in Periodic acid and 1 x 15 minutes Schiff reagent. Again, 
the stained tissue slides were fixed through an ascending series of ethanol (70%, 
80%, 90%, 100%), 1 x 1 minutes each, then into Neo-clear or Xylol, 1 x 15 
minutes. The slides are counterstained with Neo-Mount or Entellan New. Both 
H&E and PAS stained tissue slides are examined under a Light microscope 
(Olympus BX51®).     
3.5.10 Immunohistochemistry (IHC) of maternal main investigated organs
Immunohistochemistry (IHC) refers to the process of localizing proteins in cells of 
a tissue section exploiting the principle of antibodies binding specifically to 
antigens in biological tissues. Two-step Indirect Immunohistochemistry  is used 
to stain CD4+ T cells, TLR2 and TLR4 expressed by APC- and Trophoblast cells 
by Vector® M.O.M.TM Immunodetection Kit for both HPR (Horseradish 
Peroxidase) or AP (Alkaline Phosphatase) systems. The indirect method of 
immunohistochemical staining involves an unlabeled primary antibody, for a 
specific tissue antigen, and a labeled secondary antibody, which binds the 
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primary antibody (the secondary antibody must be against the IgG of the animal 
species in which the primary antibody has been raised). The method is very 
sensitive due to signal amplification, through several secondary antibody 
reactions with different antigenic sites on the primary antibody. Commonly, the 
biotinylated secondary antibody is coupled with Streptavidin-Horseradish
Peroxidase (S-HRP) or Streptavidin-Alkaline Phosphatase (S-AP). This reacts 
with 3, 3'-Diaminobenzidine (DAB) in order to produce a brown staining. The 
primary and secondary antibodies are attached in this procedure known as DAB 
staining. The reaction can be enhanced using Nickel (Ni), producing a deep 
purple-gray staining at the end for HRP system. In case of AP system the 







labelled secondary antibody reacts
with primary antibody bound to tissue
antigen (according to: Boenisch, T.,
et al., 2001. Immunohistological
staining methods. Handbook the 3rd
Edition, Dako Cytomation,
Carpinteria, California, USA) 
® TMTo obtain the tissue slides, a microtome (Accu-Cut  SRM 200 Rotary 
microtome, Sakura Finetek, USA Inc.) is applied. It is a mechanical instrument 
used to cut biological specimens into very thin segments for microscopic 
examination. Most microtomes use a steel blade for cuting animal tissues in very 
fine histological sections. The most common applications of microtomes used 
are: (i) traditional histological technique: tissues are hardened by replacing water 
with paraffin. The tissue is then cut in the microtome varying from 2 to 25 μm 
thickness. Thus, tissue is mounted on a microscope slide stained and examined 
using a light microscope (LM) or fluorescent microscope (FM); (ii) cryosections: 
water-rich tissues are hardened by freezing and cut frozen; sections are specific 
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stained and examined by a light microscope. Accordingly, in our study maternal 
paraffine-embeded tissues like small intestine, spleen and placenta as well as 
offspring lung are used. The 3 m sections are deparaffinized and rehydrated 
performing steps described at H&E/PAS staining. Moreover, the maternal cryo-
embeded tissues of 10 m cryosections, are rehydrated in Xylene for 2 x 15 
minutes and different concentrations of ethanol (100%, 90%, 80%, 70% and 
50%) for 2 x 5 minutes. Sections are rinsed in tap water for 5minutes and the 
antigen retrieval applied by boiling the sections into microwave using a 10 mM 
Citrate buffer. The sections are immediately cool down in ice for 20 minutes. The 
cryosections are dried in air for 10 minutes and fixed in cold acetone for 10 
minutes. The endogenous peroxidase activity is blocked with a blocking solution 
of 5% goat- or rabbit serum anti-mouse IgG reconstituted in sterile 1x PBS for 5 
minutes. The enzimatical activity can be inhibiting by a mixture of sodium azide 
and H O2 2. The sections are rinsed in PBS and the first antibody (1:100), such as 
polyclonal rabbit anti-mouse TLR2, TLR4 or CD4 T cells applied, for 2 hours of 
incubation time. Afterwards, the secondary antibody - biotinylated goat anti-rabbit 
(1:200) is applied for 1 hour of incubation time. Using light microscopy the 
sections are covered with undiluted streptavidin – peroxidase-conjugated reagent 
for 15 minutes. Fluorescence microscopy requested a streptavidin – FITC-
conjugated reagent for 5 minutes. The peroxidase substrate of 0.1% DAB - 0.3% 
H O (v/v)2 2 is applied for 10 minutes, increasing the staining procedure intensity. 
The counterstaining is performed using a Mayer Hematoxylin staining solution, 
for 6-8 minutes or Fluorescein depending on the preferred microscopy. Then, the 
sections are blue  with a solution of 1% NaOH (v/v) reconstituted in distilated 
water, pH 9.5-9.8, for 3 minutes. The preceding paraffine sections passed 
backward through ethanol baths and xylol to fix the staining (as described at 
H&E/PAS staining). The stained tissues are covered with colorless nail polish or 
other alcohol insoluble covering media (Histomount mounting solution, Zymed 
Laboratories, San Francisco, USA) and studied under the light microscope, 
respective fluorescent microscope (Olympus BX51®, Olympus Deutschland 
GmbH), using particular  filters. 
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3.5.11 Electron microscopy of placenta after prenatal supplementation 
After embedding tissues in Epoxy resin, a microtome equipped with a glass or 
diamond knife is used to cut very thin sections (typically 60 to 100 nanometers). 
Sections are stained and examined with a transmission electron microscope.
This instrument is often called an ultramicrotome. Placenta samples were fixed 
by immersion into a mixture of 1% glutardialdehyde and 1% paraformaldehyde in 
0.1 M sodium cacodylate buffer, pH 7.4 for 2 hours in the cold PBS. After rinsing 
with 0.1 M sodium cacodylate buffer, samples are post-fixed with 1% osmium 
tetroxide in 0.1 M sodium cacodylate buffer for 2 hours, rinsed in the same buffer 
for 4 x 5 minutes, washed in distilled water for 2 x 5 minutes, and stained on-bloc 
in half-saturated uranyl acetate over night. After rinsing with distilled water 4 x 5 
minutes, samples are dehydrated through an ascending series of acetone (70%, 
90%, 100%) for 2 x 10 minutes, transferred into a 1:1 mixture of acetone and 
Araldite for 1 hour and finally, into pure Araldite, over night. After transfer into 
fresh resin, samples are polymerised at 60°C for three days. Ultrathin sections 
are cut on an Ultracut-E® (Reichart-Jung, Wien, Austria), collected on coated 
nickel grids, stained with lead citrate and uranyl acetate, and analysed using a 
Zeiss EM 900 (Zeiss®, Oberkochen, Germany) (according to: Fehrenbach, H,  
2007).
0.2 M Cacodylate buffer - stock solution
250 ml distillated H20
20.15 g sodium cacodylate trihydrate (MW = 214)
0.1 ml HCl
pHfinal 7.4 
0.1 M Cacodylate buffer, solution with 3% sucrose and 0.1% CaCl2
30 g RNAase-free sucrose (can use regular sucrose if not making it for EM)
0.05 g CaCl2 or 1 ml of a 1M CaCl2 stock solution
250 ml 0.2 M cacodylate stock solution
250 ml distillated H20
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3.6 Lung function analysis. Measurement of Airwayhyperreactivity 
(AHR) to -Methyl-Acetylcholine (MCh) using Head-out-body-
plethysmography 
Changes in lung functions were determined by noninvasive head-out body 
plethysmography. The development of acute airway obstruction after OVA 
challenge and airwayhyperreactivity (AHR) after methacholine aerosol 
application (after 24 hours from last challenge) were assessed by a decrease in 
the mid-expiratory flow rate (EF50). The Head-out Body Plethysmograph (HOBP) 
system is a glass made cylinder-like attached to aerosol exposure chamber 
(Forschungsstätten Medical School Hannover, Gemany). Each mouse is 
positioned in the head-out body plethysmograph while the head of the animal 
protuded through a neck collar (9 mm inner side diameter; RoekoLangenau, 
Germany) into the aerosol exposure chamber which is ventilated by continuous 










. . . .
. . . .
Exposure chamber
Exhaust
Fig.3.6 Offspring lung function analysis. Schematically illustration of measurement of airway 
hyperreactivity (AHR) to -Methyl-Acetyl-Choline (MCh) by Head-out-body-plethysmography 
(according to: Wegmann, M., Animal Models of Experimental Asthma. In Animal Models of T Cell 
Mediated Skin Diseases. Erst Schering Res Found Workshop. Axel Springer Verlag 2004(50): 
69-87)
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For airflow measurement, a calibrated Pneumotachograph (PTM 378/1.2; Hugo 
Sachs Elektronik, March-Hugstetten, Germany) and a differential Pressure 
Transducer (8T-2; Gaeltec, Dunvegan, Scotland) couplet to an Amplifier (HSE-
IA; Hugo Sachs Elektronic) are attached to the top port of each plethysmograph. 
For each animal, the amplified analog signal from the pressure transducer was 
digitized via an Analog-Digital Converter (DT301 PCI; Data Translation 
Marlboro, MA). For data calculation Notocord hem 3.5 Software (Notocord®,
Paris, France) is used. During continuous assessment of EF50, mice were 
exposed to -Acetyl-Methacoline (MCh) aerosols with rising concentrations 
(12.5, 25, 50, 75, 100 or 125 mg/ml), and airway hyperreactivity was expressed 
as the concentration of MCh that caused a 50% reduction in baseline mid-
expiratory airflow (MCh mg/ml) using subsequently parameters:   
15 `baseline measurement 
15 `10 `` PBS 
19 `50 `` - 12.5 mg/ml MCh
24 `30 `` - 25.0 mg/ml MCh
29 `10 `` - 50.0 mg/ml MCh
33 `50 `` - 75.0 mg/ml MCh
38 `20 `` - 100  mg/ml MCh
43 `10 `` - 125  mg/ml MCh
46 `40 `` end of measurement 
    
The -Acetyl-Methacholine (MCh) is a derivative of the neurotransmitter 
acetylcholine, with potential action transmission in the neurons and 
neuromuscular synapse. The animals tested inhaled the MCh aerosol that binds 
into to the cholinergic receptors the neuromuscular synapse, and give a signal to 
muscle contraction. However, the effect is only locally on the smooth respiratory 
muscles. Therefore, the resulting bronchial obstruction shows an increase in 
respiratory resistance. This means that each animal have to breathe against an 
increase in respiratory resistance, leading to a slow down expiration, meaning a 
reduced expiratory respiratory flow.
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In animals with an allergic inflammation in the lungs is an increased sensitivity to 
non-specific stimuli like MCh, thus those animals may respond significantly to 
lower concentrations of MCh with a 50% reduction in the EF50. Diversity of values 
depends on the species used. They are modified by the genome of the 
respective animal, so it is necessary to measure for any attempt an appropriate 
number of appropriate controls - depends on the experimental protocol and the 
species used.
3.7 Statistics 
Analysies done with Microsoft Excel as well with One-way ANOVA or Student’s 
unpaired t -test (GraphPad Prism® Software, version 4.01) to determine the level 
of significance between the treated and untreated animal groups. All numerical 
data expressed MEAN ± S.E.M (Standard error of the mean value). Results are 
considered statistically significant for p< 0.05. 
3.8 Materials 
Consumables Provider
Centrifuge tubes, sterile (15 ml, 50 ml) VWR GmbH, Germany
CASYcup with lid Innovatis AG, Bielefeld, Germany
FACS tubes without lid Sarstedt GmbH, Nümbrecht, 551579, 
Germany
Plasma tubes (Microvette #500K3E, 
contain Tri-K-EDTA)
Sarstedt GmbH, Nümbrecht, 551579, 
Germany
ELISA 96-well plates Nunc Maxisorp, NUNC, 437958, 
Germany
Cell culture 24-well plates Nunc Maxisorp, NUNC, 142475, 
Germany
2)Cell culture bottles (25cm Nunc Maxisorp, NUNC, 156367, 
Germany
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2)Cell culture bottles (75cm Nunc Maxisorp, NUNC, 156499, 
Germany
Perfusion butterfly needle BD Bioscience, Heidelberg, Germany
Syringes and needles for injection BD Bioscience, Heidelberg, Germany
Nylon Cell sieves (100μm) Falcon BD, Heidelberg, 352360, 
Germany
Syringe-Fitting, 50μm CN01330, 79400 Medicons Dako 
GmbH, Germany
Filter paper Whatmann, Maidstone, UK
2) Menzel-Glass, GermanyGlass cover slips(24 x 50mm
Cryotubes(2 ml) Sarstedt GmbH, Nümbrecht, 
72694106, Germany 
Filters (0.22 μm  and 0.45 μm) Kobe Lab.& Intsr., Marburg, FA0371-
1, Germany 
LC capillary Roche GmbH, 1909339, Germany 
Hand gloves (S,M size) NOBA GmbH & Co., 905451/2, 
Germany
Hyperbond Nitrocellulose Membrane Amersham GmbH, 25012345, 
Germany
DF-Membrane Millipore GmbH, IPVH 00010, 
Germany
Antibodies, Enzymes and Kits Provider
Ovalbumin chicken Egg Grade VI 
(OVA)
Sigma GmbH, A-2512, Germany 
Monoclonal Anti-Chicken Egg 
Albumin(Clone Ova-14) 
Sigma GmH, A-6075, Germany
Mouse Serum BioMedizinisches Forschung 
Zentrum, Marburg, Germany 
dNTp Mix 10 mMol Invitrogen GmbH, 18427-088, 
Germany
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RNA Later Qiagen GmbH, Hilden, Germany 
RNA Sample Buffer Sigma GmH, r4268, Germany
DNA 100bp plus 100-3000bp Peqlab GmbH, Germany 
DNA 50bd -Leiter Peqlab GmbH, Germany 
DNA Leiter High Range Mix Peqlab GmbH, Germany 
BDTM Cytometric Bead Array(CBA) Kit BD Biosciences, San Diego, CA, USA 
RNeasy Mini Kit(50) Qiagen GmbH, Hilden, Germany 
Rneasy Lipid Tissue Mini Kit(50) Qiagen GmbH, Hilden, Germany 
DNA-free Set Ambion, Austin, TX, USA 
RNase-free DNase Set Qiagen GmbH, Hilden, Germany 
Rneasy Cleanup Mini Kit (50) Qiagen GmbH, Hilden, Germany 
Omniscript RT Kit(200) Qiagen GmbH, Hilden, Germany 
Avidin Biotin Blocking Kit Vector Lab. USA, sp-2001 
CBA mouse inflamation Kit BD Bioscience, Heidelberg 
HotStart Taq Master Mi Kit Qiagen GmbH, Hilden, Germany 
MOM Basic Kit Vector Laboratories, USA 
MOM Fluorecein Kit Vector Laboratories, FMK-2201, USA 
PAS Staining Kit Merk GmbH, Germany 
Quanti Tect SyberGreen® PCR Kit Qiagen GmbH, Hilden, Germany 
Antibodies used in IHC Provider
Purified anti-mouse CD4(L3T4) BD Pharmingen, Heidelberg, 550280, 
Germany
Purified rabbit anti-mouse TLR2 Technical University of München, 
Germany(clone 2.5 mT2) 
Purified rabbit anti-mouse TLR4/MD2 
(clone MT S510) 
eBioscience, Heidelberg, Germany 
Goat anti-rabbit IgG polyclonal biotin. BD Bioscience, Heidelberg, Germany 
OVA specific Antibodies for ELISA Provider
Anti-mouse IgE biotinylated BD Pharmingen, 553419, Heidelberg, 
Germany
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Anti-mouse IgG1 biotinylated BD Pharmingen, 553441, Heidelberg, 
Germany
Anti-mouse IgG2a biotinylated BD Pharmingen, 553388, Heidelberg, 
Germany
Antibodies used in WB Provider
Rabbit serum anti-mouseTLR2 
polyclonal(clone 2.7 mT2) 
Technical University of München, 
Germany
Rabbit serum anti-mouseTLR4 
polyclon.
eBioscience, 24900491, Heidelberg, 
Germany
Antibodies used in BDTM Cytometric 
Bead Array Kit 
Provider
Interleukin-4 CBA Kit 558298, BD Biosciences, 
San Diego, CA, USA
Interleukin-5 CBA Kit 558302, BD Biosciences, 
San Diego, CA, USA
Interleukin-10 CBA Kit 558300, BD Biosciences, 
San Diego, CA, USA 
Interleukin-12p70 CBA Kit 558303, BD Biosciences, 
San Diego, CA, USA
Macrophage Chemotactic CBA Kit 558342, BD Biosciences, 
San Diego, CA, USAProtein-1(MCP-1)
Tumor Necrosis Factor- CBA Kit 558299, BD Biosciences, 
San Diego, CA, USA
Interferon- CBA Kit 558296, BD Biosciences, 
San Diego, CA, USA
Antibodies used in FACS analysis Provider
Rat IgM,k – FITC BD Pharmigen, USA 
Rat IgG2a,k – PE BD Pharmigen, 553930, USA
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Rat IgG2a,k – PerCP BD Biosciences, 553933, San Diego, 
CA, USA
Rat IgG2b,k – APC BD Biosciences, 553991, San Diego, 
CA, USA
Rat anti-mouse CD3e - FITC BD Biosciences, 01084D, San Diego, 
CA, USA
Rat anti-mouse CD25 - FITC BD Pharmigen, 553071, USA
Rat anti-mouse Pan-NK cells - FITC BD Biosciences, 09944D, San Diego, 
CA, USA
Rat anti-mouse CD11c - FITC BD Pharmigen, USA 
Rat anti-mouse CD8a - PE BD Pharmigen, 553033, USA 
Rat anti-mouse CD 69 - PE BD Pharmigen, 01505B, USA
Rat anti-mouse CD45R/B220 - PE BD Biosciences, 553089, San Diego, 
CA, USA
Rat anti-mouse CD11b - PE BD Pharmigen, M041984, USA
Rat anti-mouse CD4 - PerCP BD Pharmigen, 553052, USA
Rat anti-mouse CD3e – PerCP BD Pharmigen, USA 
Rat anti-mouse CD45 - APC BD Pharmigen, 559864, USA
Anaesthetics Provider
Isoflurane Abbott, Wiesbaden, Germany 
Ketanest 50mg/ml Fa.Parke-Davis, USA 
Ketaminhydrochlorid PZN 7810239, Reg.Nr.K693, 
Germany
Rompun 2% injection solution Fa.Bayer, Germany 
Xylazinhydrochloride PZN 1320422, Reg.Nr.R1061, 
Germany
Reagents Provider
0.9% NaCl sol., physiological B.Braun AG, 7275A251, Melsungen, 
Germany
Al(OH) Pierce Company, 77161, Illinois, USA, 3
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1x Trypsin EDTA PAA Laboratories GmbH, Germany 
10x Trypsin EDTA PAA Laboratories GmbH, Germnay 
RPMI 1640 without L-Glutamine Cambrex, East Rutherford, NJ 
Penicilline -Streptomiycine PAA Laboratories GmbH, Germany 
Actynomycine PAA Laboratories GmbH, Germany 
L-Glutamine Gibco GmbH, 25030-024, Germany 
Na Pyruvat 100mM PAA Laboratories GmbH,s11-003, 
Germnay
Na CO powder Merk, A 407992, Germany 2 3
Fetal Calf Serum Gold(FCS) Biochrom AG, Berlin, Germany 
Bovines Serum Albumin (BSA) Sigma GmbH, A-9647, Germany 
Sulphuric Acid(H SO ) Merck GmbH,1.00731.1011, Germany2 4
Washing solution POD Roche GmbH, 1484281, Germany 
Tween 20 Merk GmbH, 822184, Germany 
Phosphat buffered saline solution 
(PBS)
PAA H15002, Austria 
Phosphat buffered saline 
powder(PBS)
Biochrom GmbH, L182-50, Germany 
NaHCO Merk GmbH, 6329, Germany3
Isopropanol Sigma GmbH, Germany 
Chloroform Roth GmbH, 3313.4, Germany
TriFast lysis buffer PeqLab GmbH, 30-2020, Germany 
TRIzol® Reagent Molecular Research Center Inc., 
Cincinnati, OH, USA 
TAE running buffer Sigma GmbH, Germany 
TBE running buffer Sigma GmbH, Germany 
RNA - Agarose powder Sigma GmbH, Germany 
DNA – Agarose powder Sigma GmbH, Germany 
Sample Loading Buffer Sigma GmbH, Germany 
RNA Ladder(100bp) Sigma GmbH, Germany 
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Liquid Nitrogen Chemistry Institute of Marburg, 
Germany
Tissue Tek Sakura, Zoeterwoude, NJ 
Streptavidine-HRP Sigma GmbH, S 5512, Germany 
Streptavidine-AP Sigma GmbH, Germany 
Ethanol absolute Riedel de Haen, 32205, Germany 
Xylol Vogel 1.09843, Germany 
Periodic Acid  0.5% sol Merk 1.01646./2/, Germany 
SCHIFF Reagent Merk 1.01646./1/, Germany 
Eosin 1% Merk 1.15935.0100, Germany 
Haematoxylin solution Merk 1.05174, Germany 
Neo-Mount Vogel 1.09016, Germany 
Entellan Vogel 1.07961, Germany 
Levamisol Dako GmbH, Germany 
LSAB-AP Dako GmbH, k1018, Germany
LSAB-HRP Dako GmbH, k1016, Germany
Acetyl-ß-Methacoline Sigma GmbH, A2251, Germany 
Methanol absolute Roth GmbH, Germany 
Milk powder Roth GmbH, Germany 
Percoll® / PAN-COLL mouse PAN, P04-64500, Germany 
Lympholyght M Cedarlane, Nr.GL-5035, USA
CASY ton Schärfe System, Reutlingen, 
Germany
CASY clean Schärfe System, Reutlingen, 
Germany
Cytofix cell solution BD Bioscience, Heidelberg, Germany 
Cell fix solution BD Bioscience, Heidelberg, Germany 
BSA for Molecular Biology Sigma GmbH, Germany 
FACS Clean BD Bioscience, Heidelberg, Germany 
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FACS Flow BD Bioscience, 342003, Heidelberg, 
Germany
FACS Lyse BD Bioscience, Heidelberg, Germany 
Buffers and solutions Preparation
OVA VI - Stock solution 20 mg OVA VI/1 ml PBS 
(Preserved in freezer at -20ºC) 
1% (w/v) OVA solution 1 mg OVA/100 μl PBS 
25% (v/v) Al(OH) solution dilution Al(OH) : PBS= 1:33 3
Sensitisation solution (i.p.) dilution OVA 1%:Al(OH) 25%= 1:13
Final conc.10 μg/200 μl/application
Coating Solution (ELISA) OVA VI Stock sol:PBS=1:1000 dilution 
Final concentration 20 μg/ml/well 
(Always fresh make!) 
Washing buffer (ELISA) 
47.75 g PBS/5 ml Tween 20% 
solution/5 L d.Water (Always fresh 
make!)
Blocking solution (ELISA) 15 g BSA/500 ml PBS 
(Preserved in freezer at -20ºC)3% (w/v) BSA solution 
111 μl HStop-reaction solution (ELISA) SO 96% / 9889 μl d.Water 2 4
SO solution2 M H2 4
Lämmli-Puffer Stock solution 10% SDS 1 g,10%  Saccharose 
(Sucrose) 1g (10x conc.) (WB) 
10% Glycerin 1ml in 0.1M Tris-HCl, 
pH 7.5 (1 ml HCl,1 M/10 ml d.Water) 
add.1-2 g Bromphenol Blue 
Bloking buffer (WB) 5% Fish Gelatine or 5% Casein/
1x TTBS (1x PBS/Tween 20) 
TBS buffer Stock sol. (10x conc.) 
(WB)
0.2 M Tris-Base/1.5 M NaCl/1 L 
d.Water
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TBS buffer solution 100 ml TBS Stock/1 ml Tween20/1 L 
d.Water(1x conc.) (WB)
3% (w/v) Milk solution (WB) 1.5 g Milk powder/50 ml PBS
Transfer buffer (Semidry buffer)(WB) 11.6 g Tris/Base/5.8 g Glycin/0.8 g 
SDS/400 ml EtOH abs/2 L d.Water
PBS solution (1xconc.) (WB) 9.55 g PBS powder/1 L d.Water 
Dispersive gel-buffer B (WB) 1 g SDS/45.43 gTris/Base – HCl/ 
250 ml d.Water, until pH 8.8 
Colecting gel-buffer C (WB) 1.5 g SDS/9 g Tris/Base – HCl/ 
250 ml d.Water, until pH 6.8 
Running buffer stock solution 20 g SDS/288 g Glycin/50 g Tris/Base 
(10x conc) (WB) /2 L d.Water 
Running buffer (1x conc.) (WB) Running buffer Stock solution (10x 
conc):d.Water=1:10 dilution 
Sample buffer Stock solution (10x 
conc.) (WB) 
10 g SDS/30.3 g Tris/Base/144.1 g 
Glycerin/800 ml d.Water 
(Aliquots preserved at -20°C)
Sample buffer Stock solution (2x 
conc.)
10 ml Tris/Base of 1.5 M (pH=6.8)/ 
6 ml SDS 20%/30 ml Glycerin/15 ml 
ß-ME-EtOH/1.8 g Bromphenol blue/ (WB)
100 ml d.Water 
(Aliquots preserved at -20°C)
20% (w/v) SDS (WB) 10 g SDS/50 ml d.Water 
10% (w/v) APS (WB) 10 g Amoniu Persulfat/100 ml d.Water 
(Aliquots preserved at -20°C)
Ponceau Stock solution (20x conc.) 4 g Ponceau/20 ml Acetic acid/ 
(WB) 100 ml d.Water 
Ponceau solution (1x conc.) (WB) Ponceau stock (20x conc.): d.Water 
=1:20 dilution 
Anesthetic - Stock solution (5x conc.) 10 ml Ketanest (conc.50 mg/ml)/ 
1.66 ml Rompun (conc.2%) 
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Biofuge(Microcentrifuge) Heraeus Instr.GmbH/Kobe,Marburg 
Megafuge(Macrocentrifuge) Heraeus Instr.GmbH/Kobe,Marburg 
CO Incubator cell culture Heraeus Instr.GmbH, 22017449 2
FACSCalibur with Cell Quest Program Becton Dickinson, San Jose, USA 
Light-/Fluorescent Microscope Olympus BX51, Japan 
Light Microscope Olympus Olympus, Japan, 250653 
Microtommesser Feather Type S25 PFM AG, Germany 20750000 
Ultrasonic Bath Sonorex GmbH, 50013189 
Water Bath Köttermann GmbH, Germany 
Tecan ELISA Reader Biosource, Solingen, Germany 
Head-out Body-Plethysmograph ITEM Fraunhofer Institut for 
Toxicologie and Experimental 
Medicine, Hannover 
CASY Cell Counter Schärfe System, Reutlingen 
Analyser System Modell TT Schärfe System, Reutlingen 
Spectrophotometer UV/Visile 3100pro Biochrom GmbH, 81854 
LightCycler Sistem Corporation Roche Diagnostics, Indianapolis, USA
Tab.3.8 Consumables, reagents, buffers, solutions and equipment used in the present
 doctoral study
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4.1  Intrauterine model: prenatal studies with experimental mouse model         
 
The study shows that the maternal immunity exercises an influence on 
development of the adaptive immune response in the offspring. This character 
finds possible already prenatally and operates in the early postnatal period. At 
the core of this character is the induction and instruction of a specific T-cell 
response in the child, taught by adaptive (Toll-like receptors) and innate 
(antibody) - regulatory pathways of the maternal immune system. An established 
model of pre-/postnatal (perinatal) allergen exposure is now described, involving 
molecular and cellular mechanisms with special emphasis on the prototypically 
Toll-like receptor bacteria and ligands investigated. These results demonstrated 
that maternal transfer of protection from development of allergic airway disease 
to offspring in our animal model to switch from TH2- into TH1-type immunity is 
exclusive antigen specific. 
 
4.1.1 Maternal immunosuppression effects biased by non-pathogenic 
bacterial exposure during pregnancy 
 
Reduced exposure to microbial allergens as a result of our hygienic daily life has 
been suggested as one of the possible causes. It has also been suggested that 
probiotics may provide safe alternative microbial stimulation needed for the 
developing immune system in infants. We established a non-pathogenic bacterial 
supplementation pregnant mouse protocol, in line to mimic the farming 
environment (aerosol and food allergens) exposure of pregnant woman and to 
initiate a potential protective molecular mechanism. We used Balb/c strain female 
mice, 6-8 weeks old, that received either intragastric (i.g.) Lactobacillus 
rhamnosus GG (108 
PBS), intranasal (i.n.) Lipid A, the active component of LPS - E.coli (10 µg per 
Acinetobacter lwoffii (108 CFU per application, reconstituted in a total volume of 
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supplementation starts and continued every second day until pregnancy term. 
Age-matched control animals received PBS.  
 
4.1.1.1 Maternal small intestine analysis: TLR2 and TLR4 mRNA 
expression 
 
The intestine is the body's largest immune organ. Most of the antibody-producing 
cells reside in the intestine. Moreover, the intestinal microflora induce the 
maturation of the mucosal adaptive immune system, providing protection against 
potential pathogens, one suggesting mechanisms being TLR signaling pathway. 
Our animal model, prior prenatal - intragastrical supplementation of two different 
groups of female Balb/c strain mice, 6-8 weeks old, to Lactobacillus rhamnosus 
GG (LGG) and PBS (control group), on days 5 (Trimester I) and 18 (Trimester III) 
of pregnancy. Maternal small intestine is removed to perform the expression 
mRNA TLR and immunohistochemical analysis.                                   








PBS LGG PBS LGG













Trim. I Trim. III
 
 
Fig.4.1.1.1 Maternal small intestine mRNA TLR2 and TRL4 expression. Maternal small 
intestine analysed at days 5 (Trim.I) and 18 (Trim.III) of pregnancy in the intervening time of non-
pathogenic bacterial supplementation. TLR4 shows a trend in up-regulation by LGG in first 
trimester of pregnancy. TLR2 and TLR4 primers are provided by Prof. Kirsching Laboratory  TU 




Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany 
        98 
Small intestine mRNA TLR4 expression shown a high induction in the first 
trimester of pregnancy but not mRNA TLR2 in comparison with controls, while 
mRNA TLR2 and TLR4 expression in the third trimester of pregnancy is more 
equilibrate in both groups being influenced of other pregnancy molecular factors, 
like steroid hormones. Consequently, bacterial DNA is highly enriched in 
immunostimulatory CpG motifs that bias the immune response to antigens 
initiating a potential mechanism of maternal commensal gastrointestinal bacterial 
DNA to modulate a nonallergic TH1 immune response in infancy. 
 
4.1.1.2 Maternal small intestine analysis: TLR2 and TLR4 expression 
by Immunohistochemistry (IHC)  
For immunohistochemistry analysis is necessary a preliminary preparation. 
Maternal gut is perfused with PBS buffer, pH 7.2 and fixed in situ with 4% (w/v) 
Formaldehyde solution. Entire tissue is paraffin-embedded or Tissue Teqpolymer 
cryopreservated. Later, gut tissue sections of 3 µm (paraffin-embedded gut 
tissue) and 10 µm thickness (frozen gut tissue), were obtain by fine tissue films 
cut using a Rotary Microtome and a Cryomicrotome, respectively. Indirect 
Immunohistochemistry staining for anti-mouse TLR2 in gut tissue was performed 
either with Horse Radish Peroxide (HPR) or Alkaline Phosphates (AP) systems 
as described in Materials and Methods chapter. Negative controls are performed 
on consecutive sections by replacing the primary antibody with a nonimmune 
mouse serum or PBS buffer. Tissue sections were examined by light-/fluorescent 
microscopy. Either in applied system such as HRP and/or AP staining, the TLR2 
and TLR4 expression could not show differences between bacterial 
supplemented versus control groups. This can not be taking in consideration 
looking by the fluorescence staining. It can be observed that TLR2 is constantly 
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Fig.4.1.1.2a Maternal small intestine immunohistochemistry analysis: TLR2 expression on 
duodenum of supplemented animals with PBS, in Trim.I/III of gestation (first antibody, 
monoclonal rabbit anti-mouse TLR2 from Santa Cruz Co., USA and secondary antibody  
biotinylated goat - antirabbit Streptavidine peroxidase conjugated, M.O.M. Staining Set) 
           
 
Fig.4.1.1.2b Maternal small intestine imuunohistochemistry analysis: TLR2 expression on 
gestation (first antibody, monoclonal rabbit anti-mouse TLR2 from Santa Cruz and secondary 
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Fig.4.1.1.2c Maternal small intestine immunohistochemisty analysis: TLR2 expression on 
 animals with LGG, Trim.III of 
gestation (first antibody, monoclonal rabbit anti-mouse TLR2 from Santa Cruz Co., USA and 
secondary antibody, biotinylated goat - antirabbit / Streptavidine peroxidase conjugated, M.O.M. 
Staining Set) 
                              
 
Fig.4.1.1.2d Maternal small intestine immunofluorescence analysis: TLR2 expression by  
supplemented animals with PBS, Trim.I/III of gestation (first antibody,monoclonal rabbit anti- 
mouse TLR2 from Santa Cruz Co., USA and secondary antibody, biotinylated goat antirabbit 
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Fig.4.1.1.2e Maternal small intestine immunofluorescence analysis: TLR2 expression by  
supplemented animals with LGG, Trim.I/III of gestation  (first antibody, monoclonal rabbit anti- 
mouse TLR2 from Santa Cruz Co., USA and secondary antibody, biotinylated goat - antirabbit /  
Streptavidine - FITC conjugated, M.O.M. Staining Set) 
 
4.1.1.3 Maternal spleen analysis: mRNA TLR2 and TLR4 expression  
 
The spleen has a connective tissue capsule which spreads into the parenchyma 
forming splenic trabeculae. The parenchyma consists of white and red pulp. The 
white pulp is organized into periarteriolar lymphoid sheets (PALS, representing 
mainly T cells) and lymphoid follicles, which become prominent in response to 
stimulation. The periphery of the white pulp is formed by a less densely cellular 
marginal zone. The red pulp consists of reticular tissue and venous spaces 
(Hummel, 1975) and is the site of extramedullary hematopoietic activity, which 
normally occurs in the mouse spleen. Occasional accessory splenic tissue may 
occur in the pancreas. In our animal model, prior prenatal - intragastrical 
supplementation of two different groups of female Balb/c strain mice, 6-8 weeks 
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(Trimester I) and 18 (Trimester III) of pregnancy. Maternal spleen is removed to 
perform the expression mRNA TLR and immunohistochemical analysis.     
                               










PBS LGG PBS LGG

























Fig.4.1.1.3 Maternal spleen mRNA TLR2 and TLR4 expression. mRNA TLR4 expression 
shows a trend in up-regulation by LGG only in first trimester of pregnancy (n=4 females/group) 
 
The spleen mRNA TLR 4 expression shown an induction in first trimester of 
pregnancy but not mRNA TLR2 in comparison with controls, while mRNA TLR2 
and TLR4 expression in the third trimester of pregnancy is more equilibrate in 
both groups being influenced of other molecular factors, mostly the steroid 
hormones variability during the evolution of pregnancy. 
 
4.1.1.4 Maternal spleen analysis: TLR2 and TLR4 expression by 
Immunohistochemistry (IHC) 
 
For immunohistochemistry analysis is necessary a preliminary preparation as 
discribe for gut tissue. Indirect Immunohistochemistry staining is applied for anti-
mouse TLR2 expression on maternal spleen tissue using either HPR or AP 
systems and examined by fluorescent microscopy. A significant difference 
between groups is not confirmed by mRNA TLR2 expression of the maternal 
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              PBS LGG  
 
Fig.4.1.1.4a Immunohistochemistry (IHC) of maternal spleen anti-mouse TLR2 after LGG 
prenatal supplementation - gestation at term (first antibody, monoclonal rabbit anti-mouse 
TLR2 provided by Prof. Kirsching Laboratory  TU München, Germany and Santa Cruz Co., USA; 
secondary antibody, biotinylated goat  anti-rabbit/ Streptavidine  HPR conjugated, M.O.M. 
Staining Set).  
 
              PBS LGG  
 
Fig.4.1.1.4b Immunofluorescence (IF) staining of maternal spleen anti-mouse TLR2 after 
LGG prenatal supplementation  gestation at term (first antibody, monoclonal rabbit anti-
mouse TLR2 provided by Prof. Kirsching Laboratory  TU München, Germany and Santa Cruz 
Co., USA; secondary antibody, biotinylated goat  anti-rabbit/ Streptavidine  FITC conjugated, 
M.O.M. Staining Set).  
 
Consequently, the immunohistochemical analysis of maternal spleen tissue, anti-
mouse TLR2 expression, respectively does not reveal any significant variation 
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4.1.1.5 Term Placenta Tissue Analysis: mRNA TLR expression 
 
RNA was isolated from maternal organs, such as spleen and placenta via the 
TriFast method (Peqlab, Erlangen, Germany). Previously, 50-100 mg of organs 
are perfused with PBS, freeze in liquid nitrogen avoiding the RNA degradation at 
room temperature and homogenized in TriFast lysis buffer, after disruption 
tissues being done mechanically using a mortar and pestile. The Reverse 
Transcription and qRT-PCR are performed in order to obtain expression of 
mRNA - TLR, cytokines and chemokine. Variation in placental mRNA TLR 
expression is seen in supplemented Balb/c mice when compared with controls. 
Steroid hormones, host cell - intracellular TLR non-/dependent molecular 
mediators signalling pathway and bacterial CpG could be involved in the variation 




































Fig.4.1.1.5a Variation in placental mRNA-TLR expression in LGG supplemented group 
versus control. TLR4 and TLR7 are suppressed, while TLR9 expression is high induced (*P< 
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Fig.4.1.1.5b Variation in placental mRNA-TLR expression in Ac.lwoffii supplemented group 
versus control. TLR6 and TLR9 are suppressed, while TLR4, TR5 and TLR7 expression is very 
high induced. (*P< 0.05, **P< 0.01 and ***P< 0.001 versus control; shown are mean ± SEM; n= 
































Fig.4.1.1.5c Variation in placental mRNA-TLR expression in Lipid A supplemented group 
versus control. TLR7 is suppressed, while TLR1, TLR4, TLR5 and TLR9 expression is high 
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In LGG supplemented group mRNA TLR4 and TLR7 are suppressed, while TLR9 
expression is high induced. Also, Ac.lwoffii supplemented group shown that 
TLR6 and TLR9 are suppressed, whereas TLR4, TLR5 and TLR7 expression is 
high induced. Variation in placental TLR mRNA expression in LA supplemented 
group in comparison with control we also observed. TLR7 expression is down-
regulated, at the same time as TLR1, TLR4, TLR5 and TLR9 signals are 
significantly induced. Consequently, trends in LGG and LA supplemented mice 
embrace increasing TLR1 and TLR9, and decreasing of TLR7 expression, while 
in Ac.lwoffii group TLR7 expression is up-regulated and at the same time the 
TLR6, respective TLR9 signals are suppressed. Differences between 
supplemented groups include a significant increase only in TLR4 and TLR5 
expression in LA and Ac.lwoffii supplemented mice, opposing to LGG 
supplemented group which reveal a significant suppression of mRNA TLR4 
expression.  
 
4.1.1.6 Term placenta tissue analysis: mRNA TH1/TH2 cytokine and 
chemokine expression 
Furthermore, differences in mRNA TH1/TH2 cytokine expression were also 
considering. There is a balance between TH1/TH2 cytokine which can successful 
maintain pregnancy. The cytokine expression could be promoted either by 
trophoblasts and maternal-foetal interface lymphocytes. The analysis is 
performed as described in expression of mRNA TLR. Also, other studies 
(Szekeres-Bartho, 1989 and 1990) demonstrated that, steroid hormones have a 
to term of pregnancy. Here, the LA, the active component of LPS, is leading a 
biochemical instruction during the systemically absorption, activating the lipid 
metabolism, whereas the supplementation with entire bacteria organisms (LGG 
and Ac.lwoffii) revealed us opposing results.  Accordingly, as regulators of lipid 
and lipoprotein metabolism, glucose homeostasis and cellular differentiation, in 
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indicate their implication in cancer development as well as in the control of the 
inflammatory response and inflammation-related disorders. All PPARs 
heterodimerize with the retinoid X receptor (RXR) and bind to specific regions on 
the DNA of target genes. These DNA sequences are termed Peroxisome 
Proliferator Hormone Response Elements (PPREs). The DNA consensus 
sequence is AGGTCAXAGGTCA, with X being a random nucleotide. In general, 
this sequence occurs in the promotor region of a gene, when the PPAR binds its 
ligand, transcription of target genes is increased or decreased, depending on the 
gene. But the function of PPARs is modified by the precise shape of their ligand-
binding domain, induced by ligand binding and by a number of coactivator and 
corepressor proteins, the presence of which can stimulate or inhibit receptor 
function, respectively.      




















PBS        IL 1 IL 4         IL 10        TNF IFN 
**
LGG                                                      
Fig.4.1.1.6a Evaluation of placental mRNA TH1/TH2 cytokine expression in LGG 
supplemented group versus control. The variation between LGG and PBS groups is observed 
- (*P< 0.05 and **P< 0.01 
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all cytokines























PBS         IL 1 IL 4          IL 10        TNF IFN 
Ac.lwoffii  
 
Fig.4.1.1.6b Evaluation of placental mRNA TH1/TH2 cytokine expression in Ac. lwoffii 
supplemented group versus control. The variation between A. lwoffii and PBS groups is 
- -4, IL-
suppressed. (*P< 0.05 and **P< 0.01 vs. crtl; shown are mean ± SEM; n=10 females/study 
group). 


























Fig.4.1.1.6c Evaluation of placental mRNA TH1/TH2 cytokine expression in Lipid A 
supplemented group vs control. The variation between Lipid A and PBS groups is observed in 
high expression of  IL-4, IL- - (*P< 0.05 and **P< 




Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany 
        109 
Trends in supplemented mice include an increase in placental TH2 cytokines 
such as IL-4 and IL-10 in LGG, respective LA supplemented groups, at the same 
time as Ac. lwoffii group shown a significant decrease of these cytokines. 
Furthermore, the LGG and Ac. lwoffii groups demonstrated an increase in pro-
inflammatory cytokines like IL- -regulation of this cytokine in 
LA supplemented animals is observed. Also, significant differences between all 
Certain adaptor molecules and TLR signalling mechanisms mediators, 
transcription factors and chemokine (NF-kB, MCP-1, T-bet, Gata-3, FoxP3, CD3, 
CD14, CD11) which play an immunomodulatory role in inflammatory response 
and revealed an induction into TH1 response at placental mRNA level, were 
evaluated in groups supplemented either with LA and Ac. lwoffii F78, in 
comparison with controls.         



























































PBS        Ac.lwoffii
MCP1  
 
Fig.4.1.1.6d Variation of mouse placental transcription factors and chemokine NF-kB, 
MCP-1 (equivalent of IL-8 in human) at mRNA level in Ac. lwoffii supplemented group in 
comparison with control. 
annihilate foreign pathogens. The pathway is tightly regulated by some coactivator proteins 
(membrane cofactor protein1, MCP-1) at the key steps of initiation, amplification and membrane 
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Fig.4.1.1.6e Variation of placental transcription factors T-bet, Gata-3 mRNA expression in 
Ac. lwoffii supplemented group in comparison with controls. FoxP3 mRNA do not show a 
significant difference between supplemented and control groups. (*P< 0.05 and **P< 0.01 vs. crtl; 
shown are mean ± SEM; n= 10 females/study group). 
        















































Fig.4.1.1.6f Variation in placental mRNA CD3 and CD14 expression in Lipid A 
supplemented group in comparison with control. CD3 mRNA expression is strong up-
regulated, while the CD14 mRNA shown a trend in downregulation and CD11 mRNA expression 
do not reveal any differences between groups. (*P< 0.05 and **P< 0.01 vs. crtl; shown is mean ± 
SEM; n= 8 females/study group) 
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4.1.1.7 Microscopical examination of mouse placenta  
 
 
The recent insight that the intrauterine environment has a profound effect on 
predisposition to chronic illness later in life (Barker, 2004) has led to a high 
interest in placental development and function. Furthermore, because of the ease 
of genetic manipulation, the mouse is increasingly being used as an experimental 
model system to investigate placental development. In our prenatal study, the 
immunology of placenta was examined in detail, to acquire an underlying 
potential maternal immune-protective molecular mechanism to her progenies 
against allergies. Significant morphological differences exist between the human 
and the mouse placentas, but at the ultra-structural level comparisons are limited 
because little information was available up to know for the mouse (Enders, 1965. 
Kirby & Brandbury, 1965. Björkman, 1970. Martinek, 1971). In our study, in 
collaboration with Prof. Dr. H.Fehrenbach we performed a transmission electron 
microscopy in an ultra-structural description of murine placenta, either in control 
and supplemented animals. We followed the method used in Prof. Fehrenbach 
Laboratory as described in Materials and Methods chapter.   
Fig.4.1.1.6g Variation in placental 
mRNA CD11 expression in Lipid A 
supplemented group in comparison with 
control. CD3 mRNA expression is strong up-
regulated, while the CD14 mRNA shown a 
trend in downregulation and CD11 mRNA 
expression do not reveal any differences 
between groups. (*P< 0.05 and **P< 0.01 vs. 
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   PBS Lipid A   
 
Fig.4.1.1.7a Placenta electro-micrographs: Transmission electron micrograph of the 
placental barrier shown in Lipid A group versus control. Pictures illustrate the interaction 
between trophoblasts layers and blood spaces within the labyrinth. Note the three trophoblast 
layers (I, II, and III) and fetal endothelial cell (e) separating the maternal (m) and fetal (f) blood 
spaces. Analysis performed with assistance of Prof.Dr. Heinz Fehrenbach, Clinical Research 
Group "Chronic Airway Diseases", Clinic of Internal Medicine and Respiratory Medicine, Philipps 
University of Marburg / Lahn, Germany. 
The term placenta contains cells of both fetal and maternal origin, subdivided into 
three zones. Closest to the fetus is the labyrinthine zone (LZ), which consists of a 
complex interconnecting system of maternal blood spaces separated by 
trabecular cords of fetal tissue containing capillaries. Three layers of fetally 
derived trophoblast separate the fetal capillaries from the maternal blood, and 
hence the murine placenta is classified as haemotrichorial. The outer layer of 
trophoblasts bathed directly by maternal blood (trophoblast layer I, TI) is cellular 
mononucleated, the cytotrophoblast (CT), whereas both the inner two layers 
(trophoblasts layers II and III, TII and TIII) are multinucleated  
syncytiotrophoblast (ST) (Mossman, 1987). The LZ is playing a main role in 
nutrients, gas and waste are exchanged between mother and fetus, and as 
gestation progresses this compartment occupies the majority of the placental 
area (Coan et al. 2004). However, the exact contribution each component of the 
trichorial membrane makes towards facilitation or impedance of exchange has 
yet to be revealed. Separating the labyrinthine zone from the maternal uterine 
    T I 
 










Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany 
        113 
tissue is the basal / junctional zone (JZ). This zone is a cellular compartment 
consisting of at least two distinct cell types after embryonic day E12.5: 
spongiotrophoblast (SPT) and glycogen cells (GCs). Both these cells express the 
genetic marker Tpbpa and the spongiotrophoblast marker Ascl2 (Cross, 2005). 
The function of this zone is yet to be fully understood (Georgiades, 2002), but it is 
essential for the fetal survival as demonstrated by the Ascl2-/- mouse that lacks 
this zone and is lethal around E10.5 (Guillemot, 1994). Bordering the JZ and the 
maternal decidua is a unicellular discontinuous layer of trophoblasts giant cells 
(GCs), (Pijnenborg, 1981). They are distinct from cells of the JZ in expressing the 
giant cell-specific marker Hand1 (Hemberger & Cross, 2001). These large 
mononuclear, polyploidy (Zybina & Zybina, 1996) trophoblasts produce a variety 
of hormones and chemokines), (Malassiné, 2003), which may alter maternal 
physiology and immunology in order to accommodate the fetal allograft.  
Furthermore, the structure of the murine placenta at the gross morphological and 
light microscopically levels has been reviewed by other groups, too (Georgiades, 
2002 and Malassiné, 2003), as have the molecular mechanisms supporting cell 
lineage, proliferation and differentiation (Rossant & Cross, 2001; Downs, 2002). 
In our experimental protocol, after animal sacrification the placentas were cut 
transversally and fixed in situ with Formaldehyde 4% (wt/vol) sol. Both pieces of 
placenta tissue was Paraffin-embedded or Tissue Teq polymer cryopreserved 
and 3 µm, respective 10 µm sections, previously cut by using a Rotary 
Microtome and Cryomicrotome were stained with Haematoxylin and Eosin (H&E) 
for tissues characterization and cell profiles of inflammatory cells state via High-
power light microscopy (HPLM). Indirect Immunohistochemistry staining such as 
Horse-Radish Peroxidase (HPR) or Alkaline-Phosphate (AP) systems for anti-
mouseTLR2 and anti-mouseTLR4 on lymphocytes and/or trophoblasts is used. 
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Fig.4.1.1.7b Placenta histology  sagital sections - from LGG (a), Ac.lwoffii (b), Lipid A (c) 
supplemented groups. Placenta tissues illustrate the same architecture: unmodified structure 
and a normal alignment of the specific trophoblasts layers. Magnification of 10x and 4x by light 
microscopy. 
 
It is obviously that closest to the fetus (umbilical blood cord) is the chorionic plate 
(CP) and the labyrinthine zone (LZ), which consists of a complex interconnecting 
system of maternal blood spaces separated by trabecular cords of fetal tissue, 
containing capillaries. Three layers of fetally derived trophoblast (one layer 
cytotrophoblast, respective two layers of derived syncytiotrophoblats) separate 
the fetal capillaries from the maternal blood, and hence the murine placenta is 
classified as haemotrichorial.  
 
On the opposite side, the decidualised trophoblasts (D) are naturally developed, 
playing the most important role in implantation, maternal immunospupression, 
maintaining the TH1/TH2 balance and at term of pregnancy, being first cells  
signaling the labor process or baby delivery. 
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Fig.4.1.1.7c Placenta histology  the labyrinth (H&E staining) of PBS, LGG, Ac. lwoffii, 
Lipid A supplemented groups. Placenta tissues show the same architecture: unmodified 
structure and a normal alignment of the specific trophoblasts layers. Magnification of 20x by light 
microscopy.   
 
Fig.4.1.1.7d Immunohistochemistry: Placental anti-mouse TLR 2  FITC, M.O.M kit  AP 
and HRP staining systems. Tissues of PBS (a), LGG Gram+ bacterium (b) and Lipid A/LPS-
E.coli Gram- bacterium (c) supplemented groups could not be specific stained for TLR2. Light 
microscopy is used with magnification of 20x.   
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Fig.4.1.1.7e Immunofluorescence: Placental anti-mouse TLR 2  FITC, M.O.M system. 
Mouse placenta electronmicrographs illustrate the placental barrier architecture in very well-
designed way. Both tissues of control and treated mother mice reveal an identical structure, 
consequently the supplementation did not influence placenta histomorphology, but very much its 
physiology as is demonstrated at the molecular experimental level. Nevertheless, the expression 
of placental TLR2 at the protein level by IHC could not be properly detected since a specific 
antigen-retrieval and an enzymatic inhibitor for peroxidase or alkaline phosphatase applied on 
placental tissue are not  commercial available. Fluorescence microscopy is used with 
magnification of 20x.     
 
Thus, the whole knowledge obtained by ultra-/gross microscopy of the mouse 
placenta - the trophoblast subclasses (placental barrier), respective the detailed 
description of the placental layers/trophoblast classes (fetal and maternal cell 
lineages, feto-maternal interface), allowed us to understand the cellular and 
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4.1.2 t stem cells analysis 
 
Trophoblast Stem Cells (TSCs), SM10 cell line are still present in term placenta 
labyrinth, under the chorionic plate and could be maintained undifferentiated but 
commitment state in cell culture. The cells were passage several weeks until the 
cell number was adequate for stimulation and then, four different allergens such 
as Lactobacillus rhamnosus GG (LGG), Lipid A (LA-LPS/E.coli), 
Lipopolysaccharide (LPS/E.coli) and Acinetobacter lwoffii F78 (Ac.lwoffii) with 
concentractions of 10, 50, 100 ng/1ml cell suspension, were applied for 24 and 
48h incubation time. The cell-free supernatants were harvested and levels of IL-
4, IL-10, IL-1ß, TNF , IFN  were measured using Enzyme-linked immunosorbent 
assay (ELISA). 
 
4.1.2.1 Trophoblast stem cells analysis: mRNA TLR, cytokine and 
chemokine expression after bacterial restimulation in culture 
 
Placental - Trophoblast Stem Cells (TSCs), SM10 cell line is passage several 
weeks until the cell number was sufficient for stimulation. After trypsination 
followed by washing steps, the cells were counted by CASY TT Cell Counter 
System, and 1 x 106 cells/ml/well cultured in 24-well flat-bottom plates at 37ºC in 
a cell incubator, under 5% CO2 and 95% humidified atmosphere. Two different 
protocols was performed, first for 3.5 x 105 cells/ml/well and secondly, 1 x 106 
cells/ml/well. Cells were stimulated with four different allergens, such as: 
Lactobacillus rhamnosus GG (LGG), Lipid A (LA/LPS/E.coli), Lipopolysaccharide 
(LPS/E.coli) and Acinetobacter lwoffii F78 (Ac. lwoffii) at three different 
concentrations of 10, 50, 100 ng per 1ml cell suspension, at incubation time of 24 
and 48 hours. Afterwards, mRNA expression of TLR, cytokine and chemokine 
analysis was performed by Quantitative Reverse Transcriptase  PCR (qRT-
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Fig.4.1.2.1a SM-10 cell line, Trophoblast Stem Cells (TSCs) - mRNA TLR1 expression after 
LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., for 24h and 
48h.    Variation between control and Ac. lwoffii in-vitro stimulated TSCs at 50ng/ml, after 24h 
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Fig.4.1.2.1b SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA TLR2 
after LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., 
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Fig.4.1.2.1c SM-10 cell line, Trophoblast Stem Cells (TSCs) - state of mRNA TLR3 
after LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., 
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Fig.4.1.2.1d SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA TLR4 after 
LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., for 24h 
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Fig.4.1.2.1e SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA TLR6 
after LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., 
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Fig.4.1.2.1f SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA TLR7 
after LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., 




Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany 





Fig.4.1.2.1g SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA TLR9 
after LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., 
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In vitro stimulated Trophoblast Stem Cells (TSCs) do not significant express 
mRNA TLR, but mRNA TLR1 after 24 hours at concentration of 50 ng 
Ac.lwoffii/1ml cell suspension. Thus, we performed comparative experiments 
between uncommitted trophoblasts stem cells and dedifferentiate trophoblasts 
(term trophoblasts), which demonstrated that TSCs need the attendance of 
growing and dedifferentiation factors, such as cytokine and chemokine (see 
Introduction chapter), being able to develop themselves and to complete their 
functions in maintenance the incomprehensible mechanisms of pregnancy.  
 
4.1.2.2 Trophoblast stem cells analysis: mRNA Th1/Th2 cytokine and 
chemokine expression after bacterial restimulation in culture 
 
The cytokines mRNA levels diverge from stimulated group to another. IL-
IL-4 expression is up-regulated in Ac. lwoffii supplemented group; respective 
LGG/LPS stimulated TSCs versus controls. Trends include an inverse 
relationship in stimulated cells, in TH2 cytokines such as IL-
H1/TH2 cytokines levels 
deliberated by ELISA shown a dramatically suppression IL-4 and IL-
.  Again, a comparison between both 
experiments, mRNA cytokines expression in TSCs and term trophoblasts, 
revealed us their behaviour and promising functions. The IL- -
inflammatory cytokine is detected in term trophoblasts as well. It principal effects 
similar to those TNF, is to attract leucocytes/endothelial adhesion molecules and 
inducing acute-phase proteins, or lymphocyte co-stimulation phagocyte 
activation, besides promoting the prostaglandin synthesis and tissue remodelling. 
Moreover, IL-4 is a TH2 cells released cytokine, which plays a key role in 
pregnancy, mediating the activation and division of B cells and promotes class 
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Fig.4.1.2.2a SM-10 cell line, Trophoblast Stem Cells (TSCs) - mRNA IL-
LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., for 24h but 
no difference between controls and in vitro stimulated TSCs, after 48h. (*P< 0.05 vs. crtl; 
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Fig.4.1.2.2b SM-10 cell line, Trophoblast Stem Cells (TSCs) - mRNA IL-4 expression after 
LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., for 24h and 
48h. No difference between controls and in vitro stimulated TSCs after 24h, but after 48h with 
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Fig.4.1.2.2c SM-10 cell line, Trophoblast Stem Cells (TSCs)  state of mRNA IL-10 after 
LGG, LA, LPS and Ac. lwoffii in vitro stimulation with 10, 50, 100 ng/ml conc., for 24h and 
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(epithelial-like cell), they do not act absolutely like immune cells, but partially. 
They interact with lymphocytes through cross-talking mechanisms, appear to be 
like sentinels against immune attack to bacterial activated lymphocytes, using 
TLR or alternative pathways, maintaining the TH1/TH2 balance pregnancy.  
 
4.1.3 Placental immune cells isolation and characterisation by 
Magneting-assesed Cell Sorting (MACS) and Flow Cytometry 
(FACS) Systems 
 
The function of the immune system is to protect the body from damage caused 
by bacteria, viruses, fungi and parasites. This defensive function is performed by 
leucocytes and a number of accessory cells (eosinophil and basophil 
granulocytes, mast cells, plateles and antigen-presenting cells), which are 
distributed throughout the body, but particularly are found in lymphoid organs 
including the bone marrow, thymus, spleen, lymph nodes and mucosa-
associated lymphoid tissues (MALT). Lymphoid organs are strategically placed to 
protect different areas of the body from infection. Cells migrate between these 
tissues via the bloodstream and lymphatic system. Thus, they interact with each 
other to generate coordinated immune responses aimed at eliminating pathogens 
or minimizing the damage they cause. During the menstrual cycle, the number of 
CD45+ leukocytes increases pre-menstrual from 10-15% to 20-25% of all 
endometrial cells (Markert, 2005). During the first trimester of pregnancy, the 
number increases further and approximately 70% of immune-competent decidual 
cells are CD45+ leukocytes. The predominant type of these cells are transient, 
pregnancy-associated uterine natural killer cells  uNKs - (46%), followed by 
macrophages (19%) and T cells (8%), mainly CD8+T cells.  
As shown in various knockout animal models, most classes of immune cells are 
crucial for successful pregnancy, but their function and way of action are 
modified compared with leukocytes from peripheral blood, other tissues of 
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on the signal transduction level, the JAK/STAT pathway. Recent data, suggests 
that this system is involved in the differentiation of T helper cells into TH1 and TH2 
subsets. Many cytokines signal via this pathway and control it. Also, the 
production of numerous cytokines and other factors depends on JAK/STAT 
signalling. Therefore, could be suggested that the regulation of the JAK/STAT 
system is essential for the development and maintenance of the immunological 
balance in the decidua and placenta necessary for successful pregnancy 
(Markert, 2005). In this regard, we speculate that placenta could plays an 
important role as a fetal lymphoid organ in pregnancy, initially protecting the fetus 
against rejection or early abortive process, suppressing the maternal immune 
system and subsequent, soon after birth and early childhood, against allergies 
such as asthma associated. In this regard, we established an experimental 
protocol, where the total CD45+ placental cells are characterised, prior using a 
positive selection method by Magneting-assesed Cell Sorting (MACS), followed 
by Flow Cytometry System (FACS) analysis. Placental MNCs were isolated in a 
similar way as splenic MNCs, described in Materials and Methods chapter. We 
used an immunofluorescent staining protocol for cell surface molecules with 
specific markers such as, CD45 for total number of leukocytes-common-antigen 
(LCA), CD3, CD4, CD8 for the T cells, respective T cell subsets (helper T cells, 
cytotoxic T cells, memory T cells), CD49b for natural killer cells (NK), CD4CD25 
for regulatory T cells, CD69 for activating Tregs and NKs, CD11b and CD11c for 
macrophages and dendritic cells (DCs). The cells were harvested and stained 
with diverse fluorochrome-conjugated mouse antibodies. Cells are analyzed by 
means of Flow Cytometry on a FACSCalibur using the CellQuest Program 
(Becton Dickinson, San Jose, California). Data analysis is performed with the 
WinMDI 2.8 Software developed by Joseph Trotter (Scripps Institute, La Jolla, 
California). The idea behind was to characterise the main immune cell classes 
(T, B, NKs, DCs) and some subclasses related to CD45+ cells (regulatory T cells, 
activated T cells and activated Tregs). They cross placenta during pregnancy and 
contribute in maintenance of the feto-maternal immunity balance, within specific 
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the Lipid A is the active component of LPS/E.coli, and moreover the postnatal 
data from our Laboratory and other groups demonstrated that Gram- bacteria 
and/or LPS in certain concentration are able to modulate allergic reactions. Here, 
we observed only a trend in induction of CD3+CD8+ T cells, but a significant 






















































Fig.4.1.3 Comparative characterization of placental immune cells  APC cells, T and Treg, 
FACS analysis demonstrated a significant 
decrease in placental NK cells of the LA (LPS/E.coli, Gram- bacterium) treated group versus 
controls, while placental histology does not reveal any differences between groups (**P< 0.01 vs. 
crtl; shown are mean ± SEM; n=6 mice/study group, n=1 placenta/mouse female). 
  
The suppression process, the cellular basis for this type of immunoregulation 
implicates some or all of these well known mechanisms: (i) a specific cytostatic 
action of CD8+ Tc cells; (ii) passive blocking of lymphocyte activation by 
sequestering essential cytokines required for cell division; (iii) secretion of 
immuno-suppressive molecules such as prostaglandins or TGF-
immunoregulatory effect caused by the local production of specific sets of 
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cells) supplying an activation signal but not the required co-stimulatory signals or 
cytokines. NK cells, the large granulated lymphocytes, are the dominant decidual 
cell population from the first stage of pregnancy. After blastocyst implantation 
and decidualization, dNK cells are activated, they produce IFN
other molecules, including angiogenetic factors. Therefore, they can control 
trophoblasts invasion through their cytotoxic activity, and also initiate vessel 
instability and remodelling the decidual arteries to increase the blood supply to 
the placental bed  Alternatively, they are involved in cytokine-mediated 
immunoregulation of the maternal immune response producing TH2-and TH3-type 
cytokines, which result in placental development, in local immunosuppression, 
respective in immunomodulation.  
 
4.1.4 Maternal blood serum and amniotic fluid analysis: measurement 
levels of steroid hormones, cytokine and chemokine by ELISA and 
CBA kit 
 
Of particular interest are the interactions between the reproductive system and 
the immune system. The reproductive system is unique in that its primary role is 
to assure the continuity of the species, while the immune system provides 
internal protection and thus, facilitates continue health and survival. The modus 
operandi of these two morphologically diffuse systems involves widely distributed 
chemical signals in response to environmental input, and both systems must 
interact for the normal functioning for each. While the major focus of 
reproductive-immune research has historically been with mammals, and has 
provided substantial insight into the interactions between these physiological 
systems, comparative studies offer unique perspectives. It is well known that 
reproductive hormones have been implicated in the development, as well as 
modulation, of the immune system (Mann, 1994). Although the effects of 
estrogen and progesterone on white blood cells are diverse, they have 
demonstrated an overall inhibitory effect on leukocyte proliferation. Also, these 
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apoptosis in mononuclear cells, T- and B-lymphocytes, neutrophils, and cancer 
cells. Of great potential importance, interactions between the reproductive 
hormones and the immune system have been investigated due to correlations in 
autoimmune diseases. Thus, women experience improvement and amelioration 
of symptoms in these diseases during pregnancy, when hormone levels increase 
(Beagley,  2003). Other researchers provided evidence that the immune system 
is suppressed by reproductive effort in that antibody response to immune 
challenge and parasite resistance are reduced, respectively. Regarding, an 
evolutionary trade-off between reproductive fitness and immune defence has 
been hypothesized due to T cells having an overall immunosuppressive effect 
(Folstad and Karter, 1992). For instance, T helper 1 (TH1) cells secrete 
- -mediated 
immune responses. T helper 2 (TH2) cells secrete cytokine that promote antibody 
production. Progesterone promotes the development of a TH2 response during 
pregancy, which antagonizes the emergence of TH1 cells. During pregnancy, 
immunoregulatory system must operate locally at the placental interface, being 
reversible to preserve the systemic immune competence of the mother. Several 
mechanisms involving steroids, especially progesterone, may contribute to fetal-
maternal protection, including altered expression of MHC class I proteins in fetal 
tissue, altered T cell subsets, reduced number of NK cells, or elaboration of 
immunosuppressive factors (Pepe, 1995).  
In our prenatal study, we monitored the development of maternal and fetal 
and Estradiol from maternal mouse blood serum and amniotic fluid. The 
experimental protocol has been established for five different groups of mouse 
females: (i) Nonpregnant/Nonsupplemented (only blood serum), (ii) 
Pregnant/nonsupplemented used as Control for all supplemented groups , (iii) 
Pregnant/PBS (control group), (iv) Pregnant/LGG, (v) Pregnant/Lipid A, (vi) 
Pregnant/Ac. lwoffii supplemented groups. Our observations reveal that in serum 
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supplemented females, while the estradiol level is suppressed in LA 
supplemented group, related to control / PBS groups.  























Fig.4.1.4a Maternal serum steroid hormone, progesterone - quantification by ELISA 
method. Progesterone is high induced in control pregnant group vs. un-pregnant and all other 
supplemented pregnant groups. Also, Ac. lwoffii supplemented group illustrate an up-regulation in 
serum progesterone level in comparison with PBS (ns-not significant; **P< 0.01 and ***P< 0.001 
vs. Control and PBS pregnant females; shown are mean ± SEM; n= 5 mice/study group) 


















Fig.4.1.4b Maternal serum steroid hormone, Estradiol - quantification by ELISA method. 
Estradiol is high induced in control pregnant group versus un-pregnant (could not been seen with 
the implemented limit detection), and all other supplemented pregnant groups. Also, it shows a 
low quantification level in Lipid A supplemented females related to PBS group (ns-not significant; 
nd-not detectable;**P< 0.01 and ***P< 0.001 vs. Control and PBS supplemented pregnant 
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Fig.4.1.4c Schematically  illustration of amniotic fluid maternal steroid hormone, such as 
Progesterone quantified by ELISA. Progesterone level was not affected after bacterial 
supplementation, related to PBS, respective Control groups (ns-not significant; shown are mean ± 
SEM; n= 5 females/study group). 
 



















Fig.4.1.4d Schematical  illustration of amniotic fluid maternal steroid hormone, such as 
Estradiol. Estradiol levels shown an inverse relationship between LA, Ac. lwoffii supplemented 
pregnant females related to PBS, respective Control group, 
signal of hormonal variation given by pregnancy state related with bacterial persuade in fetal 
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In addition to the lack of classical MHC class I and II antigens at the trophoblast 
sides the cytokines play an important role at the maternal-fetal interface. Different 
cytokines regulate the immunological processes with an emphasis on the TH1/ 
TH2 balance. Chemokine (C-C motif) ligand 2 (CCL2) is a small cytokine 
belonging to the CC chemokine family that is also known as monocyte 
chemotactic protein-1 (MCP-1). CCL2 recruits monocytes, memory T cells, and 
dendritic cells to sites of allergen reaching tissue. CCL2 causes the 
degranulation of basophils and mast cells, an effect potentiated by high 
concentration of IL-3 and/or other cytokines. 
In contrast to the peripheral blood, there is a certain composition of immune 
competent cells at the feto-maternal interface. There are many different 
interactions between the endocrine and immunological system, where the 
steroids hormones modulate the secretion of certain cytokines and vice versa.            


























Fig.4.1.4e   Amniotic fluid MCP-1 chemokine is significantly induced in LGG supplemented 
females, but not in the other groups. Measurements are performed by CBA kit (**P< 0.01 vs. 
PBS; shown are mean ± SEM; n= 5 females/study group). 
 
Equivalent measurements are performed by CBA kit (followed the manufacturer 
description) either in blood serum and amniotic fluid for other cytokines, such as 
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difference between bacterial supplemented and control groups. Therefore, it is 
expected that relatively a slight perturbations of the TH1/TH2 balance can have an 
impact, either decreasing or increasing a risk of later allergic and/or airway 
diseases.          
  
4.2 Acute asthma model: perinatal studies with experimental mouse 
model. Protective effects on the offspring observed in development 
of early allergic diseases  
 
A large number of clinical investigations direct on human or experimental, on 
animal models provided strong evidence that due to an early-life contact with 
farm animals, cowsheds and/or consumption of products like raw milk might have 
an important effect on the development allergies in order to influence allergic 
response - protective mechanisms. Thus, data on intrauterine mouse model 
(Balb/c strain) and acute asthma animal model experimental design established 
Hygiene hypothesis 
which states that a farming environment rich in microbiologic structures might 
protect against the development of allergies. Thus, certain microbes present in 
farming regions of children living, act by promoting an immune deviation from TH2 
to TH1 in the allergen  specific response. Because the innate immune system 
plays an essential role in the initial immune activation and modulates subsequent 
adaptive immune responses, we investigated in maternal tissues due to 
pregnancy period, where the existing pattern-recognition receptors (PRRs) like 
as Toll-like receptors (TLR) are involved through specific signalling pathways, in 
respect to applied bacterial supplementation. In consequence, the postnatal 
experimental part corroborates mostly with the prenatal data and reveals 
together a potential protective molecular mechanism against allergies, such as 
asthma associated. Therefore, in our supplementary experimental protocol, 
proving the TLR-mediated asthma defensive molecular mechanism, we used 
C57BL/6J strain female mice, 6- -/-, TLR-/- 
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wild type male mice, C57BL/6J background, 6-8 weeks old. All groups received 
intranasal (i.n.) lyophilized Acinetobacter lwoffii (108 CFU per application, 
-8-6-4-2 days before conception 
and subsequently, the maternal supplementation continued every second day 
until term of pregnancy. Age-matched control animals received PBS. Later on 
after birth, asthma was induced in the young animals (heterozygote offspring 
+/-, TLR+/-, TNFp55+/- 4 weeks old). Offspring are sensitized twice to 
Ovalbumin (OVA) at the age of 28 and 42 days; intraperitoneal (i.p.) injections of 
10 µg OVA are applied (grade VI; Sigma, Diesenhofen, Germany), emulsified in 
1.5 mg Al(OH)3 (Pierce, Rockford, USA) in a total volume of 200 µl. At days 48, 
49, 50 the subgroups of offspring were placed one after other in a special 
Plexiglas chamber and exposed to aerosolized 1% (wt/vol) OVA solution 
(reconstituted in PBS), 20 minutes time exposure. 
 
4.2.1 The effect of maternal non-pathogenic bacterial exposure on 
offspring lung: airway hyperresponsiveness (AHR) and 
bronhoalveolar lavage fluid (BALF) analysis 
 
To prove whether the effects of prenatal exposure to non-pathogenic bacteria 
either Gram+ and Gram- bacteria or components of Gram- bacteria, such as LA 
influences the development of experimental asthma, OVA-sensitized mice were 
aerosol allergen challenged for three times. Airway inflammation was 
investigated by analysing bronhoalveolar lavage fluid (BALF). BAL cellular 
composition is considered like: total number of leucocytes, number of 
eosinophilic cells, lymphocytes, macrophages and neutrophils. We observed that 
Acinetobacter lwoffii supplementation appears to act through maternal TLR, to 
reduce BALF cell - eosinophil and lymphocyte counts in asthmatic offspring. 
Furthermore, TLR 2/3/4/7/9+/- offspring mice have decreased numbers of BALF 
macrophages. Moreover, Ac. lwoffii action appears to be through maternal Toll-
like receptors signalling pathway, but alternative pathways can be also present 
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lwoffii on offspring cytokines and more, the course of immune response, BALF 
cytokines such as IL-10, IL- -sensitized and challenged 
mice were measured by ELISA method. Accordingly, in the absence of maternal 
TLR, Ac. lwoffii supplementation has an effect on asthmatic offspring BALF - 
- +/- offspring 
Ac. lwoffii supplemented group) K.O./Ac. lwoffii in relationship with control 
deficients (TLR+/- offspring PBS supplemented group) K.O./PBS and wild type 
wt/PBS and wt/Ac. lwoffii groups. The results reveal an opposite effect, 
respective an induction of TH2 immunity in comparison with the phenotype of 
asthmatic offspring Balb/c strain, which reveal a TH1 immunity  an up-regulation 
- acquired in our postnatal studies (Debarry, 2007). Also, TLR+/- 
offspring cover reduced BALF IL-10 production, but no difference seen in BALF 
IL-5 levels.   
 
 
































Fig.4.2.1a Effect of prenatal exposure to Ac. lwoffii on airway inflammation in OVA - 
immunized and allergen challenged mice. Wild-type and TLR+/- offsping mice, C57BL/6 
background were OVA-immunized. Both of the wt/k.o. Ac. lwoffii-exposed, respective wt/k.o. 
PBS-exposed groups were OVA aerosol challenged followed by a lavage of the airways. Cellular 
composition of BALF, such as: total number of leucocytes and eosinophils (*P< 0.05 and **P< 
0.01 Ac. lwoffii/wt versus PBS/wt; @P< 0.05 Ac. lwoffii/k.o. versus Ac. lwoffii/wt offspring groups; 
shown are mean ± SEM; n= 10 mice/study group) 
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Fig.4.2.1b Effect of prenatal 
exposure to non-pathogenic 
bacteria such as, Gram-negative 
bacteria (Ac. lwoffii) on airway 
inflammation in OVA - immunized 
and allergen challenged mice. Wild-
type and TLR+/- offsping mice, C57BL/6 
background were OVA -immunized. 
Both of the wt/ko Ac. lwoffii-exposed, 
respective wt/ko PBS-exposed groups 
were OVA aerosol challenged followed 
by a lavage of the airways. Cellular 
composition of BALF, such as: 
macrophages, neutrophils and 
lymphocytes are depicted (*P< 0.05 
and **P< 0.01 Ac. lwoffii/wt versus 
PBS/wt; @P<0.05 Ac. lwoffii/wt versus 
Ac. lwoffii/k.o. offspring groups; 
§P<0.05 PBS/k.o. versus PBS/wt. 
offspring groups; #P<0.05 Ac.lwoffii/k.o. 
versusPBS/k.o. offspring groups; 
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BAL IL-10














































                
  
 






























   
 
 
Fig.4.2.1d Effect of prenatal Ac.lwoffii 
exposure on airway-responsiveness to 
Methacholine. Analysis done by Head-out-
body plethysmography method. Both 
Ac.lwoffii-exposed wt/ko, respective wt/ko 
PBS-exposed groups were OVA-
sensitized/-aerosol challenged followed 
lung function analysis (*P< 0.05 
Ac.lwoffii/wt vs. crtl; shown are mean ± 
SEM; n= 10 mice/study group) 
Fig.4.2.1c The effect of maternal 
exposure to Ac.lwoffii on offspring 
cytokine. BAL fluids cytokines IL- 5, IL-
10, IFN- -sensitized and 
challenged mice were measured by 
ELISA (#P<0.05 and ##P< 0.01 
Ac.lwoffii/k.o. versus PBS/k.o. offspring 
groups; §§P< 0.01 PBS/k.o. versus 
PBS/WT; @@@P< 0.001 Ac. lwoffii/wt 
versus Ac. lwoffii/k.o. ; shown are mean 
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Moreover, lung function analysis was carried out using the non-invasive method 
of head-out body plethysmography. The middle-expiratory airflow (EF50) of 
bronchial responsiveness to -Acetyl-Methacoline (MCh) was measured 24 
hours after the last OVA aerosol challenge. Maternal Ac. lwoffii treatment 
reduces airway reactivity in wild type offspring. However, since there is no 
difference between WT/Ac. lwoffii and KO/Ac. lwoffii groups it cannot be state 
definitely if airway reactivity is affected through TLR signalling pathway.  
 
4.2.2  The effect of maternal non-pathogenic bacterial exposure on 
offspring spleen: cytokine and chemokine expression after in vitro 
OVA restimulation  
 
Cell counts of splenocytes (MNCs) and re-/stimulation with OVA, was done after 
48 hours from the last allergen challenge. Total spleen cell counts were isolated 
by density gradient centrifugation (Lympholyte M, Cedarlane, Burlington, MA, 
USA). After three washing steps in PBS the mononuclear cells (MNCs) were 
counted by CASY TT cell counter system. Statistical representation of the total 
spleen cell counts in asthmatic WT offspring shown that are affected by acting 
through a different mechanism than TLR2, TLR3, TLR4, TLR7, TLR9. After 
counting, the splenic mononuclear cells were seeded into a in 24-well flat-bottom 
plates at 37ºC in a cell incubator, under 5% CO2 and 95% humidified 
atmosphere. 2 x 106 cells/ml/well were stimulated with 50 µg/ml OVA in a total 
volume of 1 ml cell suspension. After 72 hours cell-free supernatants were 
harvested and levels of IL-4, IL-5, IL-10, IL-13, TNF , IFN  were measured using 
Enzyme-linked immunosorbent assay (ELISA). Spleen supernatants 
-13, IL-4 and IL-5, no differences seen 
between wild type and knockout mice, un-
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Fig.4.2.2b Measurement levels of IL-4, IL-10, IL-13 and IFN  using Enzyme-linked 
immunosorbent assay (ELISA), from 72h OVA restimulated cell-free supernatants. No 
significant expression of cytokine level in supplemented groups vs crtl. 
Fig.4.2.2a Total spleen cell counts 
after a prior isolation by density 
gradient centrifugation. (*P< 0.05 
Ac.lwoffii/wt vs. crtl; shown are mean 
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Fig.4.2.2c Measurement levels of IL-5 and TNF  using Enzyme-linked immunosorbent 
assay (ELISA), from 72h OVA restimulated cell-free supernatants. 
reduced in of Ac.lwoffii/wt group in comparison with control(***P< 0.001 Ac.lwoffii/wt vs. crtl; 
shown are mean ± SEM; n= 10 mice/study group). 
 
4.2.3 The effect of maternal non-pathogenic bacterial exposure on 
offspring blood serum antibodies titres: OVA-specific IgG1, IgG2a 
and IgE measurements by ELISA 
 
Offspring of prenatally Ac.lwoffi-exposed mother mice, strain C57BL/6 deficient 
mice, at age of 28 and 42 days were sensitize to OVA by two intra-peritonial 
injections of 10 µg OVA (grade VI; Sigma, Deisenhofen,Germany) emulsified in 
1.5 mg Al(OH)3 (Pierce Co., Rockford, IL, USA) in a total volume of 200 µL. Later 
on, the animals received three local allergen challenges performed by an 
exposure to aerosolize OVA (1% in PBS) for 20 minutes on days 48, 49 and 50.  
Twenty-four hours after the last exposure to OVA the blood was collected and 
blood serum OVA/specific antibodies titers was performed by ELISA technique. 
Levels of OVA-specific IgG1, IgG2a and IgE antibody titers were measured by the 
ELISA technique. Briefly, 96  well microtitre plates (Nunc, Wiesbaden, 
Germany) were coated with Ovalbumin (grade VI; Sigma GmbH, Germany) at a 
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with 1% bovine serum albumin (BSA)/PBS (w/v) for 2 hours a room temparature. 
Diluted serum samples and monoclonal OVA-specific IgE (Serotec, Düsseldorf, 
Germany), IgG2a (Dianova GmbH, Hamburg, Germany) and IgG1 (Sigma) 
standards were added and the plates were incubate overnight at 4°C. After the 
plates were washed, biotin-conjugated anti-mouse IgE, IgG1 or IgG2a (BD 
Biosciences Co., San Diego, U.S.A.) were added and incubate for 2 hours at 
room temperature. As a second-step reagent horse-radish peroxidase-
conjugated streptavidin (Sigma GmbH, Germany) was added for 30 minutes 
(room temperature, devoid of light). Plates were developed with peroxidase 
substrate (Roche GmbH, Mannheim, Germany).  
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Fig.4.2.3 Measurement of OVA-
specific antibodies such as IgE, 
IgG1, IgG2a titers in offspring 
serum by ELISA. No significant 
differences observed  between 
Ac.lwoffii supplemented wild type 
and TLR+/- groups versus controls 
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Microtitre plates were read in an ELISA reader (Tecan GmbH, Crailsheim, 
Germany). Trends in IgE antibody show a reduction in KO/A.lwoffii in comparison 
with controls KO mice, but no significant differences seen in the antibodies of any 
of the groups. 
 
4.2.4 The effect of maternal non-pathogenic bacterial exposure on 
offspring lung: histopathological examination 
 
Histopathological examination of young mice lungs was done, after a prior 
perfusion with PBS buffer (pH 7.2) and fixation in situ with Formaldehyde 4% 
(wt/vol) sol. Tissue characterization and cell profiles of inflammatory cells were 
observed in Haematoxylin and Eosin (H&E), respective Periodic acid-Schiffs 
(PAS) stained sections, using High-Power Light Microscopy (HPLM). Lung 
histology revealed local reduction of the inflammatory cells and mucus secretion 
into wild type supplemented mice, but no changes seen in knockout mice in 
comparison with controls. To address the role of TLR signaling in prenatal 
asthma prevention, we designed an experimental system in which recognition of 
a broad spectrum of pathogen-associated-molecular-patterns (PAMPs) was 
selectively impaired in the mother. Since MyD88-/- and TNFp55-/- mice lack of 
TLR activity, respective IL-1 and TNF  cytokine family member signaling, 
involved in the regulation of inflammatory reaction, we considered these mice 
inappropriate for our study aim. In general, mice of the C57BL/6 background per 
se develop less airwayhyperreactivity (AHR). However, a significant improvement 
in lung function could be detected in TLR+/- sensitized offspring of 
TLR+/+/Ac.lwoffii exposed females, whereas TLR+/- offspring of TLR-/-/Ac.lwoffii 
females did not show any improvement. Therefore, we as other past studies 
demonstrated that in TLR mediated signals are essentially to support allergy and 
asthma protection. Thus, asthma-induced experiment in TLR2/3/4/7/9+/- offspring 
required a total TLR signaling competence, finally resulting in the TH1 fetal 




Cecilia-Carmen Patrascan, PhD Thesis                                                            
Philipps-University of Marburg / Lahn, Hessen, Germany 
        147 















Fig.4.2.4 Mice offspring lung histo-morphological illustration (WT/TLR+/- offspring, 
supplemented with PBS/Ac. lwoffii) after OVA - sensitization/challenge. Lung tissue cross-
sections are stained either with haematoxilin-eosin (H&E, upper pictures) and periodic acid-Schiff 
(PAS, lower pictures). Haematoxylin stains cell nuclei blue, while eosin is strongly absorbed by 
red blood cells, colouring them bright red. Furthermore, it stains cytoplasm, connective tissue and 
other extracellular substances in pink or red. Periodic acid-Schiff staining is used to mark 
carbohydrates (glycogen, glycoprotein, proteoglycans) and to distinguish different types of 
glycogen storage diseases. Here, we monitor mucus producing goblet cells and airway 
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5.1 Introduction into research and methodological aspects 
From methodological point of view, the present doctoral thesis addresses 
experimental science research dealing with the evaluation of experimental 
protocols and data in the area of Biomedical Science, particularly 
The role of Toll-like 
receptors in the development of immunological tolerance in neonates is part of 
the research project so-called Sonderforschungsbereich (SFB - TR22/A18) such 
as: Mechanisms of pre- and postnatal instruction of allergic respiratory diseases 
in the mouse model of experimental asthma. Furthermore, in the present 
research was possible to identify two important bacteria strains having the 
capacity to suppress and, respectively to prevent the development of 
experimental asthma. The bacteria strains: Lactobacillus rahmnosus GG (LGG, 
Gram+ bacteria) and Acinetobacter lwoffii F78 (Ac. lwoffii F78, Gram- bacteria), 
have been originally identified in the epidemiologic longitudinal study, so-called  
PASTURE STUDY, which is an EU funded project under the leadership of the 
Technical University of Munich, Bayern, Germany. The relevant concepts are 
well defined, in addition to issues of research design and data gathering which 
are carefully discussed. Accordingly, the development of a mouse model of 
prenatal exposure to microbial compounds and the involvement of a molecular 
mechanistic design against allergic disorders, were imperiously required in this 
study. The offspring were analyzed with regard to the development of allergic 
phenotypes later in life. Thus, the first step was to acquire a broad knowledge in 
different read-outs including clinical investigations and secondly, it was 
necessary to set-up a number of assay systems, which allow us further analyzing 
the immuno-competence of placental tissue in mice (immunological medicine 
interference with cell- and molecular biology). The second step associates the 
asthmatic phenotype shown in offspring with the maternal protective molecular 
mechanism. The script confers the impasses as well as achievements gained 
throughout both, theoretical and experimental work. In an outlook on possible 
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acquired data prove that the instruction of infant immune responses in the 
perinatal period develops under the influence of maternal immunity. 
 
5.2 Lactobacillus rhamnosus GG and Acinetobacter lwoffii F78 bacteria 
strains  a perinatal regulation of allergic respiratory disease 
completed in mouse model of experimental asthma 
 
Our postnatal - acute asthma - established animal model used Balb/c and 
C57BL/6 mouse strains, perinatal exposed to bacterial allergens, such as LGG 
(Gram+ bacteria strain, present in probiotic products), Ac. lwoffii F78 (Gram- 
bacteria strain isolated from stable dust present on farmer mammalian skin) and 
- bacteria membrane). We 
observed that several mechanisms have been occurred in vitro (line-cell culture) 
and in vivo (animal studies) during the perinatal allergen exposure influencing the 
postnatal immunity but the related molecular- and cellular mechanisms with 
special emphasis on the prototypically Toll-like receptor ligands was more 
suggestive in the present work. Direct modulation of the immune system may be 
through the Toll-like receptor signaling pathways in concert with steroid 
hormones generating an anti-inflammatory cytokine cascade, increasing 
maternal production of IgG and secretory IgA, which eliminates antigens either 
from the mother and fetus intestinal mucosa and placenta. The idea is supported 
by the fact that allergic infants have been observed to have an aberrant intestinal 
microbiota. Clinical trials have shown that the standard treatment of infants with 
atopic diseases, can be significantly improved through the supplementation of 
LGG to pregnant women and subsequently, to their infants through the first 
months of extrauterine life and their exposure to farming environmental allergens 
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5.3 The essential responsibility of APC T cells cross-talk at foeto-
maternal interface in shifting the infant immune system: a bias 
against TH1-regulated in concert to a cell-mediated immunity to 
diminish the progress of asthma in children at-risk 
 
The APC  T cell-mediated immune processes also play a fundamental role in 
the postnatal life. In order to fulfill their function as antigen presenters, APC serve 
two major functions: (i) they capture the proteins from pathogens or cellular 
debris and process them in that they digest them into fragments called epitopes, 
and (ii) APC present these epitopes on either class I or class II MHC proteins for 
T lymphocyte recognition. In addition to MHC presentation of peptides, APC 
express signals required for the proliferation and differentiation of T lymphocytes 
that specifically recognize the presented antigen. Maternal immunity is gradually 
suppressed during pregnancy from the beginning to the end similar as a foreign 
organ is transplanted, but here the fetal tissue expresses histocompatible 
allergens either from father and mother. The idea behind supported by prior 
studies was to characterise in our prenatal model the main immune cell classes 
(T, APCs, NKs) and some subclasses related to CD45+ cells (regulatory T cells, 
activated T cells and activated Tregs). They cross placenta during pregnancy and 
contribute in maintenance of the foeto-maternal immunity balance, within specific 
circumstances. We preferred to investigate the LA/LPS supplemented group, 
since postnatal data (Blümer, 2005) demonstrated that LPS in certain 
concentration are able to modulate allergic reactions. Here, we observed only a 
trend in induction of CD3+CD8+ T cells, but a significant suppression of NK cells 
in LA supplemented group versus control. Furthermore, FACS analysis 
demonstrated a significant decrease in placental NK cells of the LA treated group 
versus controls. A high percentage of CD3+CD4-CD8- fetal thymus cell subset or 
Alternatively, they are involved in cytokine-mediated immunoregulation of the 
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placental development, in local immunosuppression and immunomodulation 
(Santoni, 2006).  
5.3.1 Alternative face-book of Asthma: the postnatal anti-allergic 
phenotype development is managed by cytokine expression at 
materno-fetal interface  
Furthermore, our observations including variation in TH1/TH2 (TH3) cytokine 
production was considered either in stem cell trophoblasts and term trophoblasts. 
It must be a fine balance between cytokines with light induction into TH2 
direction. The cytokine are promoted from both sides: placental trophoblasts bath 
including stem trophoblasts and term trophoblasts as well and by decidual 
lymphocytes. A helping-hand in this regard is given by steroid hormones, which 
demonstrated a consistent contribution inducing the expression of placental 
cytokines from implantation phase to term stage. Also, trends in supplemented 
mother mice include an increase in placental TH2 cytokine such as IL-4 and IL-10 
in LGG and LA, whilst in Ac. lwoffii group the production of these cytokines were 
inhibited. It might be that LA, the active component of LPS is metabolized during 
systemically absorption, respectively in the lipid metabolism. Consequential 
appear dissimilarities into LA and Ac. lwoffii experimental results. 
Proinflammatory cytokine like IL-1  was upregulated in LGG and Ac. lwoffii 
mother groups, whereas in LA mothers the effect is opposite. Also, significant 
differences between all supplemented groups include an inverse relationship 
between IFN  and TNF . Certain adaptor molecules, mediators like cytokine and 
chemokine, and transcription factors involved in TLR signaling pathways at 
mRNA level (NF-kB, MCP-1, T-bet, GATA-3, FoxP3, CD3, CD14, CD11), playing 
a key role in regulation of inflammatory response were also evaluated. We 
remarked only an upregulation of MCP-1 expression in supplemented mothers in 
comparison with controls. The expectation is achieved since the chemokine is 
involved in the complement system annihilating foreign pathogens. The 
monocyte chemotactic protein-1 (MCP-1) or CCL2 recruits monocytes, memory T 
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degranulation of basophils and mast cells. Also, mRNA CD3 expression 
illustrates an upregulation at mRNA level indicating the presence of TH2 cell in 
decidual tissue. Besides, in stem trophoblasts the mRNA TH1/TH2 cytokine 
expression diverge from stimulated cells to another. IL-1  and IL-4 expression is 
upregulated in stimulated cells versus controls. Moreover, IL-4 a TH2 cytokine is 
present either in stem- and term trophoblasts as well mediating the activation, 
differentiation and dedifferentiation of B cells, promoting class switch IgG1 and 
IgE important in immunity transfer from mother to the fetus. Trends include an 
inverse relationship in stimulated placental stem cells in TH2 cytokines such as 
IL-10 at mRNA level, while IFN  and TNF , are not expressed at all. 
Comparable, these two experiments done with stem- and term trophoblasts 
quantifying the mRNA TH1 and TH2 cytokine demonstrated their promising 
functions in pregnancy and influence of fetal immunity. The proinflammatory 
cytokine IL-1  induced in both type of cells play an important role in implantation 
when the morphology of the uterus changed becoming amplified when the 
pregnancy achieves its term. IL-1 , similar to TNF  attracts leucocytes and 
endothelial adhesion molecules at inflammation site inducing acute-phase 
proteins by activating lymphocyte co-stimulation phagocyte. Also, it promotes the 
prostaglandin synthesis and tissue remodeling avoiding any pregnancy 
pathogenesis.  
 
5.3.2 Steroid hormones: a bridge-like between endocrine and immune 
systems and their regulatory role upon pregnancy TH1/TH2 (TH3) 
cytokine balance  
Progesterone and Estradiol from supplemented mother mice blood serum and 
amniotic fluid were quantified by ELISA and CBA kit. The experimental protocol 
has been established for five different groups of mouse females: (i) Nonpregnant 
/Nonsupplemented (blood serum), (ii) Pregnant/Nonsupplemented used as 
Control for all supplemented groups , (iii) Pregnant/PBS (control group), (iv) 
Pregnant/LGG, (v) Pregnant/Lipid A, (vi) Pregnant/Ac. lwoffii supplemented 
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significantly up-regulation only in the Ac. lwoffii supplemented females, while the 
estradiol level is suppressed in LA supplemented group, related to control group. 
The hormonal variation given by pregnancy state is associated with bacterial 
supplementation and persuades fetal immunity. Furthermore, lacking of classical 
MHC class -I and -II antigens at the trophoblast sides induces immunological 
processes under hormonal control, preserving the TH1/TH2 cytokine balance. In 
contrast to the peripheral blood, at the feto-maternal interface there is present a 
certain composition of immune competent cells. Also, many different interactions 
between the endocrine and immunological system occur, where the steroids 
hormones modulate the secretion of certain cytokine and vice-versa. Similar 
measurements are performed either in blood serum and amniotic fluid of 
important cytokine, such as IL-4, IL-5, IL-10, IL-
results reveal no significant difference between bacterial supplemented and 
control groups. Nevertheless, it is expected that relatively a slight perturbations of 
the TH1/TH2 balance can have an impact, either decreasing or increasing a risk of 
later allergic and/or airway diseases. As discussed, cytokine and chemokine play 
a very important role in the reproduction (i.e. embryo implantation, endometrial 
development, and trophoblast growth and differentiation) by modulating the 
immune and endocrine systems. The close correlation between the embryo and 
sex steroid hormones, cytokine and chemokine. As a result of this closely related 
cross-talk, pregnancy is successfully maintained. Production of cytokine including 
interferon-gamma (IFN ) and tumor necrosis factor-alpha (TNF ) is an important 
early-stage host response following infection with intracellular pathogens. 
Numerous studies have shown that early cytokine responses involving IL-12 and 
IFN  are important for resistance to intracellular pathogens, whereas responses 
involving IL-4 and IL-10 increase host susceptibility. The early cytokine 
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Fig.5.3.2 Progesterone-mediated interaction between endocrine and immune system- 
Progesterone promotes the differentiation of TH2 cells and the release of TH2-cytokine (IL-4, IL-5, 
IL-6, IL-10, IL-13), inhibiting the TH1-cells differentiation and production of TH1-cytokine. 
Additionally, progesterone increased the concentration of macrophage-cell stimulating factor (M-
CSF), necessary for differentiation and proliferation of the trophoblasts, controlling the 
macrophage functions. Also, M-CSF is produced by dNK cells and promotes the secretion of 
human Choriogonadotropin (hCG) hormone by trophoblasts, which activates corpus luteum in 
production of progesterone and relaxin. Relaxin and progesterone are antagonistic of the TH1/TH2 
balance. Relaxin promotes the differentiation of TH0 into TH1 cells and the secretion of TH1-
cytokines (IL-2, IFN , TNF / ). IFN-  is secreted also of dNK-cells in presence of IL-12 and IL-2. 
The differentiation of TH0 cells in TH2 cells is determined by granulocyte-cell stimulating factor (G-
CSF), IL-4 and IL-10, and in TH1-cells by IFN  and IL-12. TH2-cytokines promote the functions of 
eosinophils and B cells and inhibit several macrophage functions. Thus, they support the cell-
independent humoral immune response. The TH1 cytokine production activates macrophages, 
funded CTLs (cytotoxic T lymphocytes) and inhibits B-cells, as an effect of the phagocytosis-
mediated cellular immune response (according to: Geis K., Dietl J., Die Rolle der Zytokine an de 
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The characterization of CD4+T helper cell responses as TH1 or TH2-type is based 
mostly on the cytokine profiles and has been used in recent years to account for 
the innate resistance and susceptibility of different inbred strains of mice to 
several intracellular pathogens (Ulett, 2000). The apparent paradox that embryo 
is not rejected by the maternal immune system despite the presence of paternal 
MHC histocompatibility antigens has been explained in mice by a TH2 switch at 
the level of the materno-fetal interface. Therefore, steroid hormones enhanced 
during pregnancy can affect the development of CD4+T helper cells into type-1 
(TH1) or type-2 (TH2) effectors and responses, respectively. Progesterone, at 
concentrations comparable to those found at foeto-maternal interface, promotes 
the production of IL-4 and IL-5, whereas relaxin promotes the production of IFN  
by T cells. Additionally, other factors such as leukaemia inhibitory factor (LIF) 
essential for embryo implantation associates with TH2 cells and is up-regulated 
by IL-4 and progesterone. Thus, LIF is down-regulated by TH1 inducers (IL-12, 
IFN  and IFN ). Furthermore, a decreased production of LIF, IL-4 and IL-10 by 
decidual T-cells was remarked from many studies, in women with recurrent 
abortions in comparison with women with normal gestation. But the decreased 
production of LIF, IL-4 and IL-10 was not observed in peripheral-blood T-cells. 
These results suggest that the local production of LIF and/or TH2 cytokines may 
contribute to the maintenance of pregnancy. Furthermore, TH1-type cytokines 
promote allograft rejection compromising pregnancy, whereas TH2-type cytokines 
inhibit TH1 responses and allow allograft tolerance. Thus, a direct cause effect 
relationship between the defective production of LIF, macrophage-stimulating 
factor (M-CSF) and TH2-type cytokines produced by T cells present at feto-
maternal interface and the pregnancy loss has been observed (Piccinni, 2000). 
 
5.3.3 TLR expression in maternal tissues is imperiously required in 
prevention of allergic diseases 
While the clinical benefits of prenatal and early postnatal LGG consumption are 
limited, but clearly indicates the demand using microbes or microbial components 
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(mouse) for various allergic phenotypes including acute experimental asthma 
with the development of airway remodelling was designed in our laboratory. We 
observed that intestinal colonization with LGG as observed in mother mice only, 
but not in the offspring (Blümer, 2007). Furthermore, in LGG maternal 
supplemented small intestine, the mRNA TLR4 expression shows a high 
induction in the 1st trimester of gestation but not mRNA TLR2 which is 
insignificant in comparison with control group. Also, in the 3rd trimester of 
pregnancy the expression of mRNA TLR2 and TLR4 from LGG mothers remain 
insignificant in association with control group. Consequently, bacterial DNA is 
highly enriched in immunomodulatory DNA containing CpG motifs that bias the 
immune response to antigens and thus, influence and developing an anti-allergic 
immune response in infancy. Moreover, maternal LGG supplemented spleen 
mRNA TLR4 expression shown an induction only in 1st trimester of pregnancy 
but not mRNA TLR2, while in the 3rd trimester the expression at spleen mRNA 
level of both TLR is more equilibrate in supplemented group in association with 
control group. In conclusion, the first maternal immunity suppression signal 
during pregnancy which appeared in immune organs as small intestine and 
spleen is represent by increasing of TLR4. The immunosuppresion is balanced 
with evolution of gestation, being influenced by increasing levels of other 
immunomodulatory factors such as cytokine and chemokine, antibodies and 
steroid hormones. The relevance for a potential therapeutically strategy against 
allergic asthma might met the Acinetobacter lwoffi F78 (Gram- bacteria), which is 
present in high amount into cowshed microflora. Besides, a variation in all tem 
placental mRNA TLR expression was remarked in supplemented groups in 
comparison with controls. We demonstrated that trends in LGG and LA 
supplemented mother mice embrace increasing of TLR1 and TLR9 and a 
dramatically suppression of TLR7, respectively. In Ac. lwoffii group mRNA TLR7 
expression is upregulated, whilst TLR6 and TLR9 signals are suppressed. 
Differences in expression of TLR signals in supplemented LA and Ac. lwoffii 
groups include a high regulation in TLR4 and surprising in TLR5 at mRNA level, 
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signal in comparison with controls. Steroid hormones, adaptor molecules and 
transcription factors, bacterial CpG could complete the picture of TLRs signaling 
dissimilarity in placental tissue at term. Additionally, in vitro bacterial stimulated 
Trophoblast Stem Cells do not shown any significance in mRNA TLR expression, 
with exception of those stimulated with Ac. lwoffi mRNA TLR1 was upregulated 
after 24 hours. Thus, these comparative experiments in trophoblasts stem cells 
and dedifferentiated trophoblasts existing in term placenta, revealed the 
incapacity of immature placental stem cells at the uncommitted stage to express 
any TLR. The TSCs need the attendance of growing and dedifferentiation 
factors, which are normally present in vivo, such as cytokine and chemokine, 
thus being able to develop themselves and to complete their multifunction in 
maintenance the incomprehensible mechanism of tolerance and 
immunoprotection of pregnancy. It is thought that an adverse intrauterine 
environment during a critical stage of development permanently alters or 
and this allows the fetus to survive but with critical consequences in postnatal 
life. Nevertheless, the expression of placental TLR by IHC or IHF was not 
properly elucidated since a specific antigen-retrieval and specific placental 
enzymatic inhibitors were not commercial available.  
5.3.4 Farming allergens: the best educators for the prenatal epigenetic 
programming of the postnatal TH1 immunity 
In early mammalian development (fertilization to eight-cell stage), the genome is 
demethylated. From the eight-cell stage to the morula, de novo methylation of the 
genome occurs, modifying and adding epigenetic information to the genome. By 
blastula stage, the methylation is complete. This process is referred to as 
epigenetic reprogramming (Mann, 2002; Weaver, 2007). The importance of 
methylation was shown in knockout mutants without DNA-methyltransferase 
which died at the morula stage. Increasing evidence is revealing a role of 
methylation in the interaction of environmental factors with genetic expression. 
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differential methylation patterns in some promoter regions and thus influencing 
gene expression (Nakayama, 2001). Furthermore, even-more-dynamic 
processes such as interleukin signaling have been shown to be regulated by 
methylation (Bird, 2003). Latest epigenetic studies indicate that some epigenetic 
mechanisms play a crucial role in the prevention or inception of chronic diseases, 
regulating the expression of specific genes by adaptive processes in the 
genome, either by disabling (transcriptional silencing) or by activation of genes 
without sacrificing the primary DNA sequence. The genomic adaptation 
processes are taught by environmental influences and modern lifestyle (synthetic 
and natural allergens). The potential perinatal mechanisms by which epigenetic 
processes in the silencing or activation of specific genes involved are currently 
being discussed: the direct chemical modification of the DNA region by 
methylation or by modification of proteins (histones)-closely associated with the 
corresponding locus and manipulates the accessibility of chromatin for the 
transcription (Grewal, 2004; Walsh, 2006). Furthermore, newer study shows that 
the diet (food allergens), particularly in the early development phase of the 
prenatal period, the stable gene expression in adulthood is already compromised 
(metabolic programming).  Besides, we believe that Gram- bacterial membrane 
component LPS and bacterial DNA are the principal promoters in activation of 
the maternal immunoprotective mechanisms using TLRs pathways. It is well 
known that the bacterial DNA is highly enriched in immunostimulatory DNA 
containing CpG motifs that bias the immune response to antigens to a non-
allergic TH1 phenotype. This property of bacterial DNA provides a potential 
mechanism for gastrointestinal bacterial DNA to modulate the developing 
immune response in infancy. Bacterial CpG motifs are a 6-base pair sequence of 
noncoding DNA, unmethylated and functional, whereas vertebrate CpG is 
methylated and lacks significant immunostimulatory activity. The CpG motifs act 
indirectly on T lymphocytes as they are take up by cells of the innate immune 
system that secrete cytokines (IL-
develop into TH1 cells. In mouse models of asthma, immunostimulatory DNA 
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airway hyperreactivity to methacholine. The immunostimulatory DNA sequences 
are effective when administered systemically or mucosally. Studies in humans 
are currently evaluating whether the use of these immunostimulatory DNA 
sequences can inhibit allergic responses in humans as they do in animal models 
of allergy. Nowadays, is known that an allergic individual is more sensitive than 
non-allergic ones to the bronchoconstrictive properties of inhaled LPS. An 
explanation for the directed bronchoconstrictor response to high doses of inhaled 
LPS is suggested from genetic studies demonstrating a mutation in the 
extracellular domain of the receptor that binds LPS, the toll like-receptor 4 
(TLR4). The TLR4 receptor polymorphism is significantly associated with those 
individuals who are resistant to the bronchoconstrictor effects to high doses of 
inhaled LPS. But inflammation is a complex response to infection and tissue 
injury (Nathan, 2002), therefore we anticipated that Toll-like receptors (TLRs) 
have a crucial role in the inflammatory response to infection and allergy, 
especially in children through an immunity still vulnerable. Thus, bacterial 
lipopolysaccharide (LPS) signals through TLR4, being one of the most potent 
inducer of inflammation (Takeda, 2003). Multiple regulatory mechanisms could 
take place, controlling the degree and/or duration of TLR-induced inflammation: 
(i) the inhibition of TLR signaling by inducible negative regulators, (ii) production 
of anti-inflammatory cytokines and, (iii) alterations of the TLR signaling cascade 
(Liew, 2005). Collectively, these mechanisms contribute to the phenomenon of 
LPS tolerance: the transient unresponsiveness of cells or organisms to repeated 
or prolonged stimulation with LPS (Beeson, 1947a/b; West, 2002; Cavaillon, 
2006). LPS tolerance has traditionally been viewed as a hyporesponsive state of 
macrophages resulting from receptor desensitization (Dobrovolskaia, 2002/2003; 
Fujihara, 2000/2003; Medvedev, 2000/2002). However, TLRs induce expression 
of hundreds of genes with different functions (Huang, 2001) and therefore 
different regulatory requirements. Thus, it is not known that all TLR-induced 
genes are controlled exclusively at the signaling level. This would not 
discriminate between gene subsets with distinct functions because not all TLR-
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encoding anti-microbial effectors that are essential for the early-host defense 
from infection. Thus, a transient disruption of TLR-induced expression of these 
genes would leave the host immunocompromised.  
5.4 Beneficial effects observed in mouse offspring prior perinatal       
farming allergens exposure  
 
Since the innate immune system plays an essential role in the initial immune 
activation and modulates subsequent adaptive immune responses, we 
investigated in maternal tissues due to pregnancy period, where the existing 
pattern-recognition receptors (PRRs) such as Toll-like receptors (TLR) are 
involved through specific signalling pathways, after bacterial supplementation. 
Consequently, the postnatal experimental part corroborates mostly with the 
prenatal data and reveals together a potential protective molecular mechanism 
against allergies, such as asthma associated. Therefore, in this supplementary 
experimental protocol, providing that the TLR-mediate asthma defensive 
molecular mechanism, were used C57BL/6J strain female mice, 6-8 weeks old 
-/-, TLR-/- (TLR2/3/4/7/9-/-), TNFp55-/- versus wild type female 
mice (wild type male bred). In heterozygote asthmatic induced offspring we 
observed that Acinetobacter lwoffii F78 supplementation appears to act through 
maternal TLR, to reduce BAL cell - eosinophil and lymphocyte, and decreased 
number of macrophages. Furthermore, offspring of TLR knockout mice have 
decreased numbers of BAL macrophages. Moreover, Acinetobacter lwoffii action 
appears to be through maternal Toll-like receptors signalling pathway, but it 
thought that an alternative system occur to affect BAL neutrophils. To observe 
the effects of maternal exposure to Ac. lwoffii on offspring cytokine and more, the 
course of immune response, BAL fluids cytokines such as IL-10, IL-
from OVA-sensitized and challenged mice were measured by ELISA method. 
Accordingly, in the absence of maternal TLR, Ac. lwoffii supplementation has an 
effect on asthmatic offspring BAL - -
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KO/PBS and WT/Ac. lwoffii and WT/PBS groups. This result reveal an opposite 
effect, respective an induction of TH2 immunity in comparison with the phenotype 
of asthmatic offspring Balb/c strain, which reveal a TH1 immunity  an up-
+/- offspring cover reduced BAL IL-10 
production, but no difference seen in BAL IL-5 levels. Moreover, lung function 
analysis was carried out using the non-invasive method of head-out body 
plethysmography. The middle-expiratory airflow (EF50) of bronchial 
responsiveness to -Acetyl-Methacoline (MCh) was measured 24 hours after the 
last OVA aerosol challenge. Maternal Ac. lwoffii supplementation reduces airway 
reactivity in wild type (WT) offspring. However, since there is no difference 
between WT/Ac. lwoffii and K.O./Ac. lwoffii groups it cannot be state definitely if 
airway reactivity is affected through TLR signalling pathway. Therefore, the 
reduction of hyper-sensitivity reaction in OVA-sensitized offspring against 
controls littermates depends by the transferred maternal allergen-specific IgG1 
antibodies. This shows that unlike the offspring of control mice, the offspring of 
OVA-sensitized mice developed a qualitatively and quantitatively higher anti-
allergen-specific immune response. An allergen re-exposure of these animals 
reveals a suppression of the allergen-specific IgE and IgG1 production, even 
these animals could develop immediate a hypersensitivity reaction. These data 
demonstrate that the postnatal TH2 immunity suppression could be dependent on 
the perinatal transfer of the maternal antibodies IgG1 subclass. Thus, this might 
be an explanation why some mouse strains are immunological resistant by 
generating of an allergic phenotype (e.g. BL57C/6 background). In conclusion, all 
these studies prove evidence that the maternal immunity exercises a decisive 
influence on development of the adaptive immune response in the offspring. This 
character finds possible already prenatally, and operates in the early postnatal 
period. The basement of this character is the induction and instruction of a 
specific T-cell response in the child, educated by maternal adaptive- and innate 
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5.5 The immunity transfer from mother to child - a potential maternal 
anti-allergic immunoprotective mechanism evolved through 
pregnancy with effectiveness in spring age children  
 
Atopic children are born in a healthy state. The earliest clinical manifestation of 
the atopic syndrome manifests not before the first few months of extrauterine life, 
and primarily location occurs on the skin tissue (atopic eczema), gut (food 
allergy) and later, into respiratory tract (asthma). In our focus, the direction of the 
promising process per-allergic vs. anti-allergic within the perinatal stage is 
essentially determined by two aspects: (i) suppression of maternal immunity 
during pregnancy (prenatally events - the maternal TH1 immunity is suppressed 
by intervention of paternal genetics); (ii) permanent exposure to micro-
environment (allergens) where bacteria components operate like anti-allergic 
adjuvants via TLR pathways (postnatally events - the infant immunity switch from 
TH2 phenotype shortly present at birth into TH1-type immunity during 1st year of 
life, developing an anti-allergic phenotype).  Regarding, the particular importance 
of TH1, TH2 and Treg cells in perinatal stage was monitored in the maternal tissues 
induction and instruction of a specific T-cell response (e.g. CD4) in the child 
might be mediated by innate regulatory pathways, such as Toll-like receptors 
jointly maternal humoral immunity. There is a correlation among maternal 
activated adaptive and innate systems through the environmental allergens 
which modulate the plasticity of the child immune responses. The transfer of 
antibodies is a mandatory molecular mechanism which occurs only in pregnancy 
and confers a compensated molecular protective mechanism: (i) prenatal via 
placenta from maternal bloodstream to fetal bloodstream; (ii) postnatal via 
colostrium and breast milk direct into baby gastrointestinal tract. The maternal 
antibodies offer a passive protection and supplementary, they are actively 
involved in development of the infant immunity. Also, maternal 
immunomodulatory molecules such as soluble factors and transfer factors play a 
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Fig.5.5a Graphical illustration of the potential anti-allergic mechanisms developed during 
and after pregnancy stage and current deviations from a TH2 phenotype pregnancy. Farmer 
non-
from TH2 (before and shortly after birth, correlated with pregnancy well development) into TH1 
(correlated with anti-allergic neonate phenotype). This mechanistic molecular machinery works 
only if the expecting mother and newborn - within the 1st year of life - are daily exposed to farmer 
environment. 
 
The important meaning of the fetal acceptance and immunoprotection desired 
effect of the pregnancy TH2/TH3 immuno-deviation is the suppression of maternal 
TH1 immune responses by up-regulating T-cell functions at the maternal-fetal 
interface. Infections or environmental challenge may drive the maternal immune 
system towards a cell-mediated, like tolerogenic type response. In functioning 
immune responses, the helper- and cytotoxic T cells are activated by 
presentation of antigens to antigen-presenting cells (APCs). Following inhalation 
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the microbe begin to process antigen and migrate to peripheral lymphoid tissues, 
gut lymphoid- and placental tissue during pregnancy. In the maternal lymph node 
the APC and T cells link-up relative shortly after allergenic exposure in concert 
with paternal antigens, therefore the microenvironment of the lymph node 
significantly influences the developing T cell response in TH1 or TH2 direction. A 
shift in the maternal TH1 to TH2 immunity can result in pregnancy, as well as in 
allergic diseases. In mother, the innate response destroys or limits the 
pathological actions of allergens until adaptive immunity develops and then, the 
new concept is recognized. Any alteration in the maternal innate immune 




Fig.5.5b Schematical illustration of pregnancy immunity development in rural versus 
urban circumstances. Environmental, physiological and genetical aspects can determine the 
nature of the T cell response (TH1 or TH2 predominant phenotype) in mother inducing cytokine 
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The type of fetal immune response mounted during a prenatal microbial 
exposure is determined by the host innate response, genetics or microbial 
pathogenesis. A combination of these components determines the development 
of child TH1 or TH2 response which is dependent on the type cells and early 
signals from his innate immune system. The cells and signals of innate immunity 
provide the major immunoregulatory functions that link both innate- and adaptive 
immunity, which develops later during 1st year of extrauterine life. Besides, some 
maternal antibodies against fetal antigens are removed as immune complexes. It 
is well known that in primates, prenatal transfer of IgG from mother to offspring 
occurs predominantly across the placenta. Although in human placental tissue a 
number of Fc-receptors and IgG binding proteins, their involvement in IgG 
transport across the placental syncytiotrophoblasts have been detected. 
Therefore, the Fc receptor architectonic -mediated protective mechanisms 
appear as a top candidate molecule to explain the postnatal immunosuppression, 
in concert with maternal IgG1 antibodies subclass. Fc receptors bind to 
antibodies that are attached to infected cells or invading pathogens. Their activity 
stimulates phagocytic or cytotoxic cells to destroy microbes, or infected cells by 
antibody-mediated phagocytosis or antibody-dependent cell-mediated 
cytotoxicity. The signal activates an inhibitory intracellular tyrosine-dependent-
activation-motif (ITAM). The signal transduction cross-talk mechanisms by which 
ITAM-associated receptors modulates signaling through Toll-like receptors 
(TLRs), TNFR family members and cytokine receptors that use the JAK STAT 
signaling pathway (Ivashkiv, 2009). ITAM-mediated cross-regulation can either 
enhance or diminish signaling by other receptors. Three major downstream 
effector signalling pathways are activated by ITAM-coupled receptors: NF- B, 
MAPKs and calcium pathways. Of these effector signalling pathways, NF- B and 
MAPKs are involved in cell activation and can also be activated by many other 
receptors, such as TLRs, and proinflammatory cytokine receptors, like the 
interleukin-1 receptor (IL-1R) and tumor necrosis factor receptor (TNFR). The 
high affinity IgG transporters are the larger protein the -chain of human FcRn 
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FcRn binds IgG on the cell surface (intestine epithelium) or in endosome 
(trophoblast). Transcytosis by FcRn occurs in multiple places in humans: carrying 
IgG into the fetal bloodstream, in the adult liver, and from blood to milk in the 
lactating mammary glands and then by breast feeding into the gastrointestinal 
tract of the newborn. FcRn binds IgG at pH 6.0, which is the pH in the maternal 
bloodstream, and releases at pH 7.4, which is the pH in the fetal bloodstream. 
Trophoblast cells in the placenta uptake fluid-phase IgG by pinocytosis, maternal 
apical vesicles are released which are acidic and cause binding between FcRn 
and IgG. FcRn transports the antibodies across the cells, and upon reaching the 
fetal bloodstream where the IgG is released. FcRn then moves back across the 
trophoblast cells to the mother, to transcytose more IgG to the fetus (Simister, 
1997). 
        
Prenatal mechanism                                              Postnatal mechanism
Fetal achievement of blood maternal IgG Neonatal achievement of milk maternal IgG
Maternal             PLACENTA Fetal               Lumen             INTESTINAL CELL OF         Basal 
circulation                                              circulation NEONATE Surface
Neonate gut epithelium and liver



























































Fig.5.5c Perinatal maternal anti-allergic immunoprotection mechanism trough IgG and 
TLRs (adaptive and innate maternal immunity). The main function of Fc-receptors that signal 
through immunoreceptor tyrosine-based activation motifs (ITAMs) is to regulate signaling by Toll-
like receptors (TLRs) under bacterial gears control (according to: Human Immune Protein FcRn: 
IgG Trancytosis and catabolism, 2003. Davidson College Biology  Immunology Course and 
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The IgG-FcRn complex is sorted into vesicles from the apical endosome, and 
transported basolaterally to release IgG extracellularly. The FcRn controls the 
catabolism of IgG in maternal body, allowing IgG to be recycled to the cell 
surface and back into the bloodstream; therefore IgG has much longer half-life 
than other antibodies. The long intron of the human or mouse FcRn gene - 
FCGRT or Fcgrt - contains sequences that bind either p65/p50 heterodimers or 
p50/p50 homodimers of the NF-kB transcription factors. The presence of NF-kB 
binding sequences located in distant intronic regions involve the NF-kB 
complexes in the instruction of FcRn, possibly in cooperation with other 
transcriptional elements in the FcRn promoter.  
Because the FcRn protein may exert both beneficial and detrimental effects in a 
variety of immune diseases, FcRn biosynthesis may be under the control of 
multiple complex regulatory mechanisms in response to an extracellular stimulus. 
This mechanism is common in cells which express FcR- and TLR receptors from 
innate and adaptive immunity. In general, the packaging of eukaryotic DNA into 
the nucleosome and higher order structures of chromatin allow for the possibility 
that the distant regulatory regions are physically close enough for direct 
interaction or communication through bridging molecules. It is tempting to 
speculate that the transcriptional factors binding to the proximal region of the 
FcRn promoter interact functionally with NF-kB dimer bound to the intronic 
sequences after induction by stimuli, such as TLR ligands. Thus, a protein 
complex is formed between an FcRn intron and an FcRn promoter region using a 
chromatin looping mechanism. Obviusly, NF-kB is clearly involved in the 
transcriptional regulation of many genes. Its activity can be modulated 
significantly by factors that bind to motifs adjacent to, overlapping with or distant 
from that of NF-kB binding sequences. These protein-protein interactions may be 
involved in mediating the transcriptional regulation of the FcRn genes  FCGRT 
or Fcgrt - in response to stimuli and can functionally cooperate to elicit maximal 
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The role of Toll-like receptors in the development of immunological 
tolerance in neonates 
Epidemiological and clinical studies based on Hygiene hypothesis indicate that 
maternal exposure to bacterial environment may modulate allergic diseases later 
in life. Also, evidences suggest that priming of the immune responses against 
allergens happens already in utero. This is a nature’s lesson taught by pregnancy 
immunity: maternal innate immunity via placental TLR signaling and adaptive 
immunity via maternal IgG and IgA transfer to fetus. The antibodies provide not 
only a passive protection, but are actively involved in the immunity of the child. 
Toll-like receptors (TLR) expressed on gut lymphoid tissue and epithelial cells of 
gastrointestinal-/respiratory tract, placenta etc. interact with environmental 
bacterial molecular patterns (e.g. endotoxin - LPS, DNA, LTA, dsRNA, ssRNA, 
flagellin etc.) and modulate maternal innate-/adaptive immune responses. In 
parallel, it also seems the T-cell system of the mother influences the 
development of children immune responses. Thus, in mother an appropriate 
colonization with probiotics helps to produce a balanced T helper cell response 
(TH1/TH2). Nevertheless, the (maternal and infant) respiratory tract has an 
obvious relationship with the environment and continuous exposure to microbial 
environment. Regarding, an important aspect of the study was to investigate the
impact of non-pathogenic Gram+ (LGG), Gram- bacteria (Ac.lwoffii) or bacterial 
gears, (LA/LPS/ E.coli) to allergic asthma, and hypothesised that the activation of 
Toll-like receptors in the placenta plays an important role in prenatal transmission 
of protective immunological effects from mother to fetus. Consequently, the full 
development of innate host defense responses in the offspring lung requires 
expression of the maternal TLR in placenta. The receptors enhance expression 
of IL-1 , TNF , IL-4, IL-10 and IFN . A balance of TH1/TH2 cytokine regulates the 
intensity and nature of the response. Maternal anti-allergic mechanism via TLR 
signaling is in general associated with the maturation and migration of the lung 
dendritic cells to the lymph nodes and production of TH1 cytokine (IL-12), 
6. Summary 
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increasing the IFN  production either in the lung and in the early placenta. Thus, 
we associated suppression of allergen-mediated inflammatory responses in 
placenta with: a cross-talk between trophoblasts and activated lymphocytes, 
using TLR pathways by maintaining the TH1/TH2 balance pregnancy; secretion of 
immuno-suppressive molecules such as steroid hormones (progesterone, 
estradiol), prostaglandins, TGF  by trophoblasts and decidual immune cells; a 
significant increase of placental mRNA TNF  and mRNA IL-1  cytokine, resulting 
in a down-regulation of mRNA IFN  expression under control of steroid 
hormones; passive blocking of lymphocyte activation by essential cytokine 
required for cell division, like IL-10; an immunoregulatory effect caused by the 
placental local production of specific sets of cytokine or chemokine, such as IL-4 
and MCP-1; a specific cytostatic action of placenta CD8+ Tc cells, where the 
trend appears dominant in supplemented group; decidual NK cells – high amount 
in the early pregnancy are reduced in the 3rd trimester being unable to produce 
IFN , supporting the TH2 pregnancy phenotype and avoiding abortion; a strong 
induction of placental mRNA TLR4 and an oscilation in expression of mRNA 
TLR1, TLR2, TLR5, TLR7, TLR9 expression into Gram- bacteria/gears 
supplemented group; placental cytokine modulate the TLR gene expression, but 
the effect varied between different cell types; maternal antibodies transfer to the 
fetus (a mechanism via trophoblast’s and gut’s IgG-FcRn complex induced by 
TLR signaling cascade). Moreover, frequent perinatal bacterial exposure 
suppressed in susceptible offspring: the allergen-specific sensitization - IgE 
production; the numbers of inflammatory cells, such as eosinophils in BALF and 
TH2 cytokines (IL-4, IL-5, IL-13) expressed in BALF and serum; in vivo, airway 
reactivity in response to Methacholine; lung mucus production. There is no doubt 
that early programming contributes to a large extend to the development of a 
normal state of immunological responses in offspring. A diminished expression 
and function of maternal TLR may help explain the poor adaptive immune 
responses, increasing the susceptibility to infections and allergies in the 
offspring. However, once a pregnancy is well developed, the newborn has a 
6. Summary 
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weakly TH2-biased immune response, and there is required a rapid postnatal 
down-regulated immunity. Therefore, the development of TH1 anti-allergic 
immunity in neonates, could be associated with the IFN  compensation induced 
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Die Rolle von Toll-like Rezeptoren bei der Entwicklung immunologischer 
Toleranz bei Neugeborenen 
Epidemiologische und klinische Studien unterstützt durch die Hygiene Hypothese 
beweisen, dass die mütterliche Exposition gegenüber einer bakteriellen Umwelt 
allergische Erkrankungen im späteren Leben modulieren kann. Es ist 
nachgewiesen, dass die Ursachen dieser Immunantwort gegen Allergene bereits 
in utero zu finden sind. Das ist eine Lektion der Natur, die durch die 
Schwangerschaftsimmunität gelehrt wird:die angeborene (via Plazenta-TLR-
Signalen) und die adaptive Immunität der Mutter. Die Antikörper bieten nicht nur 
einen passiven Schutz, sondern sind aktiv am Immunsystem des Kindes 
beteiligt. Toll-like Rezeptoren (TLR) wie z. B. am Darm-Lymphgewebe sowie den 
Epithelzellen des Magen-Darm-Trakts, der Atemwege und der Plazenta 
interagieren mit bakteriellen molekularen Mustern der Umwelt (z. B. Endotoxin-
LPS, DNA, LTA, dsRNA, ssRNA, Flagellin etc.) und modulieren die angeborene 
und adaptive Immunantwort der Mutter. Parallel dazu scheint auch das T-Zell-
System der Mutter die Entwicklung der kindlichen Immunantwort zu beeinflussen. 
So trägt eine geeignete Besiedelung der Mutter mit Probiotika dazu bei, eine 
ausgewogene T-Helferzellen-Antwort (T 1/T 2) zu produzieren. Ein wichtiger 
Aspekt der Studie war es, die Auswirkungen der nicht-pathogenen Gram
H H
+
Bakterien (LGG), Gram  Bakterien (Ac.lwoffii) oder - bakteriellen Komponenten
(E.coli/LPS/LA) auf allergisches Asthma zu untersuchen. Diesbezüglich wird die 
Hypothese aufgestellt, dass die Aktivierung von Toll-like Rezeptoren in der 
Plazenta eine wichtige Rolle in der pränatalen Übertragung einer 
immunologischen Schutzwirkung von der Mutter zum Fötus spielt. Folglich ist die 
Expression des mütterlichen TLR sowie die Fähigkeit, durch diese Rezeptoren 
Signale zu senden, für die volle Entfaltung der angeborenen Reaktionen des 
Abwehrsystems in der Lunge der Nachkommen erforderlich. Die Rezeptoren 
steigern die Expression von IL-1 , TNF , IL-4, IL-10 und IFN . Ein Gleichgewicht 
der T 1- und T 2-Zytokine reguliert die Intensität und Art der Immun-Antwort. H H
6. Zusammenfassung 
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Dies bedeutet, dass – im Gegensatz zu den bekannten verschlimmernden 
Auswirkungen auf Asthma – die Exposition gegenüber Gram  Bakterien, Gram
Bakterien oder anderen TLR-Liganden in der frühen Kindheit Schutz übertragen 
oder zu einer Abnahme der Häufigkeit von Asthma im späteren Leben führen 
kann.
+ -
Der mütterliche Anti-Allergie-Mechanismus mittels TLR-Signalisierung wird 
allgemein mit der Reifung von dendritischen Zellen der Lunge und ihrer Migration 
zu den Lymphknoten sowie der Produktion von T 1-Zytokin (IL-12) verbunden, 
was zu einem Anstieg der IFN  Produktion in der Lunge und der frühen Plazenta 
führt. Auf diese Weise wurde der Zusammenhang zwischen der Unterdrückung 
der durch Allergene hervorgerufenen entzündlichen Reaktionen in der Plazenta 
und einer Reihe weiterer Phänomene festgestellt: cross-talk-Mechanismus
zwischen Trophoblasten und aktivierten Lymphozyten, der die TLR-Signalwege 
unter Wahrung der Balance von T 1/T 2 in der Schwangerschaft verwendet; 
Sekretion von immunsuppressiven Molekülen, wie z. B. Steroidhormone 
(Progesteron, Estradiol), Prostaglandine, TGF  durch Trophoblasten und 
Dezidua-Immunzellen;signifikante Zunahme der mRNA TNF und mRNA IL-1
Zytokinen in der Plazenta, was unter der Kontrolle von Steroidhormonen eine 
Unterdrückung der mRNA IFN  zur Folge hat; passives Blockieren der 
Lymphozyten-Aktivierung durch essentielle Zytokine, die für die Zellteilung 
erforderlich sind, wie z. B. IL-10; immunregulatorischer Effekt, ausgelöst durch 
die lokale Produktion von bestimmten Arten von Zytokinen oder Chemokinen, 
wie IL-4 und MCP-1, in der Plazenta; dominanter Trend in der behandelten 
Gruppe, vermutlich aufgrund einer spezifischen zytostatischen Wirkung der 
plazentaeigenen CD8 Tc-Zellen; deziduale NK-Zellen – sie sind in großer 
Menge in der frühen Schwangerschaft vorhanden und werden im 3. Trimester 
reduziert, da sie nicht in der Lage sind, IFN  zu produzieren – womit der T 2-
Phänotyp der Schwangerschaft unterstützt und eine Fehlgeburt vermieden wird; 





variieren in der mRNA TLR1, 
TLR2, TLR5, TLR7, TLR9 Expression in der Plazenta, der mit Gram-
6. Zusammenfassung 
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Eine verminderte Expression und Funktion der mütterlichen TLR könnte zur 
Bakterien/Komponenten behandelten Gruppe; Modulierung der TLR-
Genexpression erfolgt durch plazentaeigenes Zytokin, aber die Wirkung ist bei 
verschiedenen Zelltypen unterschiedlich; mütterliche Antikörper werden an den 
Fötus weitergegeben (ein Mechanismus, der über den FcRn IgG-Komplex der 
Trophoblasten und des Darms abläuft und durch eine TLR-Signalkaskade 
angestoßen wird).
Darüber hinaus unterdrückt häufige perinatale bakterielle Belastung der 
prädisponierten Nachkommen: die allergen-spezifische Sensibilisierung - IgE-
Produktion; die Zahl der Entzündungszellen, wie Eosinophile in BALF und T 2-
Zytokinen (IL-4, IL-5, IL-13) exprimiert in BALF und Serum; in vivo 
Atemwegsreaktivität als Immunantwort auf Methacholine; die Produktion von 
Lungenschleim. Dennoch besteht kein Zweifel daran, dass eine frühe 
Programmierung in großem Maße zu der Entwicklung von einem normalen 
Zustand der Immunabwehr beiträgt. 
H
Erklärung der geringen adaptiven Immunantworten beitragen, die die Anfälligkeit 
für Infektionen und Allergien der Nachkommen erhöhen. Sobald sich jedoch eine 
Schwangerschaft gut entwickelt hat, hat das Neugeborene eine schwach 
verzerrte TH2-Immunantwort. Dann ist eine schnelle postnatale Unterdrückung 
der Immunität erforderlich. Daher könnte die Entwicklung von TH1-Immunität bei 
Neugeborenen, einem Anti-Allergie-Phänotyp, mit dem IFN  Ausgleich 
zusammenhängen, der durch eine stabile und spezifische perinatale nicht-
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Fig.1.4.2a An overview of placental development in mice – morphological 
aspects of early placental development. 
Fig.1.4.2b Mouse placental layers illustration.  
Fig.1.4.2c Mouse chorionic plate illustration.
Fig.1.4.2d Central uterine artery lined.  
Fig.1.4.2e Mouse placenta trophoblasts layers.  
Fig.1.4.3a Placenta endocrine functions.  
Fig. 1.4.5a, b Maternal cells of pregnant decidua. Mouse placenta 1st trimester of
pregnancy, respective E 7.5-9.5 (embryonic day)
Fig. 1.4.5c  Maternal cells of pregnant decidua. Mouse placenta E 10-13.5
(embryonic day).
Fig. 1.4.5d  Maternal cells of pregnant decidua. Mouse placenta E 17.5-20
(embryonic day) 
Fig.1.4.6 Maternal immune system influences the development of the child’s 
adaptive immune response.
Fig.1.5.1 TLR signaling pathways.  
Fig.3.1.1 Experimental protocol of prenatal supplementation with non-
pathogenic bacteria.
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Fig.3.1.2 Experimental protocol of acute asthma animal model – OVA 
sensitisation and challenge of the offspring – Ac. lwoffii F78.
Fig. 3.5.2 Enzyme-Linked Immunosorbent Assay (ELISA). 
Fig. 3.5.6 Western Blot Analysis (WB).  
Fig.3.5.7 Placental immune cells isolation by positive selection - MACS 
System and characterisation by Flow Cytometry System.
Fig.3.5.8 Schematically illustration of placental immune cells and specific 
markers.
Fig.3.5.10 Two-step indirect immunohistochemistry. 
Fig.3.6 Offspring’s lung function analysis.  
Fig.4.1.1.1  Maternal small intestine mRNA TLR2 and TRL4 expression.
Fig.4.1.1.2a  Maternal small intestine immunohistochemistry analysis: TLR2 
expression on duodenum of supplemented animals with PBS, in 
Trim.I/III of gestation
Fig.4.1.1.2b  Maternal small intestine imuunohistochemistry analysis: TLR2 
expression on jejunum, Peyer’s patch and duodenum of 
supplemented animals with LGG, Trim.I of gestation
Fig.4.1.1.2c  Maternal small intestine immunohistochemistry analysis: TLR2 
expression on jejunum, Peyer’s patch and duodenum of 
supplemented animals with LGG, Trim.III of gestation
Fig.4.1.1.2d  Maternal small intestine immunofluorescence analysis: TLR2 
expression by supplemented animals with PBS, Trim.I/III of 
gestation
Fig.4.1.1.2e  Maternal small intestine immunofluorescence analysis: TLR2 
expression by supplemented animals with LGG, Trim.I/III of 
gestation
Fig.4.1.1.3 Maternal spleen mRNA TLR2 and TLR4 expression.
Fig.4.1.1.4a  Immunohistochemistry (IHC) of maternal spleen anti-mouse TLR2 
after LGG prenatal supplementation 
Fig.4.1.1.4b  Immunofluorescence (IF) staining of maternal spleen anti-mouse 
TLR2 after LGG prenatal supplementation
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Fig.4.1.1.5a Variation in placental mRNA-TLR expression in LGG supplemented 
group versus control.
Fig.4.1.1.5b Variation in placental mRNA-TLR expression in Ac. lwoffii 
supplemented group versus control.
Fig.4.1.1.5c Variation in placental mRNA-TLR expression in Lipid A 
supplemented group versus control.
Fig.4.1.1.6a  Evaluation of placental mRNA TH1/TH2 cytokine expression in LGG 
supplemented group versus control.
Fig.4.1.1.6b Evaluation of placental mRNA TH1/TH2 cytokine expression in Ac. 
lwoffii supplemented group versus control. 
Fig.4.1.1.6c Evaluation of placental mRNA TH1/TH2 cytokine expression in Lipid 
A supplemented group versus control.
Fig.4.1.1.6d  Variation of mouse placental transcription factors and chemokine
NF-kB, MCP-1 (equivalent of IL-8 in human) at mRNA level in Ac. 
lwoffii supplemented group in comparison with control.
Fig.4.1.1.6e Variation of placental transcription factors T-bet, Gata-3, FoxP3 
mRNA expression in Ac. lwoffii supplemented group in comparison 
with controls. 
Fig.4.1.1.6f Variation in placental mRNA CD3 and CD14 expression in Lipid A 
supplemented group in comparison with control. 
Fig.4.1.1.6g Variation in placental mRNA CD11 expression in Lipid A 
supplemented group in comparison with control. 
Fig.4.1.1.7a  Placenta electro-micrographs: Transmission electron micrograph of 
the placental barrier shown in Lipid A group versus control.
Fig.4.1.1.7b  Placenta histology – sagital sections - from LGG (a), Ac. lwoffii (b), 
Lipid A (c) supplemented groups. 
Fig.4.1.1.7c  Placenta histology – the labyrinth (H&E staining) of PBS, LGG, 
Ac.lwoffii, Lipid A supplemented groups. 
Fig.4.1.1.7d Immunohistochemistry: Placental anti-mouse TLR 2 – FITC, M.O.M 
kit – AP and HRP staining systems. 
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Fig.4.1.2.1a  SM-10 cell line, Trophoblast Stem Cells (TSCs) – mRNA TLR1 
expression after LGG, LA, LPS and Ac. lwoffii in vitro stimulation. 
Fig.4.1.2.1b SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of mRNA 
TLR2 after LGG, LA, LPS and Ac. lwoffii in vitro stimulation.
Fig.4.1.2.1c SM-10 cell line, Trophoblast Stem Cells (TSCs) - state of 
mRNA TLR3 after LGG, LA, LPS and Ac. lwoffii in vitro 
stimulation.
Fig.4.1.2.1d SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of 
mRNA TLR4 after LGG, LA, LPS and Ac. lwoffii in vitro 
stimulation.
Fig.4.1.2.1e SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of 
mRNA TLR6 after LGG, LA, LPS and Ac. lwoffii in vitro 
stimulation.
Fig.4.1.2.1f  SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of mRNA 
TLR7 after LGG, LA, LPS and Ac. lwoffii in vitro stimulation. 
Fig.4.1.2.1g SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of 
mRNA TLR9 after LGG, LA, LPS and Ac. lwoffii in vitro 
stimulation.
Fig.4.1.2.2a SM-10 cell line, Trophoblast Stem Cells (TSCs) - mRNA IL-1
expression after LGG, LA, LPS and Ac. lwoffii in vitro stimulation.  
Fig.4.1.2.2b  SM-10 cell line, Trophoblast Stem Cells (TSCs) - mRNA IL-4 
expression after LGG, LA, LPS and Ac. lwoffii in vitro stimulation. 
Fig.4.1.2.2c  SM-10 cell line, Trophoblast Stem Cells (TSCs) – state of mRNA 
IL-10 after LGG, LA, LPS and Ac. lwoffii in vitro stimulation.
Fig.4.1.3  Comparative characterization of placental immune cells – APC 
cells, T and Treg, M , NKs in PBS and Lipid A. 
Fig.4.1.4a  Maternal serum steroid hormone, progesterone - quantification by 
ELISA method.
Fig.4.1.4b Maternal serum steroid hormone, Estradiol - quantification by 
ELISA method. 
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 Fig.4.1.4c Schematically illustration of amniotic fluid maternal steroid 
hormone, such as Progesterone quantified by ELISA.
Fig.4.1.4d Schematically illustration of amniotic fluid maternal steroid 
hormone, such as Estradiol. 
Fig.4.1.4e Amniotic fluid MCP-1 chemokine expression in LGG supplemented 
females.
Fig.4.2.1a  Effect of prenatal exposure to non-pathogenic bacteria such as, 
Gram- bacteria (Ac. lwoffii) on airway inflammation in OVA - 
immunized and allergen challenged mice. Total cell number of 
BALF leucocytes and eosinophils. 
Fig.4.2.1b  Effect of prenatal exposure to non-pathogenic bacteria such as, 
Gram-negative bacteria (Ac. lwoffii) on airway inflammation in OVA 
immunized and allergen challenged mice. BALF – macrophages, 
neutrophils and lymphocytes. 
Fig.4.2.1c  The effect of maternal exposure to Ac. lwoffii on offspring cytokine. 
BAL fluids cytokines IL- 5, IL-10, IFN-  levels from OVA-sensitized 
and challenged mice. 
Fig.4.2.1d  Effect of prenatal Ac. lwoffii exposure on airway-responsiveness to 
Methacholine.
Fig.4.2.2a  Total spleen cell counts after a prior isolation by density gradient 
centrifugation in wild type and deficiencies offspring.
Fig.4.2.2b     Measurement levels of IL-4, IL-10, IL-13 and IFN  using Enzyme-
linked immunosorbent assay (ELISA), from 72h OVA restimulated 
cell-free supernatants. 
Fig.4.2.2c    Measurement levels of IL-5 and TNF  using Enzyme-linked
immunosorbent assay (ELISA), from 72h OVA restimulated cell-
free supernatants. 
Fig.4.2.3 Measurement of OVA-specific antibodies such as IgE, IgG , IgG
titers in offspring serum by ELISA 
1 2a
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Fig.4.2.4 Mice offspring lung histo-morphological illustration (WT/TLR+/-
offspring, supplemented with PBS/Ac. lwoffii) after OVA - 
sensitization/challenge.
Fig.5.3.2 Progesterone-mediated interaction between endocrine and immune 
system.
Fig.5.5a Graphical illustration of the potential anti-allergic mechanisms 
developed during and after pregnancy stage and current deviations 
from a TH2 phenotype pregnancy. 
Fig.5.5b  Schematical illustration of pregnancy immunity development in rural 
versus urban circumstances.
Fig.5.5c  Perinatal maternal anti-allergic immunoprotection mechanism 
trough IgG and TLRs (adaptive and innate maternal immunity). 
Tab.1.1a IgE-mediated reactions to extrinsic antigens. 
Tab.1.1b Mammalian toll-like receptor ligands with known signalling 
pathways utilized by each receptor and their functional significance 
in asthma. 
Tab.1.2  The immunoglobulin isotypes. 
Tab.3.5.8 Experimental protocol of placental immune cells 
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8.2 List of abbreviations 
-GalCer  alfa-Galactosylceramide 
-FP   alfa-Fetoprotein 
Ac. lwoffii  Acinetobacter lwoffii F78 
AP Alkaline Phosphatase
ALEX Study  Allergy and Endotoxin Study  
AF   Amniotic Fluid 
APC   Antigen Presenting Cell  
B220 B cell isoform of 220 kDa expressed on B cells, activated T 
cells, a subset of dendritic cells and other APCs 
BCA Kit  Bicinchoninic Acid assay (Kit) 
BS   Blood Serum
BSA   Bovine Serum Albumin 
BALF   Bronchoalveolar Lavage Fluid  
CdC2   Cell division Cycle 2 protein 
CSF-1   Colony Stimulating Factor-1 
CSF-1   Colony Stimulating Factor-1
CFU   Colony Forming Unit 
CRRY   Complement receptor 1-related gene/protein y  
CD3   Cluster of Differentiation 3 for T-cell, co-receptor 
CD4 Cluster of Differentiation 4 for T helper cells, regulatory T 
cells, monocytes, macrophages, and dendritic cells
CD8 Cluster of Differentition 8 for cytotoxic T cells and natural
killer cells, co-receptor 
CD11b Cluster of Differentiation 11 for monocytes, granulocytes,
macrophages and natural kiler cells, Integrin alpha M 
(ITGAM)
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CD11c Cluster of Differentiation 11 for human dendritic cells,
monocytes, macrophages, neutrophils and B cells, Integrin 
alpha X (complement component 3 receptor 4 subunit) 
(ITGAX)
CD25   Cluster of Differentition 25 for T and B cells, co-receptor 
CD45 Cluster of Differentiation 45 for Leukocyte Common Antigen 
(LCA)
CD69   Cluster of Differentiation 69, activates T lymphocytes 
CD95   cluster of differentiation 95, Fas receptor (apoptosis) 
CBA   Cytometric Bead Array 
CpG Cytosine – phosphate – Guanine 
CTB   Cytotrophoblast
DAF   Decay Accelerating Factor 
 dDCs   decidual Dendritic Cells 
DHEA-S  Dehydroepiandrosterone - sulphate  
DC   Dendritic Cells 
DNA   Deoxyribonucleic acid 
DAB   3, 3'-Diaminobenzidine
dsRNA  double-stranded Ribonucleic Acid 
EGF   Endothelial Growth Factor 
ELISA   Enzyme-Linked ImmunoSorbent Assay 
EtOH   Ethanol 
EF50    (mid)-expiratory flow rate (50%) 
EVT   Extravillous invasive Trophoblasts
FRT   Female Reproductive Tract 
FCS   Fetal Calf Serum  
FasL   Fas ligand 
FasR   Fas receptor
FGF4   Fibroblast Growth Factor-4  
Fgfr2 Fibroblast growth factor receptor 2 
FITC   Fluorescein Isothiocyanate 
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FACS   Fluorescent-Activated Cell Sorting (system) 
FM   Fluorescent microscope 
Foxp3   Forkhead-winged-helix protein 3 
FcRn   Fragment cystallizable neonatal Receptor 
Gcm1   Glial cells missing homolog 1 - transcription factor 
gld mice  Glucose dehydrogenase gene deficient mice 
GAPDH   Glycerin-Aldehyd-Phosphate Dehyrogenase 
GPI   Glycosyl-Phosphatidyl-Inositol 
G-CSF  Granulocyte Colony-Stimulating Factor   
GM-CSF  Granulocyte-Macrophage Colony-Stimulating Factor 
GALT   Gut-associated Lymphatic Tissue
H&E   Haematoxylin & Eosin (Staining) 
HOBP   Head-out Body Plethysmograph  
HRP   Horseradish peroxidase 
HLA-G Human Leukocyte Antigen-G
hCGH   human Chorionic Gonadotrophin Hormone  
hPGH   human Placental Growth Hormone
hPLH   human Placental Lactogen Hormone  
IgA   Immunoglobulin A 
IgG   Immunoglobulin G  
IgM   Immunoglobulin M 
IHC   Immunohistochemistry 
IDO   Indoleamine 2,3-dioxigenase 
iKIRs   inhibitory Killer Ig-like Receptors 
ICM   Inner Cell Mass 
IGF   Insuline like-Growth Factor  
IGF-1   Insulin-like Growth Factor-1 
IGF-BP-1  Insuline like-Growth Factor Binding Protein-1
IFN    Interferone gamma  
IRF-3   Interferon Regulatory Factor 3 
IRF-7   Interferon Regulatory Factor 7 
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ISRE   Interferon Stimulated Response Element 
IRAK-1  IL-1 Receptor Associated Kinase-1  
IRAK-4  IL-1 Receptor Associated Kinase-4 
IL-1   Interleukin-1  
IL-1    Interleukin -1 beta 
IL-1 RA  Interleukin -1 receptor antagonist
IL-11R  Interleukin –11 receptor 
IL-12p70   Interleukin 12 heterodimer formed with IL-12p35 
IUGR   Intrauterine Growth Restriction
J 281   subtype of NK T cells (mouse)
LGG   Lactobacillus rhamnosus GG  
LIF   Leukemia Inhibitory Factor  
LIFR   Leukemia Inhibitory Factor Receptor 
LM   Light microscope 
LA   Lipid A  
LTA   Lipotheicoic Acid 
LBP   Lipopolysaccharide Binding Protein 
LPS   Lipopolysaccharide 
MD2    Lymphocyte antigen 96 
mid-G1  Phase G1, protein synthesis in cell cycle 
MACS   Magnetic-activated cell sorting 
MHC   Major Histocompatibility Complex 
MMPs   Matrix Metalloproteases 
MMP-2  Matrix metallopeptidase-2 
MCP-1  Membrane Cofactor Protein-1  
MNCs   (splenic) mononuclear cells  
MCh   -Methyl-Acetyl-Choline
MAL   MyD88-adaptor protein-like  
MyD88 Myeloid Differentiation protein 88
NKT   Natural Killer T cells
NK1.1   Natural Killer cell surface marker 1.1 in mice
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NDV   Newcastle Disease Virus 
NaCl   Sodium Chloride 
OcT3   Organic cation Transporter 3
OVA   Ovalbumin
PAMPs  Pathogen Associated Molecular Patterns  
PG   Peptidoglycan 
Per CP  Peridinin Chlorophyll Protein 
PAS   Periodic acid-Schiff  
PBS   Phosphate Buffered Saline 
PE Phycoerythrin 
PGH Placental Growth Hormone
pDC plasmacytoid Dendritic Cells 
PAI-2   Plasminogen Activator Inhibitor-2  
PAF   Platelet-Activating Factor  
PCBs   Polychlorinated Biphenils  
poly I:C  poly-Inosine:poly-Cytidilic acid  
PVDF   Polyvinylidene difluoride 
P   Progesterone 
PGF -2  Prostaglandin 
PGE2    Prostaglandin  
PIBF   Progesterone induced blocking factor 
RIP1   Receptor Interacting Protein-1 
RANTES Regulated upon Activation Normal T-cell Expressed and 
Secreted
RNA   Ribonucleic acid 
RPMI   ‘’Roswell Park Memorial Institute’’ cell culture media 
STAT4  Signal-Transducing Activator -4 of Transcription  
STAT6  Signal-Transducing Activator -6 of Transcription  
ssRNA  single-stranded Ribonucleic acid 
sCD14 soluble CD14 (cluster of differentiation 14, cell surface 
marker protein, a pattern recognition receptor)
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sTLR2  soluble Toll-like receptor2 
S-AP   Streptavidin-Alkaline Phosphatase 
S-HRP Streptavidin-Horseradish Peroxidase 
TBK1   TANK Binding Kinase 1 
TCR    T cell receptor alfa (complex) 
TIRAP  TIR-Associated Protein 
TICAM 1  TIR-domain Containing Adaptor Molecule 1  
TRIF   TIR-domain containing adaptor protein inducing IFN-
TIMPs   Tissue Inhibitor(s) of MMP(s) 
TRAF-6  TNF Receptor Associated Factor-6  
TLR   Toll-like receptors  
TIR domain  Toll/IL1-Receptor like domain 
TGF-  / TGF-  Transforming Growth Factor -alfa and –beta 
TRAM   TRIF-related Adaptor Molecule  
TTBS    Tris-Buffered-Saline / Tween 20 mixtured buffer
TSCs   Trophoblast Stem Cells  
TNF    Tumor Necrosis Factor alfa
uPA   urokinase Plasminogen Activator   
uNKs   uterine Natural Killer cells
V 14   subtype of Natural killer T cells (mouse) 
VSV   Vesicular Stomatitis Virus 
ZO-1   Zonula Occludens-1 protein  
WB Western Blot
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